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General introduction 
 
Instead of simply analyzing naturally existing molecules, chemists began to synthesize 
organic compounds including molecules that did not exist in nature. The combination of this 
new synthetic approach with more traditional analytical approaches revolutionized chemistry, 
leading to a deep understanding of the fundamental principles of chemical structure and 
reactivity and to the emergence of the modern pharmaceutical and chemical industries. 
Natural products continue to play an important role in discovery and development of new 
pharmaceuticals, as clinically useful drugs, as starting materials to produce synthetic drugs, or 
as lead structures from which a synthetic drug can be designed.1 At the same time, synthetic 
compounds not related to natural products play an increasingly important role for drug 
discovery. Continuous improvements in synthetic methodology have provided a convenient 
access to a vast array of synthetic substances. 
 
Bioactive products include, for example, antibiotic, anti-infective, anticancer, cardio-
vascular agents. The development of new antimicrobial agents represents an important field in 
medicinal chemistry, due to the increasing problem of the formation of resistant strains of 
bacterial pathogens. Natural products often represent important lead structures for the 
development of new antibiotics.2 In fact, a number of natural products exhibit antibiotic 
activity. Since the discovery of penicillin, a large number of antibiotics have been isolated 
from scores of microorganisms.3 The discovery of new important anti-infective compounds 
includes both plant and animal sources. For example, astemisinin, a sesquiterpene with 
endoperoxide moiety, was isolated from Astemisia annua, a Chinese medicinal plant, which 
has been used in China for centuries for treatment of malaria. Subsequent efforts included the 
development of astemisinin derivatives with more desirable pharmaceutical properties. The 
development of new drugs includes synthetic and semi-synthetic studies, microbial 
transformations, the biological screening and the study of the mechanism of action.4 The 
effort to design better anti-malaria agents has also led to the discovery of other antimicrobial 
agents including a class of synthetic antibacterial products that is in clinical use today - the 
fluoroquinolones. 
 
In the chemotherapy of cancer, natural products have provided the most important success. 
A number of anticancer drugs represent unmodified natural products isolated from plants or 
microorganisms:5 this includes bleomycin, doxorubicin, mitomycin, paclitaxel (TaxolTM); 
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examples of semi-synthetic derivatives of natural products, which are important anticancer 
drugs are, for example, ironotecan (a camptothecin derivative), etoposide or tenoposide (a 
podophyllotoxin derivative). Currently, both a semi-synthetic derivative with improved water 
solubility, docetaxel (TaxoteneTM) and paclitaxel (TaxolTM) are approved and used clinically 
in the treatment of ovarian breast cancers. 
 
Many important drugs have been developed by a combination of natural product and 
synthetic chemistry. In this context, combinatorial chemistry provides an ever-increasing pool 
for evaluation of therapeutic potential; advances in molecular biology will provide insights 
into the biological processes and, hence, possible targets for the treatment of disease. 
Bioactive natural products can serve as probes to study these molecular and pharmacological 
processes.6 
 
My studies are focused on the development of new and reliable synthetic strategies and 
their application to the preparation of natural products and pharmacologically active carba- 
and heterocycles.  
 
In the present thesis, the synthesis of natural product analogues is studied. These structures 
include salicylates, diary ethers, resorcins, dihydroisocoumarins, 4,5-diary-1,2,3-
benzenetricarboxylates and 1,2,3-triazoles. 
 
Summary  
 
A significant part of the present dissertation has been recently published. Each chapter 
contains the content of one publication and the text and schemes of these publications were 
directly used for writing the thesis. The thesis can be summarized as follows: 
 
1. Efficient synthesis of salicylates by catalytic [3+3] cyclizations of 1,3-bis(silyl enol 
ethers) with 1,1,3,3-tetramethoxypropane. This chapter includes the synthesis of novel alkyl-
substituted 1,3-bis(silyl enol ethers) 4a-v based on the known procedures. The 1,3-bis(silyl 
enol ethers) are used as starting materials for the synthesis of salicylates by catalytic [3+3] 
cyclization with 1,1,3,3-tetramethoxypropane. 
2 Synthesis of diaryl ethers based on one-pot [3+3] cyclizations of 1,3-bis(silyl enol 
ethers). This chapter includes the synthesis of diary ethers 15a-u which were prepared by 
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formal [3+3] cyclocondensation of  2-aryloxy-3-(silyloxy)alk-2-en-1-one 14a-i with 1,3-
bis(silyl enol ethers) 4. By using this methodology I successfully synthesized highly 
functionalized diaryl ethers which are not readily available by other methods. 
3. Regioselective synthesis of functionalized resorcins by cyclization of 1,3-
bis(trimethylsilyloxy)-1,3-butadienes with 3,3-dimethoxypentanoyl chloride. In this chapter, I 
have described the regioselective synthesis of fuctionalized resorcins by formal [3+3] 
cyclocondensation of 1,3-bis(silyl enol ethers) 4 with 3,3-dimethoxypentanoyl chloride. The 
effect of Lewis acids (Me3SiOTf and TiCl4) on the regioselectivity of resorsins studied in this 
chapter. 
4  Synthesis of 3-aryl-3,4-dihydroisocoumarins by regioselective  domino ′[3+3] 
cyclization / lactonization′ reactions of 1,3-bis-(silyloxy)-1,3-butadienes with 1-hydroxy-5-
silyloxy-4-en-3-ones. This chapter includes the synthesis of 3-aryl-3,4-dihydroisocoumarins 
(3-aryl-isochroman-1-ones) by regioselective domino ′[3+3] cyclization/lactonization′ 
reactions of 1,3-bis-(silyloxy)-1,3-butadienes 4 with 1-hydroxy-5-silyloxy-4-en-3-ones. 3-
aryl-3,4-dihydroisocoumarins are of considerable pharmacological relevance and occur in 
many natural products.  
5. Synthesis of 4,5-diaryl-1,2,3-benzenetricarboxylates by reaction of 4-hydroxycyclopent- 
2-en-1-one-2-carboxylates with dimethyl acetylenedicarboxylate. This chapter includes the  
synthesis synthesis of 4-hydroxycyclo-2-penten-1-one-2-carboxylates 33a-j by cyclization of  
1,2-diketones with 1,3-dicarbonyl dianions and their conversion to novel 4,5-diaryl-1,2,3- 
benzenetricarboxylates 34a-i by acid-mediated reaction with dimethyl acetylenedicarboxylate. 
 
6. Regioselective synthesis of 1-(2,2-dimethoxyethyl)-1,2,3-triazoles by copper(I)-
catalyzed [3+2] cyclization of 2-azido-2,2-dimethoxyethane with alkynes. In this chapter, I 
have described the regioselective synthesis of 1-(2,2-dimethoxyethyl)-1,2,3-triazoles 40a-k by 
copper(I)-catalyzed [3+2] cyclization of 2-azido-2,2-dimethoxyethane with alkynes. 2-Azido-
1,1-dimethoxyethane (ADE) represents a small, but versatile C2-building block containing a 
masked aldehyde and a masked amino group. It can be readily prepared by reaction of 1-
chloro- or 1-bromo-2,2-dimethoxyethane with sodium azide. 
 
8. This chapter includes the experimental, spectroscopic data and full characterization of 
all new products has been described. 
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1.     Efficient synthesis of salicylates by catalytic [3+3] cyclizations of  
1,3-bis(silyl enol ethers) with 1,1,3,3-tetramethoxypropane 
 
1.1 Synthesis of 1,3-bis(trimethylsilyloxy)buta-1,3-dienes 
 
1.1.1 Introduction 
 
Dianions represent important building blocks for the regioselective formation of carbon-
carbon bonds. Ambident dianions are organic substrates containing two delocalized negative 
charges. Dianions can be generated by reaction of 1,3-dicarbonyl compounds in the presence 
of strong base, such as LDA or n-BuLi7. The functionalization of the terminal carbon atom of 
1,3-dicarbonyl compounds by reaction of the corresponding dianions with electrophiles 
represents an important synthetic method which has been used in the synthesis of natural 
products. The terminal carbon atom of the dianion can be regioselectively coupled with one 
equivalent of an electrophile E+ to give a monoanion which can be subsequently trapped by 
addition of a second electrophile. Two general mechanistic pathways for cyclization reactions 
of dianions can be discussed as follows7 (Scheme 1-1): 
 
OEt
O O
Mechanism
Type A
Mechanism
Type B
OEt
O O
E
Nu- E Nu
O
O
H2O
E Nu
O
O
OEt
O O
E
E+
E E
O
OEt
O
O
E E
OEt
O
or
E+ Nu-
E+ E+
 
Scheme 1-1: Possible mechanistic pathways for cyclization reactions of 1,3-dicarbonyl 
dianions. Nu = nucleophile center, E = electrophile center 
 
Mechanism type A: the dianion can react with monofunctional electrophiles with 
transposition of a negative charge from the dianion to the electrophile. This carbanion attacks 
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an E+ centre of the former dianion moiety (e.g. the ester group) to give a cyclic monoanion 
which is subsequently quenched with water. 
Mechanism type B: the dianion can react as a dinucleophile with a dielectrophile. A 
monoanion is formed, followed by attack of the latter onto a second E+ center. 
 
Cyclization reactions of dianions with dielectrophiles are synthetically useful. However, 
problems can arise since both starting materials are highly reactive compounds which have 
low reactivity matching. In addition, 1,2-dielectrophiles are often rather labile, and reactions 
with nucleophiles can result in polymerization, decomposition, formation of open-chained 
products, elimination or SET-process. These intrinsic limitations can be overcome by two 
ways: a) a proper tuning of the reactivity of dianion and dieletrophile and b) the use of 
eletroneutral dianion equivalents (masked dianions) in Lewis acid catalyzed reactions.7 
 
Many studies proved that 1,3-bis-enol silyl ethers can be considered as equivalents of the 
corresponding 1,3-dicarbonyl dianions.8 The chemistry of bis-silyl enol ethers has been 
developed during the last two decades.8d It is, for example, known that enol silyl ethers can 
condense with various carbonyl compounds in the presence of Lewis acids.9 These Lewis-
acid-mediated reactions10 (e. g. alkylation and aldol condensation) provide useful alternatives 
to classical enolate chemistry. In cyclization reactions, 1,3-bis-silyl enol ethers can react as 
1,3-dinucleophiles or, similar to the well-known Danishefsky diene11, as functionalized 
butadienes. 1,3-Bis-silyl enol ethers undergo reactions with electrophiles at the terminal 
carbon atom followed by reaction of the central carbon or the oxygen atom. Enol silyl ethers 
can be cleaved with nucleophiles such as MeLi, LiNH2 or R4N+F- to give enolates. They can 
be reacted with halides (Br2, Cl2, I2) or pseudohalides (PhSCl, PhSeCl, Cl-N=O).12 Whereas 
enolates can be alkylated only by primary or secondary halides, enol silyl ethers can be 
alkylated by tertiary halides.13  
The preparation of silyl enol ethers mainly follows the procedures reported by Chan and 
Molander. These syntheses rely on the preparation of mono-silyl enol ethers which are 
subsequently transformed into bis-silyl enol ether by deprotonation with LDA and subsequent 
silylation.14 
In this chapter, we present the synthesis of novel 4 substituted 1,3-bis(trimethylsilyoxy)-
1,3-butadiens following the procedure of Chan. 
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1.1.2 Results and discussion 
 
Following the procedures of Chan and Molander, 1,3-bis(trimethylsilyloxy)-1,3-butadiene 
4a can be prepared from the respective 1,3-dicarbonyl compound 2a in two steps. Treatment 
of the β-ketoester with NEt3, Me3SiCl afforded silyl enol ether 3a Deprotonation of the latter 
with LDA and subsequent addition of Me3SiCl afforded the diene 4a. Simchen et al. reported 
that 1,3-diketone derived bis-silyl enol ethers can be prepared in one step by treatment of an 
ether solution of the diketone with NEt3 and Me3SiOTf (2.0 equivalent)8 (Scheme 1-2). 
 
OEt
OMe3SiO
OEt
O O
OEt
OSiMe3Me3SiO
3a 4a2a
i ii
 
 
Scheme 1-2: Synthesis of 1,3-bis-silyl enol ether 4a; i) 1) NEt3 (1.5 equiv.); 2) Me3SiCl 
(1.5 equiv.), C6H6, 20 °C, 12 - 48 h; ii) 1) LDA (1.5 equiv.), THF, 0 °C, 2 h; 2) Me3SiCl 
(1.5 equiv.), –78 → 20 °C, 6 - 12 h. 
 
The synthesis of alkyl-substituted-1,3-bis-silyl enol ether derivatives requires the synthesis 
of the respective β-ketoesters 2h-w. It is known that the regioselectivities of the reactions of 
monoanions and dianions generally differ greatly. 1,3-Dicarbonyl  monoanions are generally 
alkylated at the central carbon or at the oxygen atom, whereas the formation of dianions 
allows the functionalization of the terminal carbon atom. Based on this, the 4-alkyl-3-
oxobutanoates 2h-w were prepared by reactions of the dianion of ethyl acetoacetate with the 
respective alkylhalides 1a-l (RI, RBr). These compounds were transformed, according to a 
known procedure,8 into the desired 1,3-bis-silyl enol ethers 4h-w via the respective mono-
silyl enol ethers 3h-w (Scheme 1-3, Table 1-1).  
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Scheme 1-3: Synthesis of alkyl-substituted 1,3-bis-silyl enol ether derivatives; i: 1) 2.5 LDA, 
THF, 0 °C, 1 h; 2) 1a-l, –78 → 20 °C; ii: Me3SiCl (1.5 equiv.), NEt3 (1.5 equiv.), C6H6, 20 
°C, 48 h; iii: 1) LDA (1.5 equiv.), THF, –78 °C, 1 h; 2) Me3SiCl (1.5 equiv.), 20 °C, –78 → 
20 °C. 
 
All 4-alkyl-1,3-bis-silyl enol ethers prepared could be stored at suitable conditions (-20 oC, 
dry, inert gas atmosphere) for several months without decomposition. The 1,3-bis-silyl enol 
ethers 4 used in this thesis are listed in the following table. 
 
OSiMe3
R2
Me3SiO
R1
4
 
Table 1-1: 1,3-bis(silyl enol ethers) 4 used in this thesis 
4 R1 R2
a H OEt 
b H OMe 
c H O(CH2)2OMe 
d H Bn 
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1.1.3 Conclusions 
 
The application of a the known procedure allows the synthesis of novel 4-alkyl-1,3-
bis(silyl enol ethers). These masked dianions are used in the cyclization reactions for 
synthesis of heterocycles and aromatic rings - important building blocks of natural products 
analogue. 
 
 
 
 
 
 
e H OiPr 
f Me OEt 
g Et OEt 
h nBu OMe 
i iBu OMe 
j nHex OEt 
k nHex OMe 
l nHep OMe 
m nOct Et 
n nOc OMe 
o nDec Et 
p CH2Ph OMe 
q OMe OMe 
r OtBu OEt 
s (CH2)2Ph OMe 
t (CH2)3Ph OMe 
u 
v 
(CH2)3Cl 
(CH2)6Cl 
OMe 
    OMe 
w 
x 
Allyl 
H 
OMe 
Me 
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1.2 Synthesis of salicylates 
 
1.2.1 Introduction 
 
Salicylic acid derivatives are widespread in nature and are of considerable relevance in 
medicinal chemistry.15 Synthetic approaches to salicylates mainly rely on the 
functionalization of phenols by electrophilic substitutions. The preparative scope of this 
approach is often limited by the formation of regioisomeric mixtures and by the availability of 
the starting materials. Salicylates are available also by base-mediated cyclization reactions of 
dimethyl acetone-1,3-dicarboxylate (DMAD) with 1,3-diketones,16 yn-ones and yn-als.17 The 
scope of these transformations is limited by the fact that a symmetrical, highly activated 1,3,5-
tricarbonyl compound has to be employed. Barton et al. reported the synthesis of ethyl 5-
ethylsalicylate by cyclization of the dianion of ethyl acetoacetate with 3-(N,N-
dimethylamino)-2-ethylacrolein.18 Functionalized phenols are available also by [4+2] 
cycloaddition of 1-methoxy-3-trimethylsilyloxy-1,3-butadiene (Danishefsky’s diene),19, 20 1-
methoxy-1,3-bis(trimethylsilyloxy)-1,3-butadiene (Chan’s diene)21 , 1,4-di(methoxy)-1,3-
bis(trimethylsilyloxy)-1,3-butadiene (Brassard’s diene) or related dienes.22 
 
The titanium tetrachloride (TiCl4) mediated formal [3+3] cyclization of 1,3-bis(silyl enol 
ethers)23 with 3-siloxy-2-en-1-ones provides a convenient approach to a variety of 
functionalized salicylates.24, 21a,b In addition, TiCl4 mediated cyclizations of 1,3-bis(silyl enol 
ethers) with 1,1,3,3-tetramethoxypropane and related bis(acetals) were reported21a,b,25,26. All 
these transformations rely on the employment of stoichiometric amounts of Lewis acid. 
Herein, I report what are, to the best of my knowledge, the first catalytic [3+3] cyclizations of 
1,3-bis(silyl enol ethers) with 1,1,3,3-tetramethoxypropane. These reactions provide a 
convenient approach to a variety of functionalized salicylates under mild conditions. Notably, 
the products are not directly and readily available by other methods.  
 
1.2.2 Results and discussion 
 
The trimethylsilyl-trifluoromethanesulfonate (Me3SiOTf) catalyzed condensation of silyl 
enol ethers with acetals, introduced by Noyori et al.,27 has found a number of applications in 
organic synthesis. Recently, Langer et al. reported the Me3SiOTf catalyzed condensation of 
1,3-bis(silyl enol ethers) with 1-chloro-2,2-dimethoxyethane28 and 2-azido-1,1-
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dimethoxyethane, respectively.29 The reaction of 1-ethoxy-1,3-bis(trimethylsilyloxy)-1,3-
butadiene (4a) with 1,1,3,3-tetramethoxypropane (5), in the presence of a catalytic amount of 
Me3SiOTf (0.1 equiv.), afforded ethyl 2-methoxybenzoate (6a) in up to 55% yield (Scheme 1-
4, Tables 1-3 and 1-4). During the optimization (Table 1-2), the work-up procedure (10% 
HCl), the temperature (−78 → 20 °C, 6-12 h; then 20 °C, 2-6 h), and the concentration (ca. 15 
mL of CH2Cl2 per 1 mmol of 4a) proved to be important parameters. The use of 
tetraethoxypropane proved to be unsuccessful. The amount of Me3SiOTf could be reduced to 
0.1 equiv. without decrease of yield. The use of trifluoroacetic acid (rather than Me3SiOTf) 
failed to give the desired product.  
 
The Me3SiOTf catalyzed cyclization of 5 with 1,3-bis(silyl enol ethers) 4a-d, prepared 
from ethyl, methyl, methoxyethyl and benzyl acetoacetate, afforded the 2-methoxybenzoates 
6a-d. Their formation can be explained by the mechanism depicted in Scheme 1-4: the 
Me3SiOTf catalyzed attack of the terminal carbon atom of 4 onto 5 gave intermediate A. The 
subsequent Me3SiOTf catalyzed cyclization afforded intermediate B which underwent a shift 
of the double bond to give intermediate C. Extrusion of water and methanol from C afforded 
the final product. Notably, the formation of a 2-hydroxybenzoate was not observed. The 
mechanism is supported by the isolation of a small amount of 3,5-dimethoxycyclohexanone. 
The formation of this side-product can be explained by cleavage of the ester group of 
intermediate C and decarboxylation. 
 
Table 1-2: Optimization of the synthesis of 6a 
entry 4a/5 Me3SiOTf CH2Cl2 a work-up % (6a) b 
1 1:1 0.3 eq. 2 NaHCO3 32 
2 1:1 0.3 eq. 15 NaHCO3 35 
3 1:1 0.3 eq. 15 10% HCl 54 
4 1:1 0.3 eq. 50 10% HCl 45 
5 1:1.1 0.1 eq. 15 10% HCl 55 
a mL (CH2Cl2) / mmol (4a); b yields of isolated products 
 
 
 11
OR
O
OR
OSiMe3Me3SiO
MeO OMe
OMeOMe
i4a-d
5
6a-d
MeO OMe
OMe
Me3SiO O
OR
MeO OMe
OH O
OR
MeO OMe
OH O
OR
OMe
+
+ 4a H+, H2O
C
[Me3SiOTf]
A
B
 
Scheme 1-4: Cyclization of 1,3-bis(silyl enol ethers) 4a-d with 1,1,3,3-tetramethoxypropane, 
i: 1) Me3SiOTf (0.1 equiv.), CH2Cl2, –78 → 20 °C; 2) HCl (10%) 
 
Table 1-3: Synthesis of 6a-d 
6 R % (6) a 
a Et 55 
b Me 32 
c (CH2)2OMe 30 
d Bn 40 
a Yields of isolated products 
 
The Me3SiOTf catalyzed cyclization of 1,3-bis(silyl enol ether) 4f, prepared from ethyl 3-
oxopentanoate, afforded ethyl 3-methylsalicylate (i. e. ethyl 3-methyl-2-hydroxybenzoate) 
(7a) (Scheme 1-5, Table 1-4). Notably, the formation of ethyl 5-methyl-2-methoxybenzoate 
was not observed. The formation of 7a can be explained, in analogy to the formation of 6a-d, 
by attack of 4f onto 5 to give intermediate D and subsequent cyclization to give E (which 
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correspond to intermediates A and B shown in Scheme 1-4). Intermediate E undergoes a rapid 
extrusion of two molecules of methanol (rather than a shift of the double bond as discussed 
for the formation of 6a-d). In fact, the presence of the substituent R1 seems to enhance the rate 
of the elimination of methanol from intermediate E. 
 
The Me3SiOTf catalyzed cyclization of 5 with 1,3-bis(silyl enol ethers) 4f-v afforded the 
salicylates 7a-n. The cyclization of 5 with 1,4-di(methoxy)-1,3-bis(trimethylsilyloxy)-1,3-
butadiene (4q) gave salicylate 7m containing a protected and a non-protected hydroxy group. 
Ethyl 2,3-dihydroxysalicylate (7n) was prepared from 1-ethoxy-4-(tert-butoxy)-1,3-
bis(trimethylsiloxy)-1,3-butadiene (4r). The tert-butyl group was cleaved during the reaction. 
The Me3SiOTf catalyzed cyclization of 5 with 1,3-bis(silyl enol ethers) derived from 1,3-
diketones (e. g. acetylacetone and benzoylacetone) proved to be unsuccessful (formation of 
complex mixtures). 
 
OSiMe3Me3SiO
OR2
R1
MeO OMe
MeO OMe
OH
OR2
O
R1
i
4f-u 7a-n
5
OH
OR2
O
R1
E
MeO OMeMeO OMe
OMe
Me3SiO O
OR2
D
R1
 
 
Scheme 1-5: Cyclization of 1,3-bis(silyl enol ethers) 4f-r with 1,1,3,3-tetramethoxypropane, 
i: 1) Me3SiOTf (0.1 equiv.), CH2Cl2, –78 → 20 °C; 2) HCl (10%)  
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Table 1-4: Synthesis of 7a-n 
4 7 R1 R2 % (7) a 
f a Me Et 45 
g b Et Et 40 
h c nBu Me 60 
i d iBu Me 45 
j e nHex Et 50 
l f nHept Me 59 
m g nOct Et 56 
o h nDec Et 54 
v i (CH2)6Cl Me 67 
n j (CH2)2CH=CH2 Me 63 
p k CH2Ph Me 57 
t l (CH2)3Ph Me 61 
q m OMe Me 32 
r n OH Et 27 b 
    a Yields of isolated products; b from 4r (R1 = OtBu) 
 
1.2.3 Conclusions 
 
In conclusion, a variety of salicylates were prepared by Me3SiOTf catalyzed formal [3+3] 
cyclization of 1,3-bis(silyl enol ethers) with 1,1,3,3-tetamethoxypropane. The use of 1,3-
bis(silyl enol ethers) 4a-d, containing no substituent at carbon atom C-4, resulted in the 
formation of 2-methoxybenzoates 6a-d. The best yield was obtained for salicylate 6a. The 
yields depend on the quality of the silyl enol ether and on the handling of each individual 
experiment. 2-Hydroxy- rather than 2-methoxybenzoates were generally formed when 1,3-
bis(silyl enol ethers) 4, containing a substituent located at carbon atom C-4, were employed. 
The best yields were obtained for alkyl-, ω-chloroalkyl-, ω-phenylalkyl-, and thiophenoxy-
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substituted 1,3-bis(silyl enol ethers)  4h-o, 4v, 4n, 4p and 4t. The method reported provides a 
convenient approach to salicylates under mild conditions. 
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2. Synthesis of diaryl ethers based on one-pot [3+3] cyclizations of 1,3-
bis(silyl enol ethers)  
 
2.1 Introduction 
 
Diaryl ethers containing an ester or carboxylic acid function constitute an import subgroup 
of the pharmacologically important substance class of diaryl ethers.15 They occur in a number 
of natural product, such as geodinhydrate methylester and methyl chloroasterrate,30a,b 1-
desgalloylsanguiin,31 dehydrotrigallic acid 8,32  epiphorellic acid 9,33 jolkianin,34 remurin A,35  
or micareic acid 10.36 Diaryl ethers are available by classic Ullmann reactions and related 
methods.37 In recent years, the Buchwald-Hartwig reaction and related transformations proved 
to be versatile methods for the synthesis of diaryl ethers.38 Recently, Beller et al. reported the 
transition metal catalyzed coupling of phenols with aryl chlorides.39 Despite their great 
synthetic utility, the scope of all these methods is limited by the availability of the starting 
materials. In fact, the synthesis of more complex aryl halides or triflates by regioselective 
functionalization of arenes is often a difficult task. In addition, the transition metal catalyzed 
formation of diaryl ethers containing a sterically encumbered ether linkage often proceeds in 
low yield or not at all.  
 
O
CO2Me
HO
C5H11
OMe
OH
C5H11O
O
CO2H
OH
OHOH
HO
CO2HHO
HO
OH
CO2H
O nHep
OMe
CO2H
nHep
HO2C
HO
9
10
8
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The formal [3+3] cyclization of 1,3-bis(silyl enol ethers)23a with 3-(siloxy)alk-2-en-1-ones 
provides a versatile method for the synthesis of functionalized arenes.23b Recently, Langer et 
al. reported the application of this method to the synthesis of functionalized diaryl ethers.40 
Herein, I report full details of these studies. With regard to our preliminary communication,40 
the preparative scope has been significantly extended. Our method relies on assembly of one 
of the two arene moieties (in contrast to transition metal catalysed C-O coupling reactions). 
Notably, functionalized and sterically encumberd diaryl ethers, which are not readily available 
by other methods, can be prepared.  
 
2.2 Results and discussion 
 
3-(Phenoxy)pentane-2,4-diones 13a-i were prepared, following a known procedure,41 by 
potassium carbonate mediated reaction of phenols 11a-i with 3-(chloro)pentane-2,4-dione 
(12). The synthesis of derivatives 13a and 13d was previously reported.41 The silylation21c of 
13a-i afforded the novel 2-aryloxy-3-(silyloxy)alk-2-en-1-ones 14a-i (Scheme 2-1, Table 2-
1). Only moderate to low yields were obtained for 13a-i. The silylation proceeded in very 
good yields. 
 
Me Me
O O
Cl
Me Me
O O
O
Me Me
Me3SiO O
O
14a-i
i
11a-i
ii
13a-i
12
R3
R2
R1
R2
R1R3
OH
R2
R1R3
For substituents
R1 - R3: see Table 2.1
 
Scheme 2-1: Synthesis of 14a-i, i: K2CO3, acetone, 2 h, reflux; ii: Me3SiCl, NEt3, C6H6, 20 
°C, 72 h 
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 Table 2-1: Synthesis of 13a-i and 14a-i 
13,14 R1 R2 R3 % (13)a  %(14)a 
a H H H - b 91 
b Me H Me 20 94 
c H Et H 35 80 
d H Cl H - b 96 
e H OMe H 24 95 
f OMe OMe H 40 97 
g H Br H 25 84 
h H CN H 25 82 
i H CH2CO2Me H 26 87 
a Yields of isolated products; b commercially available 
 
The TiCl4 mediated cyclization of 2-aryloxy-3-(silyloxy)alk-2-en-1-one 14a-i with 1,3-
bis(silyl enol ethers) 4 afforded the diaryl ethers 15a-u in moderate to good yields (Scheme 2-
2, Table 2-2). The reactions were carried out following a typical procedure previously 
reported for related [3+3] cyclizations.23b The best results were obtained when stoichiometric 
amounts of the starting materials and of TiCl4 were used. The latter was added to a 
dichloromethane solution of the starting materials at –78 °C with subsequent warming of the 
mixture to 20 °C. The high concentration of the solution (only 2 mL of solvent per 1 mmol of 
starting material) proved to be a very important parameter. The yields significantly decreased 
when the reactions were carried out in more dilute solutions. The quality of the starting 
materials, reagents and solvent also played an important role.  
 
Notably, the presence of functional groups (chloride, bromide, cyano, ester or methoxy 
groups) proved to be – in principle - compatible with the reaction conditions. A variety of 
functionalized diaryl ethers (15h-u) were successfully prepared without any decrease in yield 
compared to reactions of non-functionalized substrates. In most of the cyclization reactions, 
β-ketoester derived 1,3-bis(silyl enol ethers) were employed. However, the use of 1,3-bis(silyl 
enol ether) 4x, prepared from acetylacetone, also proved to be successful. In contrast, 
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employment of 1,3-bis(trimethylsilyloxy)-1-phenyl-1,3-butadiene (derived from  
benzoylacetone) resulted in the formation of complex mixtures. This can be explained by its 
lower reactivity compared to β-ketoester derived 1,3-bis(silyl enol ethers). The cyclization of 
2-aryloxy-3-(silyloxy)alk-2-en-1-ones with 1,3-bis(silyl enol ethers) 15a, 15b, 15d, 15f, 15h, 
15i, 15l, 15s and 5u, containing an additional alkyl group attached to carbon atom C-4, 
afforded heavily substituted diaryl ethers in good yield. However, most derivatives (15a, 15b, 
15j, 15l and 15u) were obtained in relatively low yield. On the other hand, no decrease of the 
yield was observed in case of 15h and 15s. In conclusion, relatively low yields were obtained 
for diaryl ethers 15a-b, 15d, 15f, 15j, 15l, and 15u. The reason for this remains unclear at 
present, since considerably better yields were obtained for closely related derivatives. 
Therefore, the quality of the starting materials employed for each individual experiment 
seems to play an important role. 
 
The structures of diaryl ethers 15 were proved by spectroscopic methods. The structure of 
derivative 15c and 15o were independently confirmed by X-ray crystal structure analysis 
(Figure 2.1 and 2.2).84 
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Scheme 2-2: Synthesis of 15a-u: Reagents and conditions: i: TiCl4, CH2Cl2, –78 → 20 
°C,20h 
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 Table 2-2: Synthesis of 15a-u  
4 14 15 R1 R2 R3 R4 R5  %(15)a 
f a a H H H Me OEt 30 
g a b H H H Et OEt 32 
a b c Me H Me H OEt 58 
f b d Me H Me Me OEt 39 
a c e H Et H H OEt 60 
f c f H Et H Me OEt 36 
b d g H Cl H H OMe 54 
f d h H Cl H Me OEt 49 
g d i H Cl H Et OEt 43 
a e j H OMe H H OEt 30 
a f k OMe OMe H H OEt 58 
f f l OMe OMe H Me OEt 35 
a g m H Br H H OEt 58 
d g n H Br H H OCH2Ph 59 
a h o H CN H H OEt 50 
d h p H CN H H OCH2Ph 54 
a i q H CH2CO2Me H H OEt 50 
d i r H CH2CO2Me H H OCH2Ph 65 
j i s H CH2CO2Me H nHex OEt 54 
x i t H CH2CO2Me H H Me 55 
f e u H OMe H Me OEt 30 
a Yields of isolated products 
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              Figure 2.1: Ortep plot of 15c 
 
 
 
              Figure 2.2: Ortep plot of 15o 
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2.3 Conclusions 
 
In conclusion, a variety of functionalized and sterically encumbered diaryl ethers were 
prepared by formal [3+3] cyclizations of 1,3-bis(silyl enol ethers) with 2-aryloxy-3-
(silyloxy)alk-2-en-1-ones. A general rule for the influence of a specific substitution pattern of 
the starting materials on the yield of the reactions could not be observed. In contrast, the 
quality of the starting materials employed for each individual experiment seems to play an 
important role. 
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3. Regioselective synthesis of functionalized resorcins by cyclization of 
1,3-bis(trimethylsilyloxy)-1,3-butadienes with 3,3-dimethoxypentanoyl 
chloride 
 
3.1 Introduction 
 
A great variety of pharmacologically important natural products are biosynthetically 
derived from poly(β-oxo)carboxylic acids (polyketides).42 Harris and coworkers reported the 
biomimetic synthesis of various 1,3,5,7-tetracarbonyl compounds and their higher 
homologues based on condensations of 1,3-dicarbonyl dianions or 1,3,5-tricarbonyl trianions 
with esters and diesters, Weinreb amides, and salts of β-ketoesters.43,16e These products are 
unstable and rapidly undergo an intramolecular Aldol-condensation to give polyhydroxylated 
arenes present in many poylyketide-derived natural products. 1,3-Bis(trimethylsilyloxy)-1,3-
butadienes can be regarded as electroneutral equivalents of 1,3-dicarbonyl dianions (masked 
dianions).23 Chan and coworkers were the first to report the reaction of 1-methoxy-1,3-
bis(trimethylsiloxy)-1,3-butadiene with acetyl chloride.44 Salicylates were prepared by Lewis 
acid mediated [5+1] cyclization of 1-methoxy-1,3,5-tris(trimethylsiloxy)-1,3,5-hexatriene 
with acid chlorides and imidazolides.45 Langer et al. reported the reaction of 1,3-
bis(trimethylsilyloxy)-1,3-butadienes with various acid chlorides.46,47 γ-Alkylidenebutenolides 
are available by cyclization of 1,3-bis(silyl enol ethers) with oxalyl chloride48 and phthaloyl 
chloride.49 Recently, Langer et al. reported the synthesis of new 1,3,5,7-tetracarbonyl 
compounds by condensation of 1,3-bis(trimethylsilyloxy)-1,3-butadienes with methyl malonyl 
chloride.50 Herein, I report an efficient synthetic approach to functionalized resorcins based 
on what are, to the best of my knowledge, the first formal [3+3] cyclizations of 1,3-bis(silyl 
enol ethers) with 3,3-dimethoxypentanoyl chloride.51  
 
3.2 Results and discussion 
  
3,3-Dimethoxypentanoyl chloride was prepared in three steps as shown in Scheme 3-1. 
The Me3SiOTf-catalyzed reaction of 19 with 1,3-bis(trimethylsilyloxy)-1,3-butadienes 4, 
prepared from the corresponding β-ketoesters,23 afforded the 6-hydroxysalicylates 20a-m 
(Scheme 3-2, Table 3-1). The best yields were obtained when 0.5 equiv. of Me3SiOTf was 
employed. The yield decreased when the amount of Me3SiOTf was reduced. The use of more 
Lewis acid (1.0 equiv.) did not result in an increase of the yield. The formation of the 
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products can be explained by regioselective attack of the terminal carbon atom of the 4 onto 
the acetal and subsequent attack of the central carbon onto the acid chloride. The structures of 
resorcins 20a-m were proved by spectroscopic methods.   
 
Et
O O
OMe
O
OMe
OMe
MeO
Et
O
OH
OMe
MeO
Et
O
Cl
OMe
MeO
Et
16 17 (75%)
18 (62%)19 (85%)
i
ii
iii
 
 
Scheme 3-1: Synthesis of 19; i: HC(OMe)3 (6.0 equiv.), amberlite IR 120+; ii: NaOH, H2O, 
12 h, 20 0C; iii: (COCl)2, C6H6, 2 h, reflux 
 
Table 3-1: Synthesis of 20a-m 
4 20 R1 R2 %(20)a 
b a H Me 43 
a b H Et 47 
e c H iPr 56 
d d H CH2Ph 52 
c e H (CH2)2OMe 38 
f f Me Me 35 
i g Cl(CH2)3 Me 40 
h i nBu Et 50 
s j (CH2)2Ph Me 36 
q k MeO Me 34 
g 
w 
l 
m 
Et 
Allyl 
Et 
Me 
60 
36 
   a Yields of isolated products 
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Scheme 3-2: Synthesis of 20a-m; i: Me3SiOTf (0.5 equiv.), CH2Cl2, –78 → 20 °C 
 
The TiCl4-mediated reaction of 19 with 1,3-bis(trimethylsilyloxy)-1,3-butadienes 4 
afforded the 4-hydroxysalicylates 21a-j (Scheme 3-3, Table 3-2). The formation of products 
21 can be explained by regioselective attack of the terminal carbon atom of the 1,3-
bis(trimethylsilyloxy)-1,3-butadiene onto the acid chloride and subsequent attack of the 
central carbon atom onto the acetal. The structures of resorcins 21a-j were proved by 
spectroscopic methods. The structure of 21a independently confirmed by X-ray crystal 
structure analysis (Figure 3.1).84 
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Scheme 3-3: Synthesis of 21a-j; i: 1) TiCl4 (1.0 equiv.), CH2Cl2, –78 → 20 °C, 2) H2O 
Table 3-2: Synthesis of 21a-j 
4 21 R1 R2 %(21)a 
b a H Me 61 
a b H Et 40 
d c H CH2Ph 34 
c d H (CH2)2OMe 40 
f e Me Me 65 
i f iBu Me 66 
m g nOct Et 53 
l h nHep Me 57 
k 
t 
i 
j 
nHex 
(CH2)3Ph 
Me 
Me 
52 
46 
a Yields of isolated products 
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Figure: 3.1. Ortep plot of 21a 
Figure 3.2: ORTEP-plot of the hydrogen bonding scheme for 21a at the 50% level for the 
displacement ellipsoids  
 
3.3 Conclusions 
 
In conclusion, functionalized resorcins were prepared by cyclization of 1,3-
bis(trimethylsilyloxy)-1,3-butadienes with 3,3-dimethoxypentanoyl chloride. The 
regioselectivity depends on the type of Lewis acid employed. 
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4. Synthesis of 3-aryl-3,4-dihydroisocoumarins by regioselective  domino 
[3+3] cyclization/lactonization′ reactions of 1,3-bis-(silyloxy)-1,3-
butadienes with 1-hydroxy-5-silyloxy-4-en-3-ones 
 
4.1 Introduction 
 
3-Aryl-3,4-dihydroisocoumarins (3-aryl-isochroman-1-ones) are of considerable 
pharmacological relevance and occur in many natural products. For example, the natural 
products thunberginol C, D, and E (22, 23, 24) and related natural products have been 
reported to promote the adipogenesis of murine 3T3-L1 cells52a and show antiproliferative 
activity against mouse splenocytes.52b Hydrangenol 22 exhibits cytotoxic activity against 
human gastric cancer cell lines and human nasopharyngeal carcinoma cell lines.53 Related 
natural products54 have been reported to show antifungal activity,55 inhibition of rat basophilic 
leukemia RBL-2H3 cells,56 antiproliferative activity against C57/BL6 mouse splenocytes,57 
antiallergic activity,58 induction of steroidogenesis,59 phagocytic activity,60 
immunomodulatory activity on spleen lymphocyte proliferation (activated by 
lipopolysaccharide, concanavalin A, and phytohemagglutinin in mice),61 and antimicrobial 
activity.62 In a number of natural products, one of the hydroxyl groups of the 3-aryl-3,4-
dihydroisocoumarin core structure is glycosylated;63 this includes, for example, (-)-
hydrangenol 4'-O-glucoside,60 and phyllodulcin 8-O-glucoside.52a,62a  
 
O
OOH
22:Hydrangenol (R1 = H, R2 = H)
23:Thunberginol C (R1 = OH, R2 = H)
24:Thunberginol D (R1 = OH, R2 = OH)
OH
R1
R2
 
 
Chan and coworkers were the first to report24 the TiCl4-mediated [3+3] cyclization23b of 1,3-
bis(trimethylsilyloxy)-1,3-butadienes23a with 3-silyloxy-2-en-1-ones which allows a 
convenient synthesis of salicylates. In recent years, Langer et al. studied the application of 
this reaction to the synthesis of various functionalized arenes. 
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Recently, Langer et al. reported the synthesis of dibenzo[b,d]pyran-6-ones based on a 
[3+3] cyclization / lactonization strategy.64 Herein, I report what are, to the best of my 
knowledge, the first domino65 ′[3+3] cyclization / lactonization′ reactions of 1,3-bis(silyloxy)-
1,3-butadienes with 1-hydroxy-5-silyloxy-4-en-3-ones. These reactions proceed with very 
good regioselectivity and provide a convenient approach to 3-aryl-3,4-dihydroisocoumarins 
which are not readily available by other methods.  
 
4.2 Results and discussion 
 
The reaction of the dianion of acetylacetone (25) with aldehydes 26a-c afforded, following 
a known procedure,66 condensation products 27a-c (Scheme 4-1, Table 4-1). The NEt3-
mediated reaction of 27a-c with Me3SiCl resulted in chemoselective formation of 1-aryl-1-
hydroxy-5-silyloxy-4-en-3-ones 28a-c. Notably, a silylation of the hydroxy group was not 
observed.  
 
25 26a-c
i
27a-c
Me
O OH
R
O
Me
O OH
R
Me3SiO
Me Me
OO O
R
+
ii
28a-c  
 
Scheme 4-1: Synthesis of 1-aryl-1-hydroxy-5-silyloxy-4-en-3-ones 28a-c: i: 1), 2.5 LDA, 
THF, 1 h, 0 °C; 2), −78 → 20 °C, 14 h; 3) NaHCO3, H2O; ii: NEt3, Me3SiCl, CH2Cl2, 20 °C, 
14 h  
 
 
 
 
 
 
 
 
 30
Table 4-1: Synthesis of 1-hydroxy-5-silyloxy-4-en-3-ones 28a-c 
 
27,28 R %a %a 
a Ph 70 86 
b 4-MeC6H4 66 92 
c 4-ClC6H4 60 88 
a Yields of isolated products 
 
The TiCl4-mediated [3+3] cyclization of 28a with 1,3-bis(silyl enol ether) 4b, readily 
available from methyl acetoacetate,24 afforded the novel 6-(2-phenyl-2-chloroethyl)salicylate 
29a (Scheme 4-2). The best yield was obtained when the reaction was carried out in a highly 
concentrated solution. Notably, the cyclization proceeded with excellent regioselectivity. In 
fact, the formation of the regioisomeric 4-(2-phenyl-2-chloroethyl)salicylate was not 
observed. The formation of product 29a might be explained by reaction of TiCl4 with 28a to 
give intermediate A and hydrogen chloride. The conjugate addition of the (most reactive) 
terminal carbon atom of 4b to A afforded intermediate B which underwent a cyclization to 
give intermediate C. The reaction of HCl with the carbon atom attached to the phenyl group 
resulted in nucleophilic substitution and formation of intermediate D. The latter underwent 
aromatization to give intermediate E. Product 29a is formed upon aqueous work-up. 
Interestingly, the presence of the free hydroxy group of 28a seems to be important to achieve 
a high degree of regioselectivity. The presence of a methoxy rather than a hydroxyl group 
resulted in the formation of a mixture of regioisomers. 
 
Stirring of a solution of 29a in wet THF in the presence of silica gel afforded the 3-phenyl-
3,4-dihydroisocoumarin 30a in 69% yield (Scheme 4-3, Table 4-2). The formation of 30a can 
be explained by acid-mediated hydrolysis of the chloride and subsequent lactonization. 
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Scheme 4-2: Possible mechanism of the formation of 29a: i: 1) TiCl4, CH2Cl2, −78 → 20 °C, 
14 h; 2) NaHCO3, H2O 
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The [3+3] cyclization of 28a with 1,3-bis(silyloxy)-1,3-butadienes 4, containing an alkyl 
group attached to carbon atom C4, directly afforded the 3-phenyl-3,4-dihydroisocoumarins 
30b-d. The formation of 30b-d can be explained by [3+3] cyclization to give 6-(2-phenyl-2-
chloroethyl)salicylates which subsequently hydrolyzed and underwent a lactonization during 
the aqueous work-up or silica gel chromatography. This process can be regarded as a domino 
′[3+3] cyclization / lactonization′ reaction. The cyclization of 28a with 1,3-bis(silyloxy)-1,3-
butadienes 4q,w resulted in the formation of 6-(2-phenyl-2-chloroethyl)salicylates 29b,c 
which were transformed, by treatment with silica gel, into the 3-phenyl-3,4-
dihydroisocoumarins 30e,f. The cyclization of 28a with 1,3-bis(silyloxy)-1,3-butadienes 4a,e 
afforded the ethyl and isopropyl salicylates 29d,e. Notably, the SiO2-mediated lactonization 
proved to be unsuccessful for these substrates. The cyclization of 28b with 4b,f,h,w directly 
afforded the 3-(4-tolyl)-3,4-dihydroisocoumarins 30g-j. The reaction of 28b with 4d gave the 
benzyl salicylate 29f which could not be transformed into 30g. The cyclization of 4b with 28c 
directly afforded the 3-(4-chlorophenyl)-3,4-dihydroisocoumarin 30k. The reaction of 28c 
with 4d gave the benzyl salicylate 29g; its transformation into 30k proved to be unsuccessful. 
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Scheme 4-3: Synthesis of 29a-g and 30a-k: i: 1) TiCl4, CH2Cl2, −78 → 20 °C, 14 h; 2) 
NaHCO3, H2O, ii: SiO2, wet THF, 14 h 
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Table 4-2: Synthesis of 6-(2-aryl-2-chloroethyl)salicylates 29a-g and 3-aryl-3,4-
dihydroisocoumarins 30a-k 
4 28 29 30 R1 R2 Ar % (29)a % (30)a 
b a a a Me H Ph 52 69 
f a  b Me Me Ph 0 48 
g a  c Me Et Ph 0 33 
o a  d Me nDec Ph 0 54 
w a b e Me Allyl Ph 33 55 
q a c f Me OMe Ph 44 66 
a a d  Et H Ph 37 0 
e a e  iPr H Ph 40 0 
b b  g Me H 4-MeC6H4 0 41 
f b  h Me Me 4-MeC6H4 0 43 
h b  i Me nBu 4-MeC6H4 0 62 
w b  j Me Allyl 4-MeC6H4 0 35 
d b f  Bn H 4-MeC6H4 32 0 
b c  k Me H 4-ClC6H4 0 55 
d c g  Bn H 4-ClC6H4 34 0 
 
a Yields of isolated products 
 
The structures of all products were confirmed by spectroscopic methods. The structure of 29a 
was independently confirmed by X-ray crystal structure analysis (Figure 6.1).84 
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Figure 4.1: Ortep plot of 29a 
 
4.3 Conclusions 
 
In conclusion, I reported a convenient synthesis of 3-aryl-3,4-dihydroisocoumarins by 
domino ′[3+3] cyclization / lactonization′ reactions of 1,3-bis(silyloxy)-1,3-butadienes with 1-
hydroxy-5-silyloxy-4-en-3-ones. These reactions proceed by regioselective [3+3] cyclization 
to give 6-(2-aryl-2-chloroethyl)salicylates and subsequent silica gel-mediated lactonization. A 
smooth lactonization is observed for methyl, but not for ethyl, isopropyl and benzyl 
salicylates. We currently study the preparative scope of our methodology and applications to 
the synthesis of pharmacologically active natural products and their analogues. 
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5. Synthesis of 4,5-diaryl-1,2,3-benzenetricarboxylates by reaction of 4-
hydroxycyclopent-2-en-1-one-2-carboxylates with  
dimethyl acetylenedicarboxylate 
 
5.1 Introduction 
 
Functionalized arenes represent important building blocks in organic and medicinal 
chemistry.67 An important strategy for the synthesis of functionalized benzene derivatives 
relies on the [4+2] cycloaddition of 1,3-dienes with alkynes and subsequent oxidation.68 It is 
known for a long time that the reaction of alkynes with heterocyclic dienes such as furans 
results in the formation of bridged oxacycles which can be transformed into functionalized 
benzene derivatives by acidic hydrolysis.69 A related strategy has been reported for the 
cycloaddition of cyclopentadienones (fulvenones) with alkynes.70 These reactions proceed by 
cycloaddition and subsequent extrusion of carbon monoxide. The acid-mediated reaction of 
alkynes with 4-hydroxycyclo-2-cyclopenten-1-ones, which represent precursors of highly 
reactive fulvenones, has been reported to give benzene derivatives.71 Langer et al. have 
recently reported72 the synthesis of 4-hydroxycyclo-2-penten-1-one-2-carboxylates73 by 
cyclization of 1,2-diketones with 1,3-dicarbonyl dianions or 1,3-bis(silyl enol ethers) (masked 
dianions). Herein, I report the synthesis of a variety of new 4-hydroxycyclo-2-penten-1-one-2-
carboxylates and their transformation into novel 4,5-diaryl-1,2,3-benzenetricarboxylates by 
acid-mediated cycloaddition. 
 
5.2 Results and discussion 
 
The reaction of the dianion of methyl acetoacetate 31a with benzil (32a) regioselectively 
afforded 4-hydroxycyclo-2-penten-1-one-2-carboxylate 33a. The reactions were carried as 
one-pot transformations: the condensation of the dianion with 32a gave an open-chained 
product which underwent cyclization upon addition of silica gel to the reaction mixture and 
reflux. Notably, the cyclization exclusively afforded the hydroxylated product 33a and not the 
corresponding fulvenone (by elimination of a second equivalent of water). This can be 
explained by the unstable nature of the fulvenone, due to its antiaromatic character.  
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The reaction of 33a with dimethyl acetylenedicarboxylate (DMAD), in the presence of 
catalytic amounts of p-toluenesulfonic acid (PTSA, 5 mol-%), afforded 4,5-diphenyl-1,2,3-
benzenetricarboxylate 34a (Scheme 5-1, Table 5-1). During the optimization of this reaction, 
the choice of the acid played an important role. The use of conc. sulphuric acid or of Lewis 
acids (BF3⋅OEt2, TiCl4) resulted in decomposition. The formation of 34a can be explained by 
PTSA-catalyzed elimination of water from 33a to give a higly reactive fulvenone. The [4+2] 
cycloaddition of the latter with DMAD afforded a bridged cycloadduct which underwent 
extrusion of carbon monoxide and aromatization to give the final product.  
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Scheme 5-1: Synthesis of 4,5-diaryl-1,2,3-benzenetricarboxylates 34a-i, a: 1) LDA (2.3 equiv.), 
THF, 0 °C, 1 h; 2) 2, –78 → 20 °C, 12 h; 3) addition of SiO2, THF, reflux, 19-26 h; b: DMAD 
(8.0 equiv.), PTSA (5 mol-%), toluene, 100 °C 
 
The scope of the reaction was studied (Table 5-1). The reaction of the dianions of β-ketoesters 
31a-e with 1,2-diketones 32a-d regioselectively afforded the 4-hydroxycyclo-2-penten-1-one-
2-carboxylates 33a-j. The reaction of cyclopentenones 33 with dimethyl 
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acetylenedicarboxylate (DMAD), in the presence of catalytic amounts of p-toluenesulfonic 
acid (PTSA, 5 mol-%), afforded the 4,5-diaryl-1,2,3-benzenetricarboxylates 34a-i (Scheme 5- 
1, Table 5-1). These experiments show that the presence of bromide or methoxy groups 
located at the aryl groups is compatible with the reaction conditions. All reactions proceeded 
in moderate to good yields. The PTSA mediated reaction of DMAD with methyl 3,4-
dimethyl-4-hydroxycyclo-2-penten-1-one-2-carboxylate, prepared from butane-2,3-dione, 
resulted in formation of a complex mixture. Likewise, the reaction of 33a with maleic 
anhydride proved to be unsuccessful (decomposition).  
 
The structures of 33b, 33j, 34a and 34c were independently confirmed by X-ray crystal 
structure analysis (Figures 5.1, 5.2, 5.3 and 5.4).84 In case of 33c, the interesting side-product 
35 was isolated in low yield. The formation of 35, the structure of which was also confirmed 
by X-ray crystal structure analysis (Figure 5.5),84 can be explained by cyclization of 33c with 
benzil (32a) based on an aldol reaction and formation of a semi-ketal. 
 
Table 5-1: Products and yields 
31 32 33,34 R1 R2 Ar % (33)a % (34)a 
a a a H Me Ph 51 46 
b a b H Et Ph 60 46 
c a c H iPr Ph 41 b 46 
d a d Et Et Ph 55 c 33 d 
a b e H Me 4-MeC6H4 36 86 
c b f H iPr 4-MeC6H4 52 40 
a c g H Me 4-(MeO)C6H4 32 40 
c c h H iPr 4-(MeO)C6H4 47 46 
b 
e 
d 
a 
i 
j 
H 
H 
Et 
tBu 
4-BrC6H4 
Ph 
42 
48 
68 
0 
a Isolated yields; b besides, a small amount of 35 was isolated (vide infra); c mixture of 
diastereomers: dr = 1:1; d a small amount of impurity could not be separated 
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Figure 5.1: Ortep plot of 33b 
 
 
Figure 5.2: Ortep plot of 33j 
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Figure 5.3: Ortep plot of 34a 
 
 
Figure 5.4: Ortep plot of 34c 
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Figure 5.5: Ortep plot of 35 
 
The reaction of the dianion of N, N-diethyl-acetylacetic amide (31f) with 32a afforded the 
3-hydroxycyclo-4-penten-1-one-2-carboxylic amide 36 and not a 4-hydroxycyclo-2-penten-1-
one-2-carboxylic amide (as observed for 33a-j) (Scheme 5-2). The formation of the different 
positional isomers can be explained by the steric interaction between the phenyl and the 
(structurally rather rigid) amide group and by the relatively low electron-withdrawing effect 
of the amide (compared to the ester). The PTSA mediated cycloaddition of 36 with DMAD 
afforded phthalate 37. 
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Scheme 5-2: Synthesis of phthalate 7, a: 1) 2.3 LDA, THF, 0 °C, 1 h, 2) 2a, –78 → 20 °C, 12 h, 3)  
addition of SiO2, THF, reflux, 17 h; b: PTSA (5 mol-%), toluene, 100 °C, 10 h 
 
5.3 Conclusions 
 
 
In conclusion, an efficient synthesis of 4,5-diaryl-1,2,3-benzenetricarboxylates by 
cycloaddition of 4-hydroxycyclo-2-penten-1-one-2-carboxylates with dimethyl 
acetylenedicarboxylate was reported. 
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6. Regioselective synthesis of 1-(2,2-dimethoxyethyl)-1,2,3-triazoles by 
copper(I)-catalyzed [3+2] cyclization of 2-azido-2,2-dimethoxyethane 
with alkynes 
 
 
6.1 Introdution 
 
2-Azido-1,1-dimethoxyethane (ADE) represents a small, but versatile C2-building block 
containing a masked aldehyde and a masked amino group. It can be readily prepared by 
reaction of 1-chloro- or 1-bromo-2,2-dimethoxyethane with sodium azide.74, 75 Despite its 
structural simplicity and potential synthetic usefulness, there are only a few reports related to 
reactions of ADE. The reaction of ADE with p-toluenesulfonic acid in acetone and water 
afforded azidoacetic aldehyde. However, no yield and procedure was reported.76 Two pyrroles 
were prepared by TiCl4 mediated condensation of ADE with silyl enol ethers and subsequent 
reductive cyclization.77 Langer et al. reported the synthesis of functionalized 2-
alkylidenepyrrolidines and pyrroles based on Me3SiOTf catalyzed reactions of ADE with 1,3-
bis(silyl enol ethers) and subsequent cyclization by Staudinger-aza-Wittig reactions.75 The 
Staudinger-aza-Wittig reaction of 2-azido-1,1-diethoxyethane with 1,3-dicarbonyl compounds 
afforded 3-(1-aza-3,3-diethoxypropyl)alk-2-en-1-ones which were subsequently transformed 
into a variety of functionalized pyrroles.78 The Staudinger-aza-Wittig reaction of ADE with 
aldehydes was reported to give iminoacetals.74 Herein, I report what are, to the best of my 
knowledge, the first [3+2] cycloaddition reactions of ADE. These reactions provide a 
convenient approach to 1-(2,2-dimethoxyethyl)-1,2,3-triazoles. To the best of my knowledge, 
only one example of this type of molecule has been reported so far.79 I believe that the 
triazoles reported herein will be useful synthetic building blocks in organic and medicinal 
chemistry. In fact, 1,2,3-triazoles are emerging as powerful pharmacophores.80 
 
6.2 Results and discussion 
 
My starting point was the reaction of ADE (1) with dimethyl acetylenedicarboxylate. The 
reaction of an ethanol solution of the starting materials in a pressure tube (2 h, 120 °C) 
afforded 1,2,3-triazole 40a in excellent yield (Scheme 6-1). The structure of 40a was 
independently confirmed by X-ray crystal structure analysis (Figure 6.1).84 
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Scheme 6-1: Synthesis of 1,2,3-triazole 40a; i: EtOH, 2 h, 120 °C 
 
 
 
 
Figure 6.1: Ortep plot of 40a 
 
 
The thermal [3+2] cyclization of azides with terminal alkynes often suffers from low 
regioselectivities.81 Sharpless et al. reported the regioselective synthesis of 1,4-disubstituted 
1,2,3-triazoles by copper(I)-catalyzed [3+2] cyclization of azides with terminal alkynes.82 The 
reaction of ADE (38) and methyl propynoate (39b), dissolved in a 1:1 mixture of water and 
tert-butanol (2 h, 110 °C), gave 1-(2,2-dimethoxyethyl)-1,2,3-triazole 40b in excellent yield 
(Scheme 6-2, Table 6-1). Likewise, the cyclization of ADE with alkynes 39c-k afforded the 1-
(2,2-dimethoxyethyl)-1,2,3-triazoles 40c-k. All products were formed in excellent yields and 
with very good regio- and chemoselectivity. Notably, a number of different functional groups 
(acetal, hydroxyl, amino and trimethylsilyl groups) proved to be compatible with the reaction 
conditions. The structure of products 40b-k was confirmed by 2D NMR experiments. 
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Scheme 6-2: Synthesis of 1,2,3-triazoles 40b-k; i: Cu/CuSO4 (5 mol-%), H2O, tBuOH, 2 h, 
110 °C 
           Table 1. Products and yields 
40 R1 % a 
b CO2Et 84 
c Ph 75 
d (CH2)2OH 82 
e C(OH)Me2 84 
f CH(OH)Me 85 
g CH2N(CH3)2 66 
h nPet 63 
i nOct 80 
j N(Me)CH2Ph 72 
k SiMe3 88 
           
          a Yields of isolated products 
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Scheme 6-3: Synthesis of 1,2,3-thiadiazole 42; i: concd. HCl, EtOH, reflux, 12 h; ii: SOCl2, 
neat, 20 °C, 2 h 
The acetal group of 1-(2,2-dimethoxyethyl)-1,2,3-triazoles 40 can be further functionalized 
as exemplified by the following experiment. The reaction of 40c with tosylhydrazine in the 
presence of hydrochloric acid and subsequent treatment with thionyl chloride83 afforded 1,2,3-
thiadiazole 42 (Scheme 6-3).  
 
6.3 Conclusions 
In conclusion, an efficiend synthesis of 1-(2,2-dimethoxyethyl)-1,2,3-triazoles 40b-k by 
copper(I) catalyzed [3+2] cyclization of 2-azido-2,2-dimethoxyethane with alkynes with very good 
regio- and chemoselectivity was reported.   
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7. Abstract 
 
Regioselective cyclocondensation reactions of 1,3-bis(silyl enol ethers) with different mono(silyl enol 
ethers) provide an elegant approach for the synthesis of various complex carba- and heterocycles from 
simple starting materials. Salicylates, diarylethers, resorcins and 3-aryl-3,4-dihydroisocoumarins are 
prepared based on regioselective [3+3] cyclocondensation reactions of 1,3-bis(silyl enol ethers) with 
1,1,3,3-tetramethoxypropane, 2-aryloxy-3-(silyloxy)alk-2-en-1-ones, 3,3-dimethoxypentanoyl chloride 
and 1-hydroxy-5-silyloxy-4-en-3-ones respectively. In addition, 4,5-diaryl-1,2,3-
benzenetricarboxylates are prepared by reaction of 4-hydroxycyclopent-2-en-1-one-2-carboxylates 
with dimethyl acetylenedicarboxylate. In addition,  1-(2,2-dimethoxyethyl)-1,2,3-triazoles are 
prepared by regioselective copper(I)-catalyzed [3+2] cyclization of 2-azido-2,2-
dimethoxyethane with alkynes. 
 
Regioselektive Cyclokondensationsreaktionen von 1,3-Bis(silylenolethern) mit unterschiedlichen 
Mono(silylenolethern) ermöglichen einen eleganten Zugang zu vielen komplexen Carba- und 
Heterocyclen ausgehend von einfachen Startmaterialien. Salicylate, Diarylether, Resorcine und 3-
Aryl-3,4-dihydroisocoumarine wurden basierend auf regioselektiven [3+3] Cyclokondensationen von 
1,3-Bis(silylenolethern) mit 1,1,3,3-Tetramethoxypropan, 2-Aryloxy-3-(silyloxy)alk-2-en-1-onen, 3,3-
Dimethoxypentanoylchloriden und 1-Hydroxy-5-silyloxy-4-en-3-onen hergestellt. Außerdem wurden 
4,5-Diaryl-1,2,3-benzentricarboxylate durch Reaktion von 4-Hydroxycyclopent-2-en-1-on-2-
carboxylaten mit Dimethylacetylendicarboxylat hergestellt. 1-(2,2-Dimethoxyethyl)-1,2,3-triazole 
wurden durch regioselektive Kupfer(I)-katalysierte [3+2] Cyclisierung von 2-Azido-2,2-
dimethoxyethan mit Alkinen erhalten. 
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 General Scheme: Reactions of bis(silyl enol ethers) developed in this thesis (only one 
substitution pattern is shown for clarity). 
Reaktionen von Bis(silylenolethern) die im Rahmen dieser Arbeit entwickelt wurden (zur 
Klarheit wurde nur ein spezifisches Substitutionsmuster angegeben). 
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8. Experimental Section: 
 
8.1 General: Equipment, chemicals and work technique 
 
1H NMR Spectroscopy:  
Bruker: AM 250, Bruker ARX 300, Bruker ARX 500; δ = 0.00 ppm for Tetramethylsilane; δ 
= 2.04 ppm for Acetone d-6; δ = 7.26 ppm for (CDCl3); 2.50 ppm for d-6 DMSO-; 
Characterization of the signal fragmentations: s = singlet, d = doublet, dd = double of doublet, 
ddd = doublet of a double doublet, t = triplet, q = quartet, quint = quintet; sext = Sextet, sept = 
Septet, m = multiplet, br = broadly. Spectra were evaluated according to first order rule. All 
coupling constants are indicated as (J). 
 
13C NMR Spectroscopy: 
 Bruker: AM 250, (62.9 MHz); Bruker: ARX 300, (75 MHz), Bruker: ARX 500, (125 MHz)  
Ref: 29.84 ± 0.01 ppm and 206.26 ± 0.13 ppm for (CD3)2CO. δ = 128.00 ppm for Acetone d-
6; δ = 77.00 ppm for CDCl3. The multiplicity of the carbon atoms was determined by the 
DEPT 135 and APT technique (APT = Attached Proton Test) and quoted as CH3, CH2, CH 
and C for primary, secondary, tertiary and quaternary carbon atoms. Characterization of the 
signal fragmentations: quart = quartet the multiplicity of the signals was determined by the 
DEPT recording technology and/or the APT recording technology. 
 
Mass Spectroscopy: 
AMD MS40, AMD 402 (AMD Intectra),  Varian MAT CH 7, MAT 731. 
 
High Resolution mass spectroscopy:  
Finnigan MAT 95 or Varian MAT 311; Bruker FT 
CIR, AMD 402 (AMD Intectra). 
 
Infrared spectroscopy (IR):  
Bruker IFS 66 (FT IR), Nicolet 205 FT IR; Nicolet Protege 460, Nicolet 360 Smart 
Orbit  (ATR); KBr ,KAP, Nujol, and ATR; Abbreviations for signal allocations: w = weak, 
m = medium, s = strong, br = broad. 
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Elementary analysis:  
LECO CHNS-932, Thermoquest Flash EA 1112. 
 
X-ray crystal structure analysis:  
Bruker X8Apex Diffractometer with CCD-Kamera (Mo-Ka und Graphit Monochromator, 
λ = 0.71073 Å). 
 
Melting points:  
Micro heating table HMK 67/1825 Kuestner (Büchi apparatus); Melting 
points are uncorrected. 
 
Column chromatography:  
Chromatography was performed over Merck silica gel 60 (0,063 -0,200 mm, 70 - 230 mesh) 
as normal and/or over mesh silica gel 60 (0,040 - 0,063 mm, 200 -400 mesh) as Flash 
Chromatography. All solvent were distilled before use. 
 
TLC:  
Merck DC finished foils silica gel 60 F254 on aluminum foil and Macherey finished 
foils Alugram® Sil G/UV254. Detection under UV light with 254 nm and/or 366 nm without 
dipping reagent, as well as with anisaldehyde sulfuric acid reagent (1 mL anisaldehyde 
consisting in 100 mL stock solution of 85% methanol, 14% acetic acid and 1% sulfuric acid). 
 
Chemicals and work technique:  
All solvents for using were distilled by standard methods. All reactions were carried out under 
an inert atmosphere, oxygen and humidity exclusion. All of the chemicals are standard, 
commercially available from Merck®, Aldrich®, Arcos® and others. The order of the 
characterized connections effected numerically, but does not correspond to the order in the 
main part of dissertation. 
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8.2 Procedures and Spectroscopic Data: 
 
General procedure for the synthesis of salicylates 6a-d and 7a-n: 
 To a CH2Cl2 solution (100 mL) of 1,3-bis(trimethylsilyloxy)-1-ethoxy-1,3-butadiene (2.00 g, 
7.28 mmol) and of 1,1,3,3-tetramethoxypropane (1.32 mL, 8.01 mmol, 1.1 equiv.) was 
dropwise added TMSOTf (0.11 mL, 0.73 mmol, 0.1 equiv.) at −78 °C. The reaction mixture 
was warmed to 20 °C during 6-12 h. After stirring for 2-6 h at 20 oC, an aqueous solution of 
HCl (10%, 50 mL) was added. The organic and the aqueous layer were separated and the 
latter was extracted with CH2Cl2 (3 x 50 mL). The combined organic layers were dried 
(MgSO4), filtered and the filtrate was concentrated in vacuo. The residue was purified by 
chromatography (silica gel, heptane/ ethyl acetate) to give 6 a-d and 7 a-n .  
 
Ethyl 2-methoxybenzoate  (6a)  
Starting with 1,3-bis(silyl enol ether), 4a (2.00 g, 7.28 mmol), 
1,1,3,3-tetramethoxypropane 5 (1.32 mL, 8.01 mmol, 1.1 equiv.) and 
TMSOTf (0.11 mL, 0.73 mmol, 0.1 equiv.), 6a was obtained as a yellow oil 
(720 mg, 55%). 1HNMR (400 MHz, CDCl3): δ = 1.37 (t, 3J = 7.1 Hz, 3H, 
CH3), 3.89 (s, 3 H, OCH3), 4.35 (q, 3J =  7.1 Hz, 2H, OCH2), 6.95-6.99 (m, 2H, Ar), 7.43-7.47 
(m, 1H, Ar), 7.78 (dd, J = 7.8, 1.8 Hz, 1H, Ar); 13C NMR (100 MHz, CDCl3): δ = 14.3 (CH3), 
56.0 (OCH3), 60.8 (OCH2), 112.0, 120.1 (CHAr), 120.5 (C) , 131.5, 133.3 (CHAr), 159.0, 
166.1 (C); IR (neat, cm−1): ~ν  = 1725 (s), 1601 (m), 1491 (s), 1436 (s), 1302 (s), 1252 (s), 
1080 (m); MS (EI, 70 eV): m/z (%): 180 (M+, 24), 135 (100), 105 (20), 92 (20), 77 (38); 
HRMS (EI): calcd. for C10H12O3 [M]+: 180.078678; found:180.07919. 
 
Methyl 2-methoxybenzoate (6b) 
Starting with 1,3-bis(silyl enol ether), 4b (500 mg, 1.92 mmol), 
1,1,3,3-tetramethoxypropane 5  (0.32 mL, 2.11 mmol, 1.1 equiv.) and 
TMSOTf (0.01 mL, 0.57 mmol, 0.1 equiv.), 6b was obtained as a yellow 
oil (100mg, 32%). 1HNMR (400 MHz, CDCl3): 3.86 (s, 3 H, OCH3), 3.87 
(s, 3 H, OCH3), 6.92-6.97 (m, 2 H, ArH), 7.41-7.47 (m,1 H, ArH), 7.77 (dd, 1 H, J = 1.7, 7.8 
Hz, ArH); 13C NMR (100 MHz, CDCl3): δ = 51.89, 55.8 ( OCH3), 111.8 (CHAr), 119.8 (C), 
120.0, 131.5, 133.4 (CHAr). 158.9, 166.6 (C); GC-MS (EI, 70eV): m/z (%): 166.1 (M+, 29), 
135.1 (100), 105.1 (17), 92.1 (23), 77.1 (43). elemental analysis: Calcd. (%) for C9H10O3 
(166.17): C 65.05  H 6.07; Found C 64.88, H 6.11.  
OEt
O
OMe
OMe
O
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2-Methoxyethyl 2-methoxybenzoate (6c) 
Starting with 1,3-bis(silyl enol ether), 4c (1.50 g, 4.92 
mmol), 1,1,3,3-tetramethoxypropane 5 (0.98 mL, 5.41 mmol, 1.1 
equiv.) and TMSOTf (0.08 mL, 0.49 mmol, 0.1 equiv.), 6c was 
obtained as a yellow oil (310 mg, 30%). 1HNMR (300 MHz, 
CDCl3): δ = 3.4 (s, 3 H, OCH3), 3.71 (t, 2 H, J = 4.8 Hz, OCH2), 3.89 (s, 3 H, OCH3), 4.44 (t, 
2 H, J = 4.8 Hz, OCH2), 6.93-6.99 (m, 2 H, ArH), 7.42-7.48 ( m, 1 H, ArH), 7.81 (dd, 1 H, J = 
1.5, 7.8 Hz, ArH); 13C NMR (100 MHz, CDCl3): δ = 55.7, 58.8 (OCH3), 63.6, 70.3 (OCH2), 
118.8 (CHAr), 119.7 (C), 119.9, 131.5, 133.4 (CAr), 159.1, 165.8 (C); IR (neat, cm−1): ~ν  = 
3430 (w), 2945 (m), 1727 (s), 1601 (m), 1492 (s), 1252 (s), 1080 (s), 1024 (m),  868 (w), 757 
(s); GC-MS (EI, 70 eV): m/z (%): 210 (M+, 15), 152 (100), 135 (71), 123 (56), 105 (30), 92 
(41), 77 (90). 
 
Benzyl 2-methoxybenzoate (6d)   
Starting with 1,3-bis(silyl enol ether), 4d (2.00 g, 5.96 mmol), 
1,1,3,3-tetramethoxypropane 5 (1.08 mL, 6.55 mmol, 1.1 equiv.) and 
TMSOTf (0.11 mL, 0.59 mmol, 0.1 equiv.), 6d was obtained as a 
yellow oil (566 mg, 40%). 1HNMR (300 MHz, CDCl3): δ = 3.89 (s, 3 
H, OCH3), 5.34 (s, 2 H, OCH2 ), 6.92-6.97 (m, 2 H, ArH), 7.33-7.46 (m, 6 H, ArH), 7.83 (dd, 
1 H, J = 1.6, 7.8 Hz, ArH); 13C NMR (100 MHz, CDCl3): δ = 55.8 (CH3), 66.3 (OCH2), 112.0 
(CHAr), 119.7 (C), 119.7 (CHAr), 127.9, 128.3, 131.6, 133.5 (CHAr), 136.1, 159.2, 165.7 (C); 
IR (neat, cm−1): ~ν  = 3434 (w), 2946 (w), 1727 (s), 1600 (s), 1491 (s), 1436 (m), 1299 (s), 
1251 (s), 1129 (m), 1073 (s), 1024 (m), 755 (s), 698 (s); GC-MS (EI, 70 eV): m/z (%): 242.1 
(M+, 51), 197.1 (14), 135.1 (100), 91.1 (82), 77.1 (30); HRMS (EI): Calcd. for C15H14O3 
[M]+: 242.093384; found: 242.09375. 
 
Ethyl 2-hydroxy-3-methylbenzoate (7a) 
Starting with 1,3-bis(silyl enol ether), 4f (2.00g, 6.93 mmol), 
1,1,3,3-tetramethoxypropane 5 (1.20 mL, 7.62 mmol, 1.1 equiv.) and 
TMSOTf (0.11 mL, 0.69 mmol, 0.1 equiv.), 7a was obtained as a yellow 
oil (570 mg, 45%). 1H NMR (300 MHz, CDCl3): δ = 1.27 (t, 3 H, J = 5.3 
Hz, OCH3), 2.13 (s, 3 H, CH3), 4.25 (q, 2 H, J = 5.3 Hz, OCH2), 6.63 (t, 1 H, J = 5.7 Hz, 
ArH), 7.16 (dd, 1 H, J = 1.5, 7.8 Hz, ArH), 7.56 (dd, 1 H, J = 1.2, 5.5 Hz, ArH); 13C NMR 
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(100 MHz, CDCl3): δ = 14.1, 15.5 (CH3), 61.2 (OCH2), 111.8 (C), 118.3 (CHAr), 126.4 (C), 
127.3, 136.2, (CHAr), 160.0, 170.6 (C); IR (neat, cm-1); ~ν  = 3397 (m), 2985 (s), 1670 (s), 
1616(m), 1435 (m), 1290 (s), 1250 (s), 1148 (s), 1083 (s), 1027 (m), 879 (w), 755 (s); GC-MS 
(EI, 70 eV): m/z (%): 180.1 (M+, 61), 134,1 (100), 106.1 (95), 77.1 (31); HRMS (EI): Calcd. 
for C10H12O3 [M]+ : 180.077698; found: 180.07810. 
 
Ethyl 3-ethyl-2-hydroxybenzoate (7b) 
Starting with 1,3-bis(silyl enol ether), 4g (2.00 g, 6.61 mmol), 
1,1,3,3-tetramethoxypropane 5 (1.2 mL, 7.27 mmol, 1.1 equiv.) and 
TMSOTf (0.11 mL, 0.66 mmol, 0.1 equiv.), 7b was obtained as a 
yellow oil (520 mg, 40%). 1H-NMR (250 MHz, CDCl3): δ = 1.61 (t, 3 
H, J = 8.1 Hz, CH3), 1.78 (t, 3 H,  J = 7.0 Hz, CH3), 3.07 (q, 2 H, J = 7.6 Hz, CH2), 4.76 (q, 2 
H, J = 4.9 Hz, OCH2), 7.20 (t, 1 H, J = 7.9 Hz, ArH), 7.69 (dd, 1 H, J = 1.5, 7.9 Hz, ArH), 
11.52 (s, 1 H, OH). 13C NMR (100 MHz, CDCl3): δ = 13.8, 14.5 (CH3), 22.8, 61.3 (OCH2), 
112.0 (C), 118.5, 127.4 (CHAr), 132.5 (C), 134.7 (CHAr), 159.8, 170.7 (C); IR (neat, cm-1): 
3164 (w), 2968 (m), 1669 (s), 1614 (m), 1459 (s), 1397 (w), 1246 (s), 1148 (s), 1092 (m), 
1023 (m), 756 (s); GC-MS (EI, 70 eV): m/z (%): 194.1 (M+, 95), 148.1 (100), 133.1 (27), 
120.1 (100), 91.1 (39), 77.1 (34); HRMS (EI): Calcd. for C11H14O3 [M]+: 194.09388; found: 
194.09375. 
 
Methyl 3-butyl-2-hydroxybenzoate (7c) 
Starting with 1,3-bis(silyl enol ether), 4h (1.50 g, 4.7 
mmol), 1,1,3,3-tetramethoxypropane 5 (0.86 mL, 5.21 mmol, 
1.1 equiv.) and TMSOTf (0.09 mL, 0.47 mmol, 0.1 equiv.), 7c 
was obtained as a yellow oil (0.59 g, 60%). 1H-NMR (300 MHz, CDCl3): δ = 0.94 (t, 3J = 
7.3Hz, 3H, CH3), 1.31-1.44, 1.55-1.65 (m, 4H, (CH2)2CH3), 2.66 (t, 3J = 7.7 Hz, 2H, CH2Ar), 
3.93 (s, 3H, OCH3), 6.78, 6.81 (dd, 3J = 7.8 Hz, 1H, H-5Ar), 7.30, 7.31 (dd, 3J = 7.4 Hz, 
4J=1.7 Hz, 1H, H-4Ar), 7.68, 7.70 (dd, 3J = 8.2 Hz, 4J = 1.7 Hz, 1H, H-6Ar), 11.03 (OH). 13C-
NMR (75 MHz, CDCl3): δ = 14.4 (CH3), 22.9, 29.7, 32.0 (CH2), 52.5 (OCH3), 112.1 (C-1), 
118.8, 127.7, 136.0 (CHAr), 131.5 (C-3), 160.1 (C-2), 171.4 (C=O). IR (neat, cm-1): ~ν  = 3178 
(w), 2958 (s), 2929 (s), 2856 (s), 1753 (s), 1714 (s), 1676 (m), 1613 (s), 1440 (m), 1341 (m), 
1307 (m), 1248 (s), 1198 (s), 1148 (s), 1103 (s), 1068 (m), 1003 (m), 842 (s), 758 (s), 646 (s), 
557 (s), 441 (s). MS (EI, 70 eV): m/z (%) = 209 (M
+
, 8), 208 (59), 177 (14), 176 (26), 165 
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(20), 159 (10), 148 (51), 147 (26), 134 (92), 133 (100), 106 (31), 105 (23), 91 (12), 77 (25), 
51(10). HRMS (EI, 70 eV): calcd for C12H16O3 [M]+: 208.1094; found: 208.1089. 
 
Methyl 2-hydroxy-3-isobutylbenzoate (7d) 
Starting with 1,3-bis(silyl enol ether), 4i (1.50 g, 4.47 
mmol), 1,1,3,3-tetramethoxypropane 5 (0.86 mL, 5.21 mmol, 
1.1 equiv.) and TMSOTf (0.08 mL, 0.44 mmol, 0.1 equiv.), 7d 
was obtained as a yellow oil (370 mg, 45%). 1HNMR (300 MHz, CDCl3): δ = 0.91 (d, 6 H, J 
= 6.6 Hz, CH3), 1.91-2.03 (m, 1 H, CH), 2.52 (d, 2 H, J = 7.2 Hz, CH2), 3.91 (s, 3 H, OCH3),  
6.97 (t, 1 H, J = 7.5 Hz, ArH), 7.27 (dd, 1 H, J = 1.8, 7.8 Hz,  ArH), 7.68 (dd, J = 1.7, 8.0 Hz, 
1H, ArH), 11.02 (s, 1 H, OH); 13C NMR (100 MHz, CDCl3): δ = 22.4 (2CH3), 28.2 (CH2), 
38.9 (CH), 52.1 (OCH3), 111.7 (C), 118.2, 127.5 (CHAr), 130.0 (C), 136.6 (CHAr), 159.9, 
171.0 (C). IR (neat, cm-1): ~ν  = 3178 (w), 2958 (s), 2929 (s), 2856 (s), 1753 (s), 1714 (s), 
1676 (m), 1613 (s), 1440 (m), 1341 (m), 1307 (m), 1248 (s), 1198 (s), 1148 (s), 1103 (s), 
1068 (m), 1003 (m), 842 (s), 758 (s), 646 (s), 557 (s), 441 (s). MS (EI, 70 eV): m/z (%): 182.1 
(M+, 68), 150.1 (80), 122.1 (100), 107.1 (32), 92.1 (17); HRMS (EI, 70 eV): calcd. for 
C9H10O4 [M]+: 182.057383; found: 182.05736. 
 
Ethyl 3-hexyl-2-hydroxybenzoate (7e) 
Starting with 1,3-bis(silyl enol ether), 4j (2.00g, 5.57 
mmol), 1,1,3,3-tetramethoxypropane 5 (1.01 mL, 6.13 mmol, 
1.1 equiv.) and TMSOTf (0.10mL, 0.55 mmol, 0.1 equiv.), 7e 
was obtained   as a yellow oil (700mg, 50%). 1HNMR (300 MHz, CDCl3): δ = 0.86 (t, 3 H, J 
= 7.0 Hz, CH3), 1.23-1.41 (m, 11 H, CH2), 2.63 (t, 2 H, J = 7.8 Hz, CH2), 4.37 (q, 2 H, J = 7.1 
Hz, OCH2), 6.77 (dd, 1 H, J = 7.7 Hz, ArH), 7.28 (dd, 1 H, J = 1.2, 7.3 Hz, ArH), 7.69 (dd, 1 
H, J = 1.7, 8.0 Hz, ArH), 11.09 (s, 1 H, OH); 13C NMR (100 MHz, CDCl3): δ = 14.10, 14.19 
(CH3), 22.6, 29.1, 29.4, 29.6, 31.7 (CH2), 61.2 (OCH2), 111.9 (C), 118.3, 127.3 (CAr),131.1 
(C), 135.5 (CAr),159.8, 170.7 (C); ); IR (neat, cm−1): ~ν  = 3147 (w), 2928 (s), 2857 (m), 1670 
(m), 1613 (m),  1451 (s), 1247 (s), 1147 (s), 1109 (w), 1025 (w), 757 (s); GC-MS (EI, 70 eV): 
m/z (%): 250.2 (M+, 54), 204.1 (22), 176.1 (38), 147.1 (38), 133.1 (100), 106.1 (23), 77.1 
(20); elemental analysis: Calcd. (%) for C15H22O3 (250.33): C 71.97, H 8.86; Found C 72.44, 
H 9.11.  
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Methyl 3-heptyl-2-hydroxylbenzoate (7f) 
Starting with 1,3-bis(silyl enol ether), 4l (1.50g, 4.28 
mmol), 1,1,3,3-tetramethoxypropane 5 (0.76 mL, 4.61 mmol, 
1.1 equiv.) and TMSOTf (0.08mL, 0.42 mmol, 0.1 equiv.), 7f 
was obtained as a yellow oil (0.61 g, 59%). 1H-NMR (300 MHz, CDCl3): δ = 0.86-0.91, 1.28-
1.34, 1.57-1.66 (m, 13H, (CH2)6CH3), 2.65 (t, 3J=7.7Hz, 2H, CH2Ar), 3.94 (s, 3H, OCH3), 
6.78, 6.81 (dd, 3J=7.8Hz, 1H, H-5Ar), 7.30, 7.32 (dd, 3J= 7.4Hz, 4J=1.4Hz, 1H, H-4Ar), 7.68, 
7.71 (dd, 3J = 8.1Hz, 4J = 1.7Hz, 1H, H-6Ar), 11.02 (OH).  13C-NMR (75 MHz, CDCl3): δ = 
14.4 (CH3), 23.0, 29.6, 29.8, 29.8, 30.0 (CH2), 52.5 (OCH3), 112.1 (C-1), 118.8, 127.7, 136.0 
(CHAr), 131.6 (C-3), 160.1(C-2), 171.4 (C=O). IR (neat, cm-1): ~ν  = 3174 (w), 2950 (s), 2925 
(s), 2860 (s), 2369 (m), 1676 (m), 1613 (s), 1440 (m), 1341 (m), 1303 (m), 1248 (s), 1198 (s), 
1148 (s), 1108 (m), 1076 (m), 996 (m), 844 (s), 757 (s), 724 (m), 647 (m), 557 (m), 441 (m). 
MS (EI, 70 eV): m/z (%) = 250 (M
+
, 48), 218 (16), 190 (30), 189 (15), 175 (10), 165 (28), 161 
(11), 148 (10), 147 (30), 134 (82), 133 (100), 106 (21), 105 (20), 91 (9), 77 (19), 41 (7). 
HRMS (EI, 70 eV): calcd. for C15H22O3 [M]+: 250.1563, found: 250.1564. 
 
Ethyl 2-hydroxy-3-octylbenzoate (7g) 
Starting with 1,3-bis(silyl enol ether), 4m (2.00g,5.17 
mmol), 1,1,3,3-tetramethoxypropane 5 (0.94 mL, 5.68 mmol, 
1.1 equiv.) and TMSOTf (0.09mL, 0.52 mmol, 0.1 equiv.), 7g 
was obtained   as a yellow oil (700mg, 56%). 1HNMR (300 MHz, CDCl3): δ = 0.86 (t, 3 H, J 
= 6.9 Hz, CH3), 1.23-1.41 (m, 15 H, CH2), 2.63 (t, 2 H, J = 7.8 Hz, CH2), 4.37 (q, 2 H, J = 7.1 
Hz, OCH2), 6.77 (dd, 1 H, J = 7.7 Hz, ArH), 7.28(dd, 1 H, J = 1.3, 7.3 Hz, ArH), 7.69 (dd, 1 
H, J = 1.7, 7.9 Hz, ArH), 11.09 (s, 1 H, OH); 13C NMR (100 MHz, CDCl3): δ = 14.0, 14.1 
(CH3), 22.6, 29.2, 29.43, 29.45, 29.5, 29.6, 31.8 (CH2), 61.2 (OCH2), 111.9 (C), 118.3, 127.3 
(CHAr),131.1 (C), 135.5 (CHAr),159.8, 170.6 (C); IR (neat, cm−1): ~ν  = 3164 (w), 2926 (s), 
2855 (s), 1670 (m), 1613 (m),  1451 (s), 1247 (s), 1147 (s), 1109 (w), 1025 (w), 757 (s);   GC-
MS (EI, 70 eV): m/z (%): 278.2 (M+, 59), 232.2 (18), 204.2 (34), 179.1 (32), 147.1 (37), 134.1 
(96), 133.1 (100), 106.1 (23); elemental analysis Calcd. (%) for C17H26O3 (278.39): C 73.44,  
H 9.41 Found: C 73.71, H 9.92. 
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Ethyl 3-decyl-2-2hydroxydecylbenzoate (7h) 
Starting with 1,3-bis(silyl enol ether), 4o (2.00g, 4.82 
mmol), 1,1,3,3-tetramethoxypropane 5 (0.88 mL, 5.31 mmol, 
1.1 equiv.) and TMSOTf (0.08mL, 0.48 mmol, 0.1 equiv.), 7h 
was obtained   as a yellow oil (790 mg, 54%). 1HNMR (300 MHz, CDCl3): δ = 0.87 (t, 3 H, J 
= 6.8 Hz, CH3), 1.25-1.42 (m, 15 H, CH2), 2.46 (t, 2 H, J = 7.8 Hz, CH2), 4.39 (q, 2 H, J = 7.1 
Hz, OCH2), 6.78 (t, 1 H, J = 7.6 Hz, ArH), 7.30 (dd, 1 H, J = 1.5, 7.3 Hz, ArH), 7.70 (dd, 1 H, 
J = 1.7, 8.0 Hz, ArH), 11.10 (s, 1 H, OH); 13C NMR (100 MHz, CDCl3): δ = 14.1, 14.19 
(CH3), 22.6, 29.3, 29.4, 29.5, 29.62, 29.69, 31.9 (CH2), 61.2 (OCH2), 11.9 (C), 118.3, 127.3 
(CHAr), 131.2 (C), 135.5 (CHAr), 159.8, 170.7 (C); IR (neat, cm-1): ~ν  = 3168 (w), 2925 (s), 
1670 (s), 1452 (s), 1373 (m), 1247 (s), 1148 (s), 1095 (w), 1025 (w), 757 (s); GC-MS (EI,70 
eV) m/z (%) = 306 (M+, 37), 260 (14), 203 (19), 174 (25), 147 (28), 133 (100); elemental 
analysis: Calcd. (%) for C19H30O3 (306.44): C 75.21,  H 8.96; Found C 75.44, H 9.03. 
 
Methyl 3-benzyl-2-hydroxybenzoate (7k) 
Starting with 1,3-bis(silyl enol ether), 4p (1.50g, 4.35 mmol), 
1,1,3,3-tetramethoxypropane 5 (0.78 mL, 4.78 mmol, 1.1 equiv.) 
and TMSOTf (0.08mL, 0.44 mmol, 0.1 equiv.), 7k was obtained   
as a yellow oil (590mg, 57%). 1HNMR (300 MHz, CDCl3): δ = 3.91 (s, 3 H, OCH3), 4.0 (s, 2 
H, CH2), 6.77 (t, 1 H, J = 7.6 Hz, ArH), 6.75-7.26 (m, 6 H, ArH), 7.70 (dd, 1 H, J = 1.5, 8.0 
Hz, ArH), 11.07 (s, 1 H, OH); 13C NMR (100 MHz, CDCl3): δ = 35.3 (CH2), 52.2 (OCH3), 
112.0 (C), 118.6, 126.0, 126.4, 128.0, 128.2, 128.6, 128.8 (CHAr), 129.6, 136.2, 140.2, 159.6, 
170.9 (C); IR (neat, cm-1): ~ν  = 3086 (s), 3062 (s), 3027 (s), 2953 (s), 2852 (s), 1945 (s), 1893 
(s), 1674 (w), 1614 (s), 1494 (s), 1440 (w), 1302 (w), 1250 (m), 1198 (m), 1145 (m), 1096 (s), 
1080 (s), 1030 (s), 997 (m), 843 (m), 788 (s), 759 (w), 698 (m), 611 (s), 556 (s), 546 (s), 475 
(s), 455 (s), 441 (s); GC-MS (EI, 70 eV): m/z (%): 242.1 (M+, 66), 210.1 (82), 182.1 (100), 
152.1 (36), 105.1 (14); HRMS (EI, 70 eV): calcd. for C15H14O3 [M]+: 242.093218; 
found:242.09375. 
 
Methyl 2-hydroxy-3-methoxybenzoate (7m) 
Starting with 1,3-bis(silyl enol ether), 4q (1.50g, 5.16 mmol), 
1,1,3,3-tetramethoxypropane 5 (0.94 mL, 5.67 mmol, 1.1 equiv.) and 
TMSOTf (0.09mL, 0.51 mmol, 0.1 equiv.), 7m was obtained   as a 
yellow solid (302mg, 32%). 1HNMR (300 MHz, CDCl3): δ = 3.89 (s, 3 H, OCH3), 3.93 (s, 3 
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H, OCH3), 6.81 (t, 1 H, J = 8.0 Hz, ArH), 7.02 (dd, 1 H, J = 1.2, 7.9 Hz,  ArH), 7.42 (dd, J = 
8.1, 1.5 Hz, 1H, ArH), 10.99 (s, 1 H, OH); 13C NMR (100 MHz, CDCl3): δ = 52.3, 56.1 
(OCH3), 112.5 (C), 116.4, 118.4, 120.9 (CHAr), 148.4 (C), 151.9, 170.7 (C); IR (KBr, cm−1): 
~ν  = 3430 (s), 2885 (m), 1672 (s), 1603 (m), 1462 (s),  1376 (s), 1273 (s), 1171 (s), 1113 (m), 
1069 (s), 913 (m), 847 (s), 761 (s), 641 (w), 585 (s); MS (EI, 70 eV): m/z (%): 182.1 (M+, 68), 
150.1 (80), 122.1 (100), 107.1 (32), 92.1 (17); HRMS (EI, 70 eV): calcd. for C9H10O4 [M]+: 
182.057383; found: 182.05736. 
 
Ethyl 2,3-dihydroxybenzoate (7n) 
Starting with 1,3-bis(silyl enol ether), 4r (1.50g, 4.38 mmol), 
1,1,3,3-tetramethoxypropane 5 (0.78 mL, 4.761 mmol, 1.1 equiv.) and 
TMSOTf (0.07mL, 0.43 mmol, 0.1 equiv.), 7n was obtained   as a 
yellow solid (220mg, 27%). 1HNMR (300 MHz, CDCl3): δ = 1.41 (t, 3 H, J = 7.1 Hz, CH3), 
4.41 (q, 2 H, J = 7.1 Hz, OCH2), 5.70 (s, 1 H, OH), 6.79 (t, 1 H, J = 8.0 Hz, ArH), 7.09 (dd, 1 
H, J = 1.5, 8.0 Hz, ArH), 7.38 (dd, 1 H, J = 1.5, 8.1 Hz, ArH), 10.99 (s, 1 H, OH); 13C NMR 
(100 MHz, CDCl3): δ = 14.1 (CH3), 61.5 (OCH2), 112.5 (C), 119.0, 119.6, 120.5 (CAr), 144.9, 
148.8, 170.3 (C); IR (KBr, cm−1): ~ν  = 3472 (s), 2885 (m), 1672 (s), 1603 (m), 1462 (s),  1376 
(s), 1273 (s), 1171 (s), 1113 (m), 1069 (s),  913 (m), 847 (s), 761 (s), 641 (w), 585 (s); GC-
MS (EI, 70 eV): m/z (%): 182.2 (M+, 28), 136.1 (100), 108.1 (15); HRMS (EI): calcd for 
C9H10O4 [M]+ : 182.056870; found: 182.05736. 
 
Synthesis of 3-(aryloxy)pentane-2,4-diones 13a-i: 
3-(Phenoxy)pentane-2,4-diones 13a-i were prepared, following a known procedure,41 by 
potassium carbonate mediated reaction of phenols 11a-i with 3-(chloro)pentane-2,4-dione 
(12). 
 
3-(3,5-dimethylphenoxy)-4-hydroxypent-3-en-2-one (13b) 
Starting with 12 (10.00 g, 74.3 mmol), 3,5-dimethylphenol (12.00 g, 
104.0 mmol) and  K2CO3 (25.00 g, 185.7 mmol), 13b was isolated as a 
yellow solid (3.00 g, 19%); mp. 83-85 °C; 1H NMR (300 MHz, CDCl3): δ = 
2.02 (s, 6 H, CH3), 2.28 (s, 3 H, CH3), 2.29 (s, 3 H, CH3), 6.51 (s, 2 H, 
ArH), 6.66 (s, 1 H, ArH), 14.41 (s, 1 H, OH); 13C NMR (75 MHz, CDCl3): 
δ = 20.8 (2C), 21.3 (2C, CH3), 111.9 (2C), 123.9 (CH), 130.9, 139.8 (2C), 158.0, 186.4 (2C, 
C); IR (KBr): ν~ = 3436 (w), 2965 (m), 1739 (m), 1610 (m), 1505 (s), 1298 (m), 1213 (m), 
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831 (m) cm−1; GC-MS (EI, 70 eV): m/z (%): 220 (M+, 100), 178 (25), 122 (88), 107 (29), 91 
(28), 77 (31), 43 (64); elemental analysis: calcd. (%) for C13H16O3 (220.26): C 70.89, H 7.32; 
found: C 71.05, H 7.07. 
3-(4-ethylphenoxy)-4-hydroxypent-3-en-2-one (13c) 
Starting with 12 (10.00 g, 74.3 mmol), 4-ethylphenol (12.90 g, 
105.5 mmol) and  K2CO3 (25.60 g, 185.7 mmol), 13c was isolated as a 
colourless oil (5.30 g, 35%); 1H NMR (300 MHz, CDCl3): δ = 1.21 (t, 3 
H, J = 7.5 Hz, CH3), 2.03 (s, 6 H, CH3), 2.60 (q, 2 H, J = 7.8 Hz, CH2), 
6.82 (d, 2 H, J = 8.7 Hz, ArH), 7.12 (d, 2 H, J = 8.8 Hz, ArH), 14.42 (s, 1 H, OH); 13C NMR 
(75 MHz, CDCl3): δ = 15.7, 20.8 (2C, CH3), 27.9 (CH2), 114.1 (2C), 129.1 (2C, CH), 131.0, 
137.9, 156.0, 186.5 (2C, C); IR (neat): ν~ = 3436 (w), 2965 (m), 1739 (m), 1610 (m), 1505 (s), 
1298 (m), 1213 (m), 831 (m) cm−1; GC-MS (EI, 70 eV): m/z (%): 220.1 (M+, 90), 178.1 (29), 
122.1 (61), 107.1 (64), 43.1 (100); HRMS (EI): calcd. for C13H16O3 [M]+: 220.1091; found: 
220.1094. 
 
3-(4-methoxyphenoxy)-4-hydroxypent-3-en-2-one (13e) 
Starting with 12 (4.00 g, 29.7 mmol), 4-methoxyphenol (5.20 g, 
42.2 mmol) and  K2CO3 (10.20 g, 74.3 mmol), 13e was isolated as a 
colourless oil (1.50 g, 24%); 1H NMR (300 MHz, CDCl3): δ = 2.02 (s, 
6 H, CH3), 3.77 (s, 3 H, OCH3), 6.83 (s, 4 H, ArH), 14.39 (s, 1 H, OH); 
13C NMR (75 MHz, CDCl3): δ = 20.8 (2C), 55.6 (CH3), 114.91 (2C), 114.95 (2C, CH), 131.2, 
151.9, 154.7, 186.5 (2C, C); IR (neat): ν~ = 3085 (w), 3003 (m), 2956 (m), 2839 (w), 1607 (s), 
1507 (s), 1309 (s), 1262 (s), 1228 (s), 1194 (s), 1166 (s), 1128 (s), 1026 (s), 951 (s), 740 (m) 
cm−1; MS (EI, 70 eV): m/z (%): 222.0 (M+, 100), 151.0 (16), 124.0 (40), 108.0 (22); HRMS 
(EI): calcd. for C12H14O4 [M]+: 222.0878; found: 222.0886. 
 
3-(3,4-dimethoxyphenoxy)-4-hydroxypent-3-en-2-one (13f) 
Starting with 12 (6.00 g, 44.5 mmol), 3,4-dimethoxyphenol 
(9.70 g, 63.3 mmol) and  K2CO3 (15.40 g, 111.4 mmol), 13f was 
isolated as a pink solid (4.50 g, 40%); 1H NMR (300 MHz, CDCl3): δ =  
2.03 (s, 6 H, CH3), 3.83 (s, 3 H, OCH3), 3.86 (s, 3 H, OCH3), 6.31 (dd, 
1 H, J = 8.7, 2.8 Hz, ArH), 6.55 (d, 1 H, J = 2.8 Hz, ArH), 6.75 (d, 1 H, J = 8.7 Hz, ArH), 
14.42 (s, 1 H, OH); 13C NMR (75 MHz, CDCl3): δ = 20.8 (2C), 55.9, 56.3 (CH3), 99.9, 103.6, 
111.8 (CH), 131.5, 144.3, 150.2, 152.4, 186.5 (2C, C); IR (KBr): ν~ = 3085 (w), 3003 (m), 
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2956 (m), 2839 (w), 1607 (s), 1507 (s), 1309 (s), 1262 (s), 1228 (s), 1194 (s), 1166 (s), 1128 
(s), 1026 (s), 951 (s), 740 (m) cm−1; MS (CI): 253.1 (100); elemental analysis: calcd. (%) for 
C13H16O5 (252.26): C 61.90, H 6.39; found: C 61.73, H 6.30.  
3-(4-bromophenoxy)-4-hydroxypent-3-en-2-one (13g) 
Starting with 12 (10.00 g, 74.3 mmol), 4-bromophenol (14.40 g, 
105.5 mmol)  and  K2CO3 (25.60 g, 185.7 mmol), 13g was isolated as a 
pink oil (5.10 g, 25%); 1H NMR (300 MHz, CDCl3): δ = 2.01 (s, 6 H, 
CH3), 6.81 (d, 2 H, J = 8.7 Hz, ArH), 7.40 (d, 2 H, J = 8.7 Hz, ArH), 
14.39 (s, 1 H, OH); 13C NMR (75 MHz, CDCl3): δ = 20.7 (2C, CH3), 114.4 (C), 116.0 (2C, 
CH), 130.7 (C), 132.8 (2C, CH), 157.1, 186.3 (2C, C); IR (neat): ν~ = 2925 (w), 1593 (m), 
1481 (s), 1303 (m), 1213 (m), 1165 (m), 1070 (m), 825 (m) cm−1; GC-MS (EI, 70 eV): m/z 
(%): 272.0 (M+, 42), 270.0 (43), 230.0 (17), 228.0 (18), 174.0 (39), 172.0 (40), 101.1 (32); 
HRMS (EI): calcd. for C11H11BrO3 [M]+: 269.9890; found: 269.9886. 
 
3-(4-Cyanophenoxy)-4-hydroxypent-3-en-2-one (13h) 
Starting with 12 (10.00 g, 74.3 mmol), 4-cyanophenol (12.50 g, 
105.5 mmol)  and  K2CO3 (26.50 g, 185.8 mmol), 13h was isolated as a 
brown solid (4.20 g, 25%); mp. 67-68 °C; 1H NMR (300 MHz, CDCl3): 
δ = 2.02 (s, 6 H, CH3), 7.02 (d, 2 H, J = 9.0 Hz, ArH), 7.65 (d, 2 H, J = 
9.0 Hz, ArH), 14.42 (s, 1 H, OH); 13C NMR (100 MHz, CDCl3): δ = 20.7 (CH3), 106.0 (C), 
115.2 (CHAr), 118.5, 130.4 (C ), 134.5 (CHAr), 161.2, 186.0 (C); IR (KBr): ν~ = 3390 (w), 
2953 (w), 1738 (s), 1611 (s), 1296 (m), 1223 (s), 1165 (m), 827 (m), 732 (s) cm−1; GC-MS 
(EI, 70 eV): m/z (%): 217 (M+, 69), 175 (25), 101 (30), 43 (100); elemental analysis: calcd 
(%) for C12H11O3N (217.23): C 66.34, H 5.11, N 6.45; found: C 65.97, H 4.88, N 6.33. 
 
Methyl 2-(4-(2,4-dioxopentane-3-yloxy)phenyl) acetate (13i) 
Starting with 12 (10.00 g, 74.3 mmol), methyl 4-
hydroxy acetate (17.20 g, 104.0 mmol) and  K2CO3 (25.60 g, 
185.7 mmol), 13i was isolated as a colourless solid (4.30 g, 
26%); 1H NMR (300 MHz, CDCl3): δ = 2.02 (s, 3 H, CH3), 
2.04 (s, 3 H, CH3), 3.69 (s, 3 H, OCH3), 5.29 (s, 2 H, CH2), 6.87 (d, 2 H, J = 8.7 Hz, ArH), 
7.22 (d, 2 H, J = 8.7 Hz, ArH), 14.42 (s, 1 H, OH); 13C NMR (100 MHz, CDCl3): δ = 20.7 
(CH3), 40.0 (CH2), 51.9 (OCH3), 114.3 (CHAr), 127.6 (C), 130.6 (CHAr), 130.8, 157.0, 172.0, 
186.3 (C); IR (KBr): ν~ = 3436 (w), 2965 (m), 1739 (m), 1610 (m), 1505 (s), 1298 (m), 1213 
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(m), 831 (m) cm−1; GC-MS (EI, 70 eV): m/z (%): 264 (M+, 100), 222.1 (36), 205.1 (47), 166.1 
(34), 107.1 (87), 43.1 (61); elemental analysis: calcd (%) for C14H16O5 (442.56): C 63.63, H 
6.10; found: C 63.26, H 5.88. 
 
Synthesis of 2-aryloxy-3-(silyloxy)alk-2-en-1-ones 14a-i:  
The reactions were carried according to a known procedure.8c Due to their low stability, silyl 
enol ethers 14a-i were used directly after their preparation and not characterized by 
spectroscopy.  
 
General procedure for the synthesis of diaryl ethers 15a-u: 
To a dichloromethane solution (2 mL/mmol) of 14 (1.0 mmol) and 4 (1.0 mmol) was added 
TiCl4 (1.0 mmol) at –78 °C. The solution was allowed to warm to ambient temperature within 
20 h. To the solution was added a saturated solution of NaHCO3 (10 mL). The organic and the 
aqueous layer were separated and the latter was extracted with diethyl ether (3 x 30 mL). The 
filtrate was concentrated in vacuo and the residue was purified by chromatography (silic a gel, 
EtOAc / n-heptane = 1:4).  
 
Ethyl 3-phenoxy-6-hydroxy-2,4,5-trimethylbenzoate (15a) 
Starting with 1,3-bis(silyl enol ether), 4f (400 mg, 1.3 mmol), 3-
(siloxy)alk-2-en-1-one 14a (367 mg, 1.3 mmol) and  TiCl4 (0.15 mL, 1.3 
mmol), 15a was isolated as a colourless solid (130 mg, 30%); 1H NMR 
(400 MHz, CDCl3): δ = 1.40 (t, 3 H, J = 7.1 Hz, CH3), 2.08 (s, 3 H, CH3), 
2.20 (s, 3 H, CH3), 2.32 (s, 3 H, CH3), 4.42 (q, 2 H, J = 7.1 Hz, OCH2), 
6.72-7.27 (m, 5 H, ArH), 11.51 (s, 1 H, OH); 13C NMR (100 MHz, CDCl3): δ = 10.9, 12.8, 
13.1, 14.3 (CH3), 60.6 (CH2), 109.4 (C), 113.5 (2C), 120.3 (CH), 123.0 (C), 128.6 (2C, CH), 
129.2, 137.1, 142.4, 156.8, 157.2, 170.9 (C); IR (KBr): ν~ = 3438 (w), 2937 (w), 1649 (s), 
1396 (s), 1293 (s), 1222 (s), 1031 (m), 810 (m), 753 (m) cm−1; MS (EI, 70 eV): m/z (%): 
300.0 (M+, 88), 254.0 (100), 226.0 (72), 211.0 (17); HRMS (EI): calcd. for C18H20O4 [M]+: 
300.13563; found: 300.13561. 
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Ethyl 5-ethyl-3-phenoxy-6-hydroxy-2,4-dimethylbenzoate (15b) 
Starting with 1,3-bis(silyl enol ether), 4g (400 mg, 1.3 mmol), 3-
(siloxy)alk-2-en-1-one 14a (349 mg, 1.3 mmol) and  TiCl4 (0.14 mL, 1.3 
mmol), 15b was isolated as a colourless solid (130 mg, 32%), 1H NMR 
(300 MHz, CDCl3): δ = 1.10 (t, 3 H, J = 7.5 Hz, CH3), 1.38 (t, 3 H, J = 
7.1 Hz, CH3), 2.09 (s, 3 H, CH3), 2.29 (s, 3 H, CH3), 2.70 (q, 2 H, J = 7.5 
Hz, CH2), 4.40 (q, 2 H, J = 7.1 Hz, OCH2), 6.69-7.23 (m, 5 H, ArH), 11.44 (s, 1 H, OH); 13C 
NMR (75 MHz, CDCl3): δ = 13.0, 13.3, 14.1, 15.3 (CH3), 19.7, 61.5 (CH2), 110.6 (C), 114.5 
(2C), 121.2, 129.6 (2C, CH), 130.1, 130.4, 137.4, 143.5, 157.6, 158.2, 171.9 (C); IR (KBr): 
ν~ = 2969 (m), 1651 (s), 1599 (m), 1492 (s), 1394 (s), 1320 (s), 1221 (s), 1052 (m), 748 (m) 
cm−1; GC-MS (EI, 70 eV): m/z (%): 314.1 (M+, 46), 268.1 (100), 240.1 (10), 225.1 (2); 
elemental analysis: calcd. (%) for C19H22O4 (314.37): C 72.59, H 7.05; found: C 72.65, H 
6.95. 
 
Ethyl 3-(3,5-dimethylphenoxy)-6-hydroxy-2,4-dimethylbenzoate (15c) 
Starting with 1,3-bis(silyl enol ether), 4a (500 mg, 1.8 mmol), 3-
(siloxy)alk-2-en-1-one 14b (533 mg, 1.8 mmol)  and TiCl4 (0.19 mL, 1.8 
mmol), 15c was isolated as a colourless solid (330 mg, 58%), mp. 125-126 
°C; 1H NMR (300 MHz, CDCl3): δ = 1.41 (t, 3 H, J = 7.1 Hz, CH3), 2.11 
(s, 3 H, CH3), 2.24 (s, 6 H, CH3), 2.34 (s, 3 H, CH3), 4.43 (q, 2 H, J = 7.1 
Hz, OCH2), 6.35 (s, 2 H, ArH), 6.62 (s, 1 H, ArH), 6.76 (s, 1 H, ArH), 11.19 (s, 1 H, OH); 13C 
NMR (75 MHz, CDCl3): δ = 14.1, 15.4, 17.3, 21.3 (2C, CH3), 61.6 (CH2), 111.1 (C), 112.1 
(2C), 117.3, 123.3 (CH), 133.7, 139.4 (2C), 139.9, 143.9, 158.0, 159.5, 171.4 (C); IR (KBr): 
ν~ = 3030 (w), 2957 (m), 1660 (s), 1505 (s), 1470 (s), 1397 (s), 1373 (s), 1313 (s), 1241 (s), 
1220 (s), 1077 (m), 826 (m), 799 (m) cm−1; GC-MS (EI, 70 eV): m/z (%): 314.2 (M+, 34), 
268.1 (100); elemental analysis: calcd. (%) for C19H22O4 (314.37): C 72.59, H 7.05; found: C 
72.18, H 6.88. 
 
 
 
 
 
 
 
O
OH
OEt
O
Et
O
OH
OEt
O
 61
Ethyl 3-(3,5-dimethylphenoxy)-6-hydroxy-2,4,5-trimethylbenzoate (15d) 
Starting with 1,3-bis(silyl enol ether), 4f (500 mg, 1.7 mmol), 3-
(siloxy)alk-2-en-1-one 14b (506 mg, 1.7 mmol)  and TiCl4 (0.18 mL, 1.7 
mmol), 15d was isolated as a colourless solid (220 mg, 39%); mp. 111-112 
°C; 1H NMR (300 MHz, CDCl3): δ = 1.42 (t, 3 H, J = 7.1 Hz, CH3), 2.09 
(s, 3 H, CH3), 2.22 (s, 3 H, CH3), 2.25 (s, 6 H, CH3), 2.33 (s, 3 H, CH3), 
4.44 (q, 2 H, J = 7.1 Hz, OCH2), 6.35 (s, 2 H, ArH), 6.62 (s, 1 H, ArH), 
11.54 (s, 1 H, OH); 13C NMR (75 MHz, CDCl3): δ = 11.9, 13.9, 14.1, 15.3, 21.3 (2C, CH3), 
61.5 (CH2), 110.3 (C), 112.2 (2C), 123.1 (CH), 123.8, 130.3, 138.2, 139.4 (2C), 143.5, 157.7, 
158.3, 172.0 (C); IR (KBr): ν~ = 3430 (w), 2921 (m), 1647 (s), 1612 (s), 1594 (s), 1400 (s), 
1378 (s), 1318 (s), 1289 (s), 1218 (s), 1142 (s), 1032 (m), 834 (m) cm−1; GC-MS (EI, 70 eV): 
m/z (%): 328.2 (M+, 38), 282.2 (100), 239.2 (14); elemental analysis: calcd. (%) for C20H24O4 
(328.40): C 73.14, H 7.36; found: C 73.16, H 7.57. 
 
Ethyl 3-(4-ethylphenoxy)-6-hydroxy-2,4-dimethylbenzoate (15e) 
Starting with 1,3-bis(silyl enol ether), 4a (500 mg, 1.8 mmol), 3-
(siloxy)alk-2-en-1-one 14c (533 mg, 1.8 mmol) and  TiCl4 (0.19 mL, 1.8 
mmol), 15e was isolated as a colourless solid (339 mg, 60%), mp. 52-53 
°C; 1H NMR (300 MHz, CDCl3): δ = 1.20 (t, 3 H, J = 7.5 Hz, CH3), 1.40 
(t, 3 H, J = 7.1 Hz, CH3), 2.10 (s, 3 H, CH3), 2.34 (s, 3 H, CH3), 2.58 (q, 2 
H, J = 7.5 Hz, CH2), 4.42 (q, 2 H, J = 7.1 Hz, OCH2), 6.65 (d, 2 H, J = 8.7 Hz, ArH), 6.75 (s, 
1 H, ArH), 7.06 (d, 2 H, J = 8.7 Hz, ArH), 11.17 (s, 1 H, OH); 13C NMR (75 MHz, CDCl3): δ 
= 14.2, 15.4, 15.7, 13.3 (CH3), 27.9, 61.7 (CH2), 111.2 (C), 114.3 (2C), 117.4, 129.9 (2C, 
CH), 133.8, 137.2, 140.0, 144.1, 156.0, 159.6, 171.5 (C); IR (KBr): ν~ = 3030 (w), 2957 (m), 
1660 (s), 1505 (s), 1470 (s), 1397 (s), 1373 (s), 1313 (s), 1241 (s), 1220 (s), 1077 (m), 826 
(m), 799 (m) cm−1; GC-MS (EI, 70 eV): m/z (%): 314.2 (M+, 29), 268.2 (100); elemental 
analysis: calcd. (%) for C19H22O4 (314.37): C 72.59, H 7.05; found: C 72.42, H 7.11. 
 
Ethyl 3-(4-ethylphenoxy)-6-hydroxy-2,4,5-trimethylbenzoate (15f) 
Starting with 1,3-bis(silyl enol ether), 4f (500 mg, 1.7 mmol), 3-
(siloxy)alk-2-en-1-one 14c (507 mg, 1.7 mmol) and TiCl4 (0.18 mL, 1.7 
mmol), 15f was isolated as a colourless solid (200 mg, 36%), mp. 49-50 
°C; 1H NMR (300 MHz, CDCl3): δ = 1.20 (t, 3 H, J = 7.5 Hz, CH3), 1.39 
(t, 3 H, J = 7.1 Hz, CH3), 2.08 (s, 3 H, CH3), 2.19 (s, 3 H, CH3), 2.31 (s, 3 
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H, CH3), 2.58 (q, 2 H, J = 7.5 Hz, CH2), 4.41 (q, 2 H, J = 7.1 Hz, OCH2), 6.63 (d, 2 H, J = 8.7 
Hz, ArH), 7.06 (d, 2 H, J = 8.7 Hz, ArH), 11.51 (s, 1 H, OH); 13C NMR (75 MHz, CDCl3): δ 
= 11.9, 13.9, 14.1, 15.3, 15.6 (CH3), 27.9, 61.6 (CH2), 110.3 (C), 114.3 (2C, CH), 123.9 (C), 
128.8 (2C, CH), 130.3, 136.9, 138.2, 143.6, 156.3, 157.7, 172.0 (C); IR (KBr): ν~ = 2969 (m), 
1651 (s), 1599 (m), 1492 (s), 1394 (s), 1320 (s), 1221 (s), 1052 (m), 748 (m) cm−1; GC-MS 
(EI, 70 eV): m/z (%): 328.2 (M+, 31), 282.2 (100), 254.2 (13), 225.1 (8); HRMS (EI): calcd. 
for C20H24O4 [M]+: 328.14543; found: 328.14541. 
 
Methyl 3-(4-chlorophenoxy)-6-hydroxy-2,4-dimethylbenzoate (15g) 
Starting with 1,3-bis(silyl enol ether), 4b (500 mg, 1.9 mmol), 3-
(siloxy)alk-2-en-1-one 14d (574 mg, 1.9 mmol)  and TiCl4 (0.21 mL, 1.9 
mmol), 15g was isolated as a colourless solid (315 mg, 54%), mp. 83 °C; 
1H NMR (300 MHz, CDCl3): δ = 2.09 (s, 3 H, CH3), 2.30 (s, 3 H, CH3), 
3.95 (s, 3 H, OCH3), 6.67 (d, 2 H, J = 9.0 Hz, ArH), 6.76 (s, 1 H, ArH), 
7.20 (d, 2 H, J = 9.0 Hz, ArH), 11.10 (s, 1 H, OH); 13C NMR (75 MHz, 
CDCl3): δ = 15.2, 17.1, 52.2 (CH3), 111.1 (C), 115.7 (2C), 117.6 (CH), 126.3 (C), 129.6 (2C, 
CH), 133.5, 139.7, 143.6, 156.5, 159.7, 171.7 (C); IR (KBr): ν~ = 3431 (m), 2959 (w), 1661 
(s), 1486 (s), 1442 (m), 1361 (m), 1326 (s), 1318 (s), 1074 (m), 825 (m), 803 (m) cm−1; GC-
MS (EI, 70 eV): m/z (%): 306 (M+, 33), 274 (100), 246 (10), 163.1 (8); elemental analysis: 
calcd. (%) for C16H15ClO4 (306.74): C 62.65, H 4.93; found: C 62.42, H 4.68. 
 
Ethyl 3-(4-chlorophenoxy)-6-hydroxy-2,4,5-trimethylbenzoate (15h)  
Starting with 1,3-bis(silyl enol ether), 4f (662 mg, 2.1 mmol), 3-
(siloxy)alk-2-en-1-one 14d (654 mg, 2.1 mmol)  and TiCl4 (0.24 mL, 2.1 
mmol), 15h was isolated as a colourless solid (325 mg, 43%); 1H NMR 
(300 MHz, CDCl3): δ = 1.40 (t, 3 H, J = 7.1 Hz, CH3), 2.06 (s, 3 H, CH3), 
2.20 (s, 3 H, CH3), 2.29 (s, 3 H, CH3), 4.42 (q, 2 H, J = 7.1 Hz, OCH2), 
6.66 (d, 2 H, J = 9.0 Hz, ArH), 7.19 (d, 2 H, J = 9.0 Hz, ArH), 11.52 (s, 1 H, OH); 13C NMR 
(75 MHz, CDCl3): δ = 11.8, 13.7, 14.1, 15.2 (CH3), 61.6 (CH2), 110.4 (C), 115.8 (2C, CH), 
124.2, 126.1 (C), 129.5 (2C, CH), 130.0, 137.7, 143.2, 156.9, 157.9, 171.8 (C); IR (KBr): ν~ = 
2978 (w), 1650 (s), 1484 (s), 1398 (m), 1316 (s), 1221 (s), 1033 (m), 805 (m) cm−1; GC-MS 
(EI, 70 eV): m/z (%): 334.1 (M+, 34), 288.1 (100), 260.1 (20); elemental analysis: calcd. (%) 
for C18H19ClO4 (334.79): C 64.57, H 5.72; found: C 64.26, H 5.86. 
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Ethyl 5-ethyl-3-(4-chlorophenoxy)-6-hydroxy-2,4-dimethylbenzoate (15i) 
Starting with 1,3-bis(silyl enol ether), 4g (662 mg, 2.1 mmol), 3-
(siloxy)alk-2-en-1-one 14d (654 mg, 2.1 mmol) and TiCl4 (0.24 mL, 2.1 
mmol), 15i was isolated as a colourless solid (325 mg, 43%); 1H NMR 
(300 MHz, CDCl3): δ = 1.12 (t, 3 H, J = 7.5 Hz, CH3), 1.40 (t, 3 H, J = 
7.1 Hz, CH3), 2.09 (s, 3 H, CH3), 2.29 (s, 3 H, CH3), 2.72 (q, 2 H, J = 
7.5 Hz, CH2), 4.42 (q, 2 H, J = 7.1 Hz, OCH2), 6.67 (d, 2 H, J = 9.0 Hz, 
ArH), 7.20 (d, 2 H, J = 9.0 Hz, ArH), 11.48 (s, 1 H, OH); 13C NMR (75 MHz, CDCl3): δ = 
13.0, 13.2, 14.1, 15.3 (CH3), 19.7, 61.6 (CH2), 110.6 (C), 115.8 (2C, CH), 126.1 (C), 129.5 
(2C, CH), 130.2, 130.3, 137.1, 143.3, 156.8, 157.8, 171.8 (C); IR (KBr): ν~ = 2978 (w), 1650 
(s), 1484 (s), 1398 (m), 1316 (s), 1221 (s), 1033 (m), 805 (m) cm−1; GC-MS (EI, 70 eV): m/z 
(%): 347.9 (M+, 51), 301.9 (100), 273.9 (38); elemental analysis: calcd. (%) for C19H21ClO4 
(347.9): C 65.42, H 6.07; found: C 65.80, H 6.22. 
 
Ethyl 3-(4-methoxyphenoxy)-6-hydroxy-2,4-dimethylbenzoate (15j) 
Starting with 1,3-bis(silyl enol ether), 4a (589 mg, 2.1 mmol), 
3-(siloxy)alk-2-en-1-one 14e (627 mg, 2.1 mmol) and TiCl4 (0.23 mL, 
2.1 mmol), 15j was isolated as a colourless solid (344 mg, 52%), mp. 
88-89 °C; 1H NMR (400 MHz, CDCl3): δ = 1.41 (t, 3 H, J = 7.1 Hz, 
CH3), 2.11 (s, 3 H, CH3), 2.35 (s, 3 H, CH3), 3.76 (s, 3 H, OCH3), 4.43 
(q, 2 H, J = 7.1 Hz, OCH2), 6.67 (d, 2 H, J = 9.1 Hz, ArH), 6.76 (s, 1 H, ArH), 6.80 (d, 2 H, J 
= 9.1 Hz, ArH), 11.67 (s, 1 H, OH); 13C NMR (100 MHz, CDCl3): δ = 14.1, 15.3, 17.2, 55.6 
(CH3), 61.6 (CH2), 111.1 (C), 114.7 (2C), 115.0 (2C), 117.4 (CH), 133.8, 139.9, 144.2, 152.0, 
154.1, 159.5, 171.3 (C); IR (KBr): ν~ = 3423 (w), 2993 (m), 1659 (s), 1505 (s), 1405 (s), 1374 
(m), 1316 (s), 1217 (s), 1075 (m), 824 (m) cm−1; GC-MS (EI, 70 eV): m/z (%): 316.2 (M+, 
58), 270.2 (100), 199.1 (5), 135.1 (14); elemental analysis: calcd. (%) for C18H20O5 (316.34): 
C 68.34, H 6.37; found: C 68.13, H 6.67. 
 
Ethyl 3-(3,4-dimethoxyphenoxy)-6-hydroxy-2,4-dimethylbenzoate (15k) 
Starting with 1,3-bis(silyl enol ether), 4a (500 mg, 1.8 mmol), 
3-(siloxy)alk-2-en-1-one 14f (590 mg, 1.8 mmol) and TiCl4 (0.19 mL, 
1.8 mmol), 15k was isolated as a colourless solid (362 mg, 58%); 1H 
NMR (300 MHz, CDCl3): δ = 1.41 (t, 3 H, J = 7.1 Hz, CH3), 2.11 (s, 3 
H, CH3), 2.35 (s, 3 H, CH3), 3.81 (s, 3 H, OCH3), 3.84 (s, 3 H, OCH3), 
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4.43 (q, 2 H, J = 7.1 Hz, OCH2), 6.05 (dd, 1 H, J = 2.8 Hz, 8.7 Hz, ArH), 6.52 (d, 1 H, J = 2.8 
Hz, ArH), 6.68 (d, 1 H, J = 8.7 Hz, ArH), 6.76 (s, 1 H, ArH), 11.17 (s, 1 H, OH); 13C NMR 
(75 MHz, CDCl3): δ = 14.1, 15.3, 17.2, 55.8, 56.3 (CH3), 61.6 (CH2), 100.0, 104.0 (CH), 
111.1 (C), 111.7, 117.4 (CH), 133.8, 139.9, 143.7, 144.0, 150.0, 152.4, 159.5, 171.3 (C); IR 
(KBr): ν~ = 3426 (w), 2939 (m), 1659 (s), 1512 (s), 1466 (s), 1450 (s), 1393 (m), 1260 (m), 
1211 (s), 1124 (m), 1023 (m), 802 (m) cm−1; GC-MS (EI, 70 eV): m/z (%): 346.2 (M+, 65), 
300.2 (100), 285.1 (19), 150.1 (7); elemental analysis: calcd. (%) for C19H22O6 (346.37): C 
65.88, H 6.40; found: C 66.10, H 6.04. 
 
Ethyl 3-(3,4-dimethoxyphenoxy)-6-hydroxy-2,4,5-trimethylbenzoate (15l) 
Starting with 1,3-bis(silyl enol ether), 4f (500 mg, 1.7 mmol), 3-
(siloxy)alk-2-en-1-one 14f (562 mg, 1.7 mmol) and TiCl4 (0.18 mL, 
1.7 mmol), 15l was isolated as a colourless solid (215 mg, 35%), mp. 
110-111 °C; 1H NMR (400 MHz, CDCl3): δ = 1.40 (t, 3 H, J = 7.1 Hz, 
CH3), 2.09 (s, 3 H, CH3), 2.20 (s, 3 H, CH3), 2.32 (s, 3 H, CH3), 3.81 
(s, 3 H, OCH3), 3.84 (s, 3 H, OCH3), 4.42 (q, 2 H, J = 7.1 Hz, OCH2), 
6.02 (dd, 1 H, J = 2.8 Hz, 8.7 Hz, ArH), 6.52 (d, 1 H, J = 2.8 Hz, ArH), 6.67 (d, 1 H, J = 8.7 
Hz, ArH), 11.51 (s, 1 H, OH); 13C NMR (100 MHz, CDCl3): δ = 11.8, 13.8, 14.1, 15.3, 55.8, 
56.3 (CH3), 61.6 (CH2), 100.1, 104.1 (CH), 110.3 (C), 111.7 (CH), 123.9, 130.3, 138.2, 
143.64, 143.69, 150.0, 152.7, 157.7, 171.9 (C); IR (KBr): ν~ = 3442 (w), 2992 (m), 1643 (s), 
1510 (s), 1447 (m), 1393 (m), 1312 (s), 1260 (s), 1212 (s), 1192 (s), 1131 (m), 836 (m) cm−1; 
GC-MS (EI, 70 eV): m/z (%): 360.2 (M+, 49), 314.2 (100), 215.1 (2), 138.1 (6); elemental 
analysis: calcd. (%) for C20H24O6 (360.40): C 66.65, H 6.71; found: C 66.47, H 7.14. 
 
Ethyl 3-(4-bromophenoxy)-6-hydroxy-2,4-dimethylbenzoate (15m) 
Starting with 1,3-bis(silyl enol ether), 4a (400 mg, 1.4 mmol), 3-
(siloxy)alk-2-en-1-one 14g (497 mg, 1.4 mmol) and TiCl4 (0.16 mL, 1.4 
mmol), 15m  was isolated as a yellow solid (305 mg, 58%), mp. 50-52 
°C; 1H NMR (300 MHz, CDCl3): δ = 1.41 (t, 3 H, J = 7.1 Hz, CH3), 2.09 
(s, 3 H, CH3), 2.31 (s, 3 H, CH3), 4.42 (q, 2 H, J = 7.1 Hz, OCH2), 6.63 
(d, 2 H, J = 9.0 Hz, ArH), 6.76 (s, 1 H, ArH), 7.34 (d, 2 H, J =9.0 Hz, 
ArH), 11.19 (s, 1 H, OH); 13C NMR (100 MHz, CDCl3): δ = 14.1, 15.3, 17.1 (CH3), 61.7 
(OCH2), 111.2, 113.6 (C), 116.0 (CHAr), 117.6 (C ), 132.5 (CHAr),139.5, 143.5, 157.1, 159.7, 
171.2 (C); IR (KBr): ν~ = 3430 (w), 2995 (m), 1660 (s), 1483 (s), 1373 (s), 1346 (m), 1316 (s), 
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1217 (s), 1067 (m), 1058 (m), 1003 (m), 836 (s), 799 (s), 599 (m), 501 (m) cm−1; GC-MS (EI, 
70 eV): m/z (%): 366 (M+,81Br 30), 364(79Br, 30), 320 (100), 318 (99), 163 (8); elemental 
analysis: calcd. (%) for C17H17O4Br (365.218): C 55.91, H 4.69; found: C 56.19, H 4.33. 
 
Benzyl 3-(4-bromophenoxy)-6-hydroxy-2,4-dimethylbenzoate (15n) 
Starting with 1,3-bis(silyl enol ether), 4d (300 mg, 0.89 
mmol), 3-(siloxy)alk-2-en-1-one 14g (306 mg, 0.89 mmol) and TiCl4 
(0.09 mL, 0.89 mmol), 15n was isolated as a yellow solid (220 mg, 
59%); 1H NMR (300 MHz, CDCl3): δ = 1.91 (s, 3 H, CH3), 2.43 (s, 3 
H, CH3), 5.26 (s, 2 H, CH2), 6.52 (d, 2 H, J = 7.1 Hz, ArH), 6.64 (s, 1 
H, ArH), 6.71 (d, 2 H, J =7.1 Hz, ArH), 7.22-7.35 (m, 5 H, ArH), 11.21 (s, 1 H, OH); 13C 
NMR (100 MHz, CDCl3): δ = 15.5, 17.2 (CH3), 67.5 (OCH2), 111.6, 113.6 (C), 116.0, 116.2, 
117.6 (CHAr), 128.5, 128.6, 132.5, 132.7 (CHAr), 134.9, 139.8, 143.5, 157.0, 159.9, 171.0, 
186.2 (C); IR (KBr): ν~ = 3033 (w), 2959 (w), 1662 (s), 1428 (s), 1385 (m), 1309 (s), 1229 (s), 
1162 (m), 1069 (s), 1005 (m),  828 (s), 697 (s) cm−1; GC-MS (EI, 70 eV): m/z (%): 428 
(M+,81Br 93), 426 (79Br, 90), 320 (88), 318 (87), 91 (100); HRMS (EI): calcd. for C22H19BrO4 
[M]+: 426.045476; found: 426.046612. 
 
Ethyl 3-(4-cyanophenoxy)-6-hydroxy-2,4-dimethylbenzoate (15o) 
Starting with 1,3-bis(silyl enol ether), 4a (500 mg, 1.82 mmol), 3-
(siloxy)alk-2-en-1-one 14h (530 mg, 1.82 mmol) and  TiCl4 (0.20 mL, 
1.82 mmol), 15o was isolated as a colourless solid (284 mg, 50%); 1H 
NMR (300 MHz, CDCl3): δ = 1.41 (t, 3 H, J = 7.1 Hz, CH3), 2.08 (s, 3 
H, CH3), 2.30 (s, 3 H, CH3), 4.44(q, 2 H, J = 7.1 Hz, OCH2), 6.80 (d, 2 
H, J = 8.5 Hz, ArH), 6.84 (s, 1 H, ArH), 7.57 (d, 2 H, J = 8.5 Hz, ArH), 
11.22 (s, 1 H, OH); 13C NMR (100 MHz, CDCl3): δ = 14.1, 15.2 (CH3), 61.8 (OCH2), 105.1, 
111.3 (C), 115.4, 117.8 (CHAr), 118.8, 133.3 (C ), 134.3 (CHAr),139.0, 142.8, 143.7, 160.1, 
161.3, 171.1 (C); IR (KBr): ν~ = 3390 (w), 2953 (w), 1738 (s), 1611 (s), 1296 (m), 1223 (s), 
1165 (m), 827 (m), 732 (s) cm−1; GC-MS (EI, 70 eV): m/z (%): 311 (M+, 26), 265(100), 135 
(4); elemental analysis: calcd. (%) for C18H17O4N (311.34): C 69.44, H 4.49; found: C 69.32, 
H 4.35. 
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Benzyl 3-(4-cyanophenoxy)-6-hydroxy-2,4-dimethylbenzoate (15p) 
Starting with 1,3-bis(silyl enol ether), 4d (400 mg, 1.19 
mmol), 3-(siloxy)alk-2-en-1-one 14h (340 mg, 1.19 mmol) and  TiCl4 
(0.13 mL, 1.19 mmol), 15p was isolated as a yellow oil (292 mg, 
54%); 1H NMR (300 MHz, CDCl3): δ = 2.02 (s, 3 H, CH3), 2.22 (s, 3 
H, CH3), 5.35 (s, 2 H, OCH2), 6.76 (d, 2 H, J = 9.0 Hz, ArH), 7.20 (s, 
1 H, ArH), 7.30-7.37 (m, 5 H, Ph), 7.50 (d, 2 H, J = 9.0 Hz, ArH), 
11.11 (s, 1 H, OH); 13C NMR (100 MHz, CDCl3): δ = 15.4, 15.7 (CH3), 67.5 (CH2), 105.0, 
111.1 (C), 115.3, 118.8 (CHAr), 118.7 (C), 125.1, 128.1, (CHAr), 128.6 (C), 133.2 (CHAr), 
134.7, 139.3, 142.7, 160.1, 161.1, 170.8 (C); MS (EI, 70 eV): m/z (%): 373 (M+, 34), 265 
(13), 91 (100); elemental analysis: calcd. (%) for C23H19NO4 (373.40): C 73.98, H 5.13, N 
3.75; found: C 73.51, H 4.98, N 3.72 
 
Ethyl 3-(4-methylacetatephenoxy)-6-hydroxy-2,4-dimethylbenzoate (15q) 
Starting with 1,3-bis(silyl enol ether), 4a (400 mg, 1.45 
mmol), 3-(siloxy)alk-2-en-1-one 14i (480 mg, 1.45 mmol) and 
TiCl4 (0.16 mL, 1.45 mmol), 15q was isolated as a colourless 
solid (259 mg, 50%), mp. 72-73 °C; 1H NMR (300 MHz, 
CDCl3): δ = 1.40 (t, 3 H, J = 7.1 Hz, CH3), 2.09 (s, 3 H, CH3), 
2.33 (s, 3 H, CH3), 3.55 (s, 2 H, CH2), 3.68 (s, 3 H, OCH3), 4.42 (q, 2 H, J = 7.1 Hz, OCH2), 
6.69 (d, 2 H, J = 8.7 Hz, ArH), 6.75 (s, 1 H, ArH), 7.15 (d, 2 H, J =8.7 Hz, ArH), 11.17 (s, 1 
H, OH); 13C NMR (100 MHz, CDCl3): δ = 14.0, 15.3, 17.2 (CH3), 40.1 (CH2), 51.9 (OCH3),  
61.6 (OCH2), 111.1 (C), 114.5, 117.4 (CHAr ), 126.8 (C) 130.4 (CHAr),136.6, 139.7, 143.7, 
157.6, 159.5, 171.3, 172.1 (C); IR (KBr): ν~ = 3438 (w), 2987 (s), 1740 (s), 1605 (s), 1505 (s), 
1318 (s), 1216 (s), 1143 (s) 1012 (m), 874 (m), 802 (s), 642 (m) cm−1; GC-MS (EI, 70 eV): 
m/z (%): 358 (M+, 28), 312(100), 253 (13); elemental analysis: calcd. (%) for C20H22O6 
(358.39): C 67.03, H 6.19; found: C 67.38, H 6.37. 
 
Benzyl 6-hydroxy 3-(4-(2-methoxy-2-oxoethyl)phenoxy)-2,4-dimethylbenzoate (15r) 
Starting with 1,3-bis(silyl enol ether), 4d (500 mg, 1.49 
mmol), 3-(siloxy)alk-2-en-1-one 14i (500 mg, 1.49 mmol) and 
TiCl4 (0.16 mL, 1.49 mmol), 15r was isolated as a yellow solid 
(292 mg, 54%); mp. 66-67 °C; 1H NMR (300 MHz, CDCl3): δ 
= 2.09 (s, 3 H, CH3), 2.30 (s, 3 H, CH3), 3.54 (s, 2 H, CH2), 
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3.68 (s, 3 H, OCH3),  5.39 (s, 2 H, OCH2), 6.67 (d, 2 H, J = 8.7 Hz, ArH), 6.76 (s, 1 H, ArH), 
7.25 (d, 2 H, J = 8.7 Hz, ArH), 7.35-7.43 (m, 5 H, Ph), 11.11 (s, 1 H, OH); 13C NMR (100 
MHz, CDCl3): δ = 15.6, 17.2 (CH3), 40.1 (CH2), 67.5 (CH2), 110.9 (C), 114.4, 114.5, 117.5 
(CHAr), 126.9 (C), 128.3, 128.5, 128.6, 130.5, 130.7 (CHAr), 133.7 134.9, 140.1, 143.7, 157.0, 
159.7, 171.1, 172.2; IR (KBr): ν~ = 3441 (w), 2955 (m), 1736 (s), 1655 (s), 1612 (m), 1509 
(s), 1435 (m), 1387 (s), 1313 (s), 1231 (s), 1161 (s), 1055 (m), 908 (m), 803 (s), 751 (s), 695 
(s), 585 (m); elemental analysis: calcd. (%) for C25H24O6 (420.45): C 71.41, H 5.75; found: C 
71.51, H 5.38. 
 
Ethyl 3-(4-(2-methoxy-2-oxoethyl)phenoxy)-5-hydroxy-4-nhexyl-2,4-dimethylbenzoate 
(15s) 
Starting with 1,3-bis(silyl enol ether), 4j (500 
mg, 1.39 mmol), 3-(siloxy)alk-2-en-1-one 14i (460 
mg, 1.39 mmol) and TiCl4 (0.15 mL, 1.39 mmol), 
15s was isolated as a yellow oil (292 mg, 54%); 1H 
NMR (300 MHz, CDCl3): δ = 0.88 (t, 3 H, J = 6.9 
Hz, CH3), 1.28-1.32 (m, 8 H, CH2), 1.39 (t, 3 H, J = 7.1 Hz, CH3), 2.09 (s, 3 H, CH3), 2.29 (s, 
3 H, CH3), 2.67 (t, 2 H, J = 8.2 Hz, CH2), 3.56 (s, 2 H, OCH2), 3.69 (s, 2 H, CH2),  4.11(q, 2 
H, J = 7.1 Hz, OCH2), 6.67 (d, 2 H, J = 8.7 Hz, ArH), 7.15 (d, 2 H, J = 8.7 Hz, ArH), 11.42 
(s, 1 H, OH); 13C NMR (100 MHz, CDCl3): δ = 13.3, 14.0, 15.3 (CH3), 22.6, 26.5, 29.0, 29.6, 
31.7, 40.2 (CH2),  52.0 (OCH3), 61.5 (CH2) , 110.5 (C), 114.6 (CHAr), 126.7, 128.9, 130.3 (C 
), 130.4 (CHAr),137.6, 143.4, 157.3, 157.8, 171.9, 172.3 (C); IR (neat): ν~ = 2954 (s), 2928 (s), 
1742 (s), 1655 (s), 1609 (m), 1373 (m), 1315 (s), 1222 (s), 1159 (m),1052 (s), 1014 (m), 806 
(s) cm−1; GC-MS (EI, 70 eV): m/z (%): 442 (M+, 100), 396(63), 367 (46), 353 (34), 326 (90), 
233 (33); elemental analysis: calcd. (%) for C28H34O6 (442.56): C 70.56, H 7.74; found: C 
70.21, H 7.30. 
 
Methyl 2-(4-(3-acetyl-4-hydroxy-2,4-dimethylphenoxy)phenyacetate (15t) 
Starting with 1,3-bis(silyl enol ether), 4x (400 mg, 1.63 
mmol), 3-(siloxy)alk-2-en-1-one 14i (540 mg, 1.63 mmol) and 
TiCl4 (0.17 mL, 1.6 mmol), 15t was isolated as a yellow oil 
(280 mg, 55%); 1H NMR (300 MHz, CDCl3): δ = 2.09 (s, 3 H, 
CH3), 2.33 (s, 3 H, CH3), 2.62 (s, 3 H, CH3), 3.57 (s, 2 H, CH2),  
3.69 (s, 3 H,  OCH3), 6.71 (d, 2 H, J = 8.6 Hz, ArH), 6.75 (s, 1 
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H, ArH), 7.17 (d, 2 H, J = 8.6 Hz, ArH), 11.91 (s, 1 H, OH); 13C NMR (100 MHz, CDCl3): δ 
= 16.0, 17.2, 33.0 (CH3), 40.0 (CH2) 51.9 (OCH3), 114.4, 118.4 (CHAr), 120.8, 127.0 (C), 
130.5 (CHAr),131.7, 140.3, 143.7, 156.8, 157.0, 172.0, 186.3, 205.3 (C); IR (neat): ν~ = 3390 
(w), 2953 (w), 1738 (s), 1611 (s), 1296 (m), 1223 (s), 1165 (m), 827 (m), 732 (s) cm−1; GC-
MS (EI, 70 eV): m/z (%): 311 (M+, 26), 265(100), 135 (4); elemental analysis: calcd. (%) for 
C19H22O4 (314.38): C 72.59, H 7.05; found: C 72.23, H 7.06. 
 
Ethyl 3-(4-methoxyphenoxy)-6-hydroxy-2,4,5-trimethylbenzoate (15u) 
Starting with 1,3-bis(silyl enol ether), 4f (341 mg, 1.2 mmol), 3-
(siloxy)alk-2-en-1-one 14e (353 mg, 1.2 mmol) and TiCl4 (0.13 mL, 
1.2 mmol), 15u was isolated as a colourless solid (120 mg, 30%); 1H 
NMR (400 MHz, CDCl3): δ = 1.40 (t, 3 H, J = 7.1 Hz, CH3), 2.08 (s, 3 
H, CH3), 2.19 (s, 3 H, CH3), 2.32 (s, 3 H, CH3), 3.75 (s, 3 H, OCH3), 
4.42 (q, 2 H, J = 7.1 Hz, OCH2), 6.65 (d, 2 H, J = 9.1 Hz, ArH), 6.78 (d, 2 H, J = 9.1 Hz, 
ArH), 11.51 (s, 1 H, OH); 13C NMR (100 MHz, CDCl3): δ = 10.8, 12.8, 13.1, 14.3, 54.6 
(CH3), 60.5 (CH2), 109.3 (C), 113.7 (2C), 114.1 (2C, CH), 122.9, 129.3, 137.2, 142.8, 151.3, 
153.0, 156.7, 170.9 (C); IR (KBr): ν~ = 2969 (m), 1651 (s), 1599 (m), 1492 (s), 1394 (s), 1320 
(s), 1221 (s), 1052 (m), 748 (m) cm−1; GC-MS (EI, 70 eV): m/z (%): 330.2 (M+, 44), 284.2 
(100); HRMS (EI): calcd. for C19H22O5 [M]+: 330.14618; found: 330.14616. 
 
General procedure for the synthesis of Resorcins a-m: 
To a CH2Cl2 solution (8 mL) of 1,3-bis(trimethylsilyloxy)-1-methoxy-1,3-butadiene 4a (860 
mg, 3.32 mmol) and of 19 (660 mg, 3.65 mmol) was dropwise added TMSOTf (0.3 mL, 1.66 
mmol, 0.5 equiv.) at −78 °C. The reaction mixture was allowed to warm to 20 °C during 6−12 
h. After stirring for additional 2−6 h at 20 °C, hydrochloric acid (10%, 25 mL) was added. 
The organic and the aqueous layers were separated and the latter was extracted with CH2Cl2 
(3 x 20 mL). The combined organic layers were dried (NaSO4), filtered and  the filtrate was 
concentrated in vacuo. The residue was purified by chromatography (silica gel, 
heptanes/EtOAc) to give 20a-m. 
 
Methyl 4-ethyl-2,6-dihydroxybenzoate (20a) 
Starting with 1,3-bis(silyl enol ether), 4b (880 mg, 3.32 mmol), 
3,3-dimethoxypentanoyl chloride 19 (660 mg, 3.65 mmol, 1.2 equiv.) 
and TMSOTf (0.3 mL, 1.66 mmol, 0.5 equiv.), 20a was isolated as 
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yellow solid (280 mg, 43%). 1H NMR (300 MHz, CDCl3): δ = 1.13 (t, 3 H, J = 7.6 Hz, CH3), 
2.48 (q, 2 H, J = 7.5 Hz, CH2), 3.99 (s, 3 H, OCH3), 6.28 (s, 2 H, CHAr), 9.54 (s, 2 H, OH); 
13C NMR (75 MHz, CDCl3): δ = 14.4 (CH3), 29.2 (CH2), 52.7 (OCH3), 97.7 (C), 107.8 (CH), 
154.6, 164.5, 169.8 (C); IR (KBr): ν~ = 3427 (s), 2960 (s), 1670 (s), 1571 (s), 1377 (m), 1257 
(s), 1103 (s), 1040 (m), 949 (m), 846 (s) 799 (s), 738 (s), 613 (s), 531 (m) cm−1; GC-MS (EI, 
70 eV): m/z (%) = 196.0 (M+, 35), 164.0 (100), 136.0 (21), 121.0 (27); elemental analysis: 
calcd. (%) for C10H12O4 (196.07): C 61.22, H 6.16; found: C 61.32, H 6.11. 
 
Ethyl 4-ethyl-2,6-dihydroxybenzoate (20b) 
Starting with 1,3-bis(silyl enol ether), 4a (1.0g, 3.64 mmol), 3,3-
dimethoxypentanoyl chloride 19 (650 mg, 4.01 mmol, 1.2 equiv.) and 
TMSOTf (0.3 mL, 1.82 mmol, 0.5 equiv.), 20b was isolated as yellow 
oil (360 mg, 47%). 1H NMR (300 MHz, CDCl3): δ = 1.20 (t, 3 H, J = 7.62 Hz, CH3), 1.47 (t, 
3 H, J = 7.14 Hz, 3 H, CH3), 2.54 (q, 2 H, J = 7.59 Hz, CH2), 4.55 (q, 2 H, J = 7.41 Hz, CH2), 
6.34 (s, 2 H, CHAr), 9.75 (s, 2 H, OH); 13C NMR (75 MHz, CDCl3): δ = 14.4, 23.7 (CH3), 
29.2, 62.4 (CH2), 97.6 (C), 107.7 (CHAr), 155.6, 160.6, 172.4 (C); IR (neat): ν~ = 3427 (s), 
2960 (s), 1670 (s), 1571 (s), 1377 (m), 1257 (s), 1103 (s), 1040 (m), 949 (m), 846 (s) 799 (s), 
738 (s), 613 (s), 531 (m) cm−1; GC-MS (EI, 70 eV): m/z (%) = 210 (M+, 8%), 164 (100), 141 
(56), 97 (12), 75 (24), 43 (21); elemental analysis: calcd. (%) for C11H14O4 (210.09): C 62.85, 
H 6.71; found: C 62.32, H 6.11. 
 
Isopropyl 4-ethyl-2,6-dihydroxybenzoate (20c) 
Starting with 1,3-bis(silyl enol ether), 4e (600 mg, 2.04 
mmol), 3,3-dimethoxypentanoyl chloride 19 (450 mg, 2.49 
mmol, 1.2 equiv.) and TMSOTf (0.4 mL, 1.02 mmol, 0.5 
equiv.), 20c was isolated as yellow oil (260 mg, 56%). 1H NMR (300 MHz, CDCl3): δ = 1.19 
(t, 3 H, J = 7.65 Hz, CH3), 1.45 (d, 6 H, J = 6.27 Hz,, (CH3)2), 2.53 (q, 2 H, J = 7.59 Hz, 
CH2), 5.39-5.47 (m, 1 H, CH), 6.32 (s, 1 H, CHAr) 9.81 (s, 2 H, OH); 13C NMR (75 MHz, 
CDCl3): δ = 14.5, 22.0 (CH3), 29.6 (CH2), 71.1 (CH), 98.0 (C), 107.7 (CHAr) 154.2, 160.8, 
169.3 (C); IR (neat): ν~ = 3439 (s), 3149 (w), 2978 (s), 1669 (s), 1571 (s), 1378 (m), 1284 (m), 
1189 (s), 1088 (s), 1040 (w), 844 (m), 706 (m), 530 (w) cm−1; GC-MS (EI, 70 eV): m/z (%) = 
224 (M+, 16%), 182 (13), 164 (100), 136 (13), 121 (21); HRMS (EI): calcd. for C12H16O4 
[M]+: 224.104661; found: 224.10431. 
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Benzyl 4-ethyl-2,6-dihydroxybenzoate (20d) 
Starting with 1,3-bis(silyl enol ether), 4d (700 mg, 2.07 
mmol), 3,3-dimethoxypentanoyl chloride 19 (450 mg, 2.49 mmol, 
1.2 equiv.) and TMSOTf (0.18 mL, 1.03 mmol, 0.5 equiv.), 20d 
was isolated as yellow oil (285 mg, 52%). 1H NMR (300 MHz, CDCl3): δ = 1.17 (t, 3 H, J = 
7.62 Hz, CH3), 2.52 (q, 2 H, J = 7.56 Hz, CH2), 5.46 (s, 2 H, CH2), 6.32 (s, 2 H, CHAr), 7.38-
7.41 (m, 5 H, Ph), 9.64 (s, 2 H, OH); 13C NMR (75 MHz, CDCl3): δ = 14.4 (CH3), 29.1, 67.9 
(CH2), 97.7 (C), 107.8 (CHAr), 125.1, (C), 126.9, 129.2, 129.2 (CHAr), 134.0, 154.6, 160.7, 
169.3 (C); IR (neat): ν~ = 3427 (s), 2960 (s), 1670 (s), 1571 (s), 1377 (m), 1257 (s), 1103 (s), 
1040 (m), 949 (m), 846 (s) 799 (s), 738 (s), 613 (s), 531 (m) cm−1; EI-MS (EI, 70 eV): m/z 
(%) = 272 (M+, 44%), 165 (9), 135 (12), 91 (100), 65 (14), 57 (6); HRMS (EI): calcd. for 
C16H16O4 [M]+: 272.104117; Found: 272.10431. 
 
2-Methoxyethyl 4-ethyl-2,6-dihydroxybenzoate (20e) 
Starting with 1,3-bis(silyl enol ether), 4c (600 mg, 1.97 
mmol), 3,3-dimethoxypentanoyl chloride 19 (425 mg, 2.36 
mmol, 1.2 equiv.) and TMSOTf (0.18 mL, 0.98 mmol, 0.5 
equiv.), 20e was isolated as yellow oil (180 mg, 38%). 1H 
NMR (300 MHz, CDCl3): δ = 1.20 (t, 3 H, J = 7.62 Hz, CH3), 2.55 (q, 2 H, J = 7.56 Hz, 
CH2), 3.43 (s, 3 H, OCH3), 3.72 (t, 2 H, J = 4.62 Hz, CH2), 4.58 (t, 2 H, J = 4.68 Hz, CH2), 
6.34 (s, 2 H, CHAr), 9.66 (s, 2 H, OH); 13C NMR (75 MHz, CDCl3): δ = 14.4 (CH3), 29.2 
(CH2), 59.0 (OCH3), 64.4, 69.6 (CH2), 97.8 (C), 107.8 (CHAr), 154.6, 160.8, 169.3 (C); IR 
(neat): ν~ = 3427 (s), 2960 (s), 1670 (s), 1571 (s), 1377 (m), 1257 (s), 1103 (s), 1040 (m), 949 
(m), 846 (s) 799 (s), 738 (s), 613 (s), 531 (m) cm−1; GC-MS (EI, 70 eV): m/z (%) = 240 (M+, 
8%), 225 (100), 207 (8), 183 (21), 141 (56), 97 (12), 75 (24), 43 (21); HRMS (EI): calcd. for 
C12H16O5 [M]+: 240.09923; found: 240.09954. 
 
Methyl 3-(3-chloropropyl)-4-ethyl-2,6-dihydrobenzoate (20g) 
Starting with 1,3-bis(silyl enol ether), 4u (600 mg, 1.78 
mmol), 3,3-dimethoxypentanoyl chloride 19 (385 mg, 2.13 
mmol, 1.2 eq) and TiCl4 (0.19 mL, 1.78 mmol), 20g was isolated 
as yellow solid (195 mg, 40 %). mp. 73-75 °C; 1H NMR (300 MHz, CDCl3): δ = 1.16 (t, 3 H, 
J = 7.4 Hz, CH3), 2.04 (q, 2 H, J = 6.7 Hz), 2.76-2.88 (m, 4 H, -CH2-CH2-), 3.52 (t, 2 H, J = 
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6.6 Hz), 3.93 (s, 3 H, OCH3), 5.62 (s, 1 H, OH), 6.2 (s, 1 H, CHAr), 11.99 (s, 1 H, OH); 13C 
NMR (75 MHz, CDCl3): δ =15.7 (CH3), 20.0, 29.6, 31.3, (CH2), 51.9 (OCH3), 104.7 (C), 
109.4 (CHAr), 111.5, 147.2, 158.5, 163.1, 172.4 (C); IR (KBr): ν~ = 3371 (w), 2959 (w), 1612 
(s), 1453 (m), 1416 (m), 1262 (s), 1198 (s), 1151 (s), 1098 (w), 983 (m), 856 (m) 765 (s) 
cm−1; GC-MS (EI, 70 eV): m/z (%) = 272 (M+,35Cl, 65%), 274 (37Cl, 6), 240 (6), 209 (77), 
205 (100), 178 (32), 77 (6). elemental analysis.: calcd. (%) for C13H17ClO4 (272.72): C 57.25, 
H 6.28; found: C 57.39, H 6.34. 
 
Methay 3-butyl-4-ethyl-2,6-dihydroxybezoate (20i) 
Starting with 1,3-bis(silyl enol ether), 4h (600 mg, 1.89 
mmol), 3,3-dimethoxypentanoyl chloride 19 (409 mg, 2.26 
mmol, 1.2 equiv.) and TMSOTf (0.17 mL, 0.94 mmol, 0.5 
equiv.), 20i was isolated as yellow solid (240 mg, 50 %). mp. 66-68 °C; 1H NMR (300 MHz, 
CDCl3): δ = 0.92 (t, 3 H, J = 7.17 Hz, CH3), 1.15 (t, 3 H, J = 7.41 Hz, CH3), 1.13-1.56 (m, 4 
H, -CH2-CH2-), 2.61 (t, 2 H, J = 7.8 Hz, CH2), 2.83 (q, 2 H, J = 7.4 Hz, CH2), 3.91 (s, 3 H, 
OCH3), 5.37 (s, 1 H, OH), 6.22 (s, 1 H, CHAr) 11.94 (s, 1 H, OH); 13C NMR (75 MHz, 
CDCl3): δ = 14.0, 15.7 (CH3), 22.6, 22.8, 29.6, 30.9 (CH2), 51.8 (OCH3), 104.6 (C), 109.3 
(CHAr), 113.6, 146.5, 158.2, 163.0, 172.4 (C); IR (KBr): ν~ = 3410 (w), 2934 (w), 1647 (s), 
1575 (s), 1421 (s), 1321 (s), 1284 (m), 1235 (s), 1175 (s), 1151 (s), 1120 (s), 1018 (m), 971 
(s), 935 (w), 810 (s) cm−1; GC-MS (EI, 70 eV): m/z (%) = 252 (M+, 27%), 220 (13), 203 (27), 
191 (15), 178 (100), 150 (12); elemental analysis: calcd. (%) for C14H20O4 (252.31): C 66.65, 
H 7.99; found: C 66.73, H 8.11. 
 
Methyl 4-ethyl-2,6-dihydroxy-3-phenethylbenzoate (20j) 
Starting with 1,3-bis(silyl enol ether), 4s (600 mg, 1.65 
mmol), 3,3-dimethoxypentanoyl chloride 19 (360 mg, 1.97 
mmol, 1.2 equiv.) and TMSOTf (0.14 mL, 0.82 mmol, 0.5 
equiv.), 20j was isolated as yellow solid (260 mg, 52 %). mp. 116-118 °C; 1H NMR (300 
MHz, CDCl3): δ = 1.14 (t, 3 H, J = 7.44 Hz, CH3), 2.83 (q, 2 H, J = 7.4 Hz, CH2), 2.88-2.93 
(m, 4 H, (CH2)2), 3.91 (s, 3 H, OCH3), 6.15 (s, 1 H, CHAr), 7.18-7.27 (m, 5 H, Ph), 11.98 (s, 1 
H, OH); 13C NMR (75 MHz, CDCl3): δ =15.7 (CH3), 22.5, 29.6, 34.8, (CH2), 51.9 (OCH3), 
104.7 (C), 109.4 (CHAr), 112.7 (C), 125.9, 128.4, (CHPh), 142.5, 146.9, 158.2, 163.1, 172.4 
(C); IR (KBr): ν~ = 3385 (w), 2974 (w), 1609 (s), 1431 (m), 1272 (s), 1195 (s), 1155 (s), 1101 
(m), 1035 (m), 839 (s) 751 (s), 698 (s) cm−1; EI-MS (EI, 70 eV): m/z (%) = 300 (M+, 65%), 
OOH
OMe
Et OH
CH3(CH2)3
OOH
OMe
Et OH
Ph(CH2)2
 72
269 (6), 209 (77), 177 (100), 91 (53); elemental analysis: calcd. (%) for C18H20O4 (300.34): C 
71.98, H 6.71; found: C 72.01, H 6.87. 
 
Methyl 4-ethyl-2,6-dihyroxy-3-methoxybenzoate (20k) 
Starting with 1,3-bis(silyl enol ether), 4q (600 mg, 2.06 
mmol), 3,3-dimethoxypentanoyl chloride 19 (440 mg, 2.47 mmol, 1.2 
equiv.) and TMSOTf (0.28 mL, 1.03 mmol, 0.5 equiv.), 20k was 
isolated as yellow oil (160 mg, 34 %). 1H NMR (300 MHz, CDCl3): δ = 1.23 (t, 3 H, J = 7.5 
Hz, CH3), 2.55 (q, 2 H, J = 7.5 Hz, CH2), 3.77 (s, 3 H, OCH3), 3.88 (s, 3 H, OCH3), 6.22 (s, 1 
H, CHAr), 11.35 (s, 1 H, OH); 13C NMR (75 MHz, CDCl3): δ = 11.6 (CH3), 34.4 (CH2), 52.6, 
60.2 (OCH3), 113.3 (CHAr), 119.9, 145.3, 153.4, 168.4, 169.3, 175.9 (C); IR (neat): ν~ = 3427 
(s), 2960 (s), 1670 (s), 1571 (s), 1377 (m), 1257 (s), 1103 (s), 1040 (m), 949 (m), 846 (s) 799 
(s), 738 (s), 613 (s), 531 (m) cm−1; GC-MS (EI, 70 eV): m/z (%) = 226 (M+, 71 %), 193 (42), 
179(26), 167 (62), 153 (100), 138 (64), 125 (23), 99 (15), 69 (25), 57 (24); HRMS (EI): calcd. 
for C11H14O5 [M]+: 226.083590; found: 226.08358. 
 
Ethyl 3,4-diethyl-2,6-dihydroxybenzoate (20l) 
Starting with 1,3-bis(silyl enol ether), 4g (500 mg, 1.65 mmol), 
3,3-dimethoxypentanoyl chloride 19 (350 mg, 1.98 mmol, 1.2 equiv.) 
and TMSOTf (0.12 mL, 0.82 mmol, 0.5 equiv.), 20l was isolated as 
white solid (237 mg, 60 %); mp. 80-81 °C; 1H NMR (300 MHz, CDCl3): 
δ = 1.12 (t, 3 H, J = 7.5 Hz, CH3), 1.17 (t, 3 H, J = 7.3 Hz, CH3), 1.40 (t, 3 H, J = 7.14 Hz, 
CH3), 2.63 (q, 2 H, J = 7.5 Hz, CH2), 2.85 (q, 2 H, J = 7.41 Hz, CH2), 4.39 (q, 2 H, J = 7.14 
Hz, CH2), 5.09 (s, 1 H, OH), 6.20 (s, 1 H, CHAr), 12.02 (s, 1 H, OH); 13C NMR (75 MHz, 
CDCl3): δ = 13.2, 14.0, 16.0 (CH3), 16.1, 29.6, 61.2 (CH2), 104.8 (C), 109.3 (CHAr), 114.8, 
146.6, 157.7, 162.9, 171.9 (C); IR (KBr): ν~ = 3464 (s), 2978 (s), 1612 (s), 1499 (w), 1479 
(m), 1424 (s), 1322 (s), 1273 (s), 1179 (s), 1113 (s), 1072 (m), 1007 (s), 841 (s), 764 (s), 622 
(m), 581 (w) cm−1; MS (CI, isobutane): 239 [(M+1)+]; elemental analysis: calcd. (%) for 
C13H18O4 (238.28): C 65.53, H 7.61; found: C 65.54, H 7.49. 
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Methyl 3-allyl-4-ethyl-2,6-dihydroxybenzoate (20m) 
Starting with 1,3-bis(silyl enol ether), 4w (500 mg, 1.66 
mmol), 3,3-dimethoxypentanoyl chloride 19 (360 mg, 1.99 mmol, 
1.2 equiv.) and TMSOTf (0.14 mL, 0.83 mmol, 0.5 equiv.), 20m 
was isolated as yellow oil (140 mg, 36 %).1H NMR (300 MHz, 
CDCl3): δ = 1.16 (t, 3 H, J = 7.4 Hz, CH3), 2.85 (q, 2 H, J = 7.4 Hz, CH2), 3.45 (d, 2 H, J = 
6.1 Hz, CH2), 3.93 (s, 3 H, OCH3), 5.06-5.11 (m, 2 H, CH2), 5.94-6.05 (m,1 H, CH), 6.27 (s, 1 
H, ArH), 12.03 (s, 1 H, OH); 13C NMR (75 MHz, CDCl3): δ = 15.7 (CH3), 27.1, 29.6 (CH2), 
51.9 (OCH3), 104.6 (C), 109.7 (CH), 110.2 (C), 115.6 (CH2), 135.9 CHAr), 147.4, 
159.1,162.6, 172.4 (C); IR (neat): ν~ = 3408 (w), 2976 (w), 1615 (s), 1414 (s), 1266 (s), 1194 
(m), 1154 (s), 1116 (m), 1028 (w), 983 (s), 910 (w), 812 (m) cm−1; GC-MS (EI, 70 eV): m/z 
(%) = 236 (M+, 47), 204 (57), 189 (75), 161 (100), 91 (14), 77 (12); elemental analysis: calcd. 
(%) for C13H16O4 (236.26): C 66.09, H 6.83; found: C 66.02, H 6.75. 
 
General procedure for the synthesis of Resorsin 21a-l: 
To a CH2Cl2 solution (5 mL) of 1,3-bis(trimethylsilyloxy)-1-methoxy-1,3-butadiene  4b (500 
mg, 1.91 mmol) and of 19 (385 mg, 2.11 mmol) was dropwise added TiCl4 (0.21 mL, 1.91 
mmol) at −78 °C. The reaction mixture was allowed to warm to 20 °C during 6−12 h. After 
stirring for additional 2−6 h at 20 °C, a saturated aqueous solution of NaHCO3 (20 mL) was 
added. The organic and the aqueous layers were separated and the latter was extracted with 
diethyl ether (3 x 25 mL). The combined organic layers were dried (NaSO4), filtered and the 
filtrate was concentrated in vacuo. The residue was purified by chromatography (silica gel, 
heptane/ ethyl acetate) to give 21a. 
 
Methyl 2-ethyl-4,6-dihydrobenzoate (21a) 
Starting with 1,3-bis(silyl enol ether), 4b (500 mg, 1.91 mmol), 
3,3-dimethoxypentanoyl chloride 19 (385 mg, 2.11 mmol, 1.2 eq) and 
TiCl4 (0.21 mL, 1.91 mmol), 21a was isolated as yellow solid (230 mg, 
61%). 1H NMR (300 MHz, CDCl3): δ = 1.30 (t, 3 H, J = 7.5 Hz, CH3), 3.28 (q, 2 H, J = 7.5 
Hz, CH2), 4.01 (s, 3 H, OCH3), 6.08 (s, 1 H, CHAr), 6.78 (s, 1 H, CHAr), 12.06 (s, 1 H, OH); 
13C NMR (75 MHz, CDCl3): δ = 14.8 (CH3), 28.8 (CH2), 52.7 (OCH3), 110.5, 116.0, 155.0, 
166.0, 167.6, 170.5, 179.9 (C); IR (KBr): ν~ = 3427 (s), 2960 (s), 1670 (s), 1571 (s), 1377 (m), 
1257 (s), 1103 (s), 1040 (m), 949 (m), 846 (s) 799 (s), 738 (s), 613 (s), 531 (m) cm−1; GC-MS 
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(EI, 70 eV): m/z (%) = 196.0 (M+, 37), 164.0 (100), 136.0 (26), 121.0 (27). HRMS (EI): calcd. 
for C10H12O4 [M]+: 196.072572; found: 196.07301. 
 
Ethyl 2-ethyl-4,6-dihydrobenzoate (21b) 
Starting with 1,3-bis(silyl enol ether), 4a (700 mg, 2.55 mmol), 
3,3-dimethoxypentanoyl chloride 19 (550 mg, 3.06 mmol, 1.2 eq) and 
TiCl4 (0.27 mL, 2.55 mmol), 21b was isolated as yellow solid (215 mg, 
40 %). 1H NMR (300 MHz, CDCl3): δ = 1.31 (t, 3 H, J = 7.5 Hz, CH3), 1.47 (t, 3 H, J = 7.1 
Hz, 3 H, CH3), 2.61 (q, 2 H, J = 7.5 Hz, CH2), 4.49 (q, 2 H, J = 7.1 Hz, CH2), 6.08 (s, 1 H, 
CHAr), 6.78 (s, 1 H, ArH), 12.17 (s, 1 H, OH); 13C NMR (75 MHz, CDCl3): δ = 14.2, 26.8 
(CH3), 28.8, 62.1 (CH2), 100.1 (C), 110.1 (CHAr), 115.1 (C), 116.0 (CHAr), 154.8, 166.1, 
170.1 (C); IR (KBr): ν~ = 3427 (s), 2960 (s), 1670 (s), 1571 (s), 1377 (m), 1257 (s), 1103 (s), 
1040 (m), 949 (m), 846 (s) 799 (s), 738 (s), 613 (s), 531 (m) cm−1; GC-MS (EI, 70 eV): m/z 
(%) = 210 (M+, 8%), 164 (100), 141 (56), 97 (12), 75 (24), 43 (21); elemental analysis: calcd 
(%) for C11H14O4 (210.09): C 62.85, H 6.71; found: C 62.32, H 6.11. 
 
Benzyl 2-ethyl-4,6-dihydrobenzoate (21c) 
Starting with 1,3-bis(silyl enol ether), 4d (600 mg, 1.78 
mmol), 3,3-dimethoxypentanoyl chloride 19 (390 mg, 2.13 mmol, 
1.2 eq) and TiCl4 (0.19 mL, 1.78 mmol), 21c was isolated as 
yellow solid (185 mg, 34%). 1H NMR (300 MHz, CDCl3): δ = 
1.18 (t, 3 H, J = 7.6 Hz, CH3), 2.25 (s, 2 H, CH2), 2.84 (q, 2 H, J = 7.4 Hz, CH2), 6.23 (s, 1 H, 
CHAr), 6.27 (s, 1 H, CHAr),  7.25-7.41 (m, 5 H, Ph), 11.70 (s, 1 H, OH); 13C NMR (75 MHz, 
CDCl3): δ = 14.4 (CH3), 29.1, 67.9 (CH2), 99.1 (C), 107.8, 128.7 (CHAr), 125.1, (C), 126.9, 
129.2, 129.2 (CHAr), 134.0, 154.6, 160.7, 169.3 (C); EI-MS (EI, 70 eV): m/z (%) = 272 (M+, 
44%), 165 (9), 135 (12), 91 (100), 65 (14), 57 (6). HRMS (EI): calcd. for C168H16O4 [M]+: 
272.104117, Found; 272.10431. 
 
2-Methoxyethyl 2-ethyl-2,6-dihydrobenzoate (21d) 
Starting with 1,3-bis(silyl enol ether), 4c (600 mg, 
1.97 mmol), 3,3-dimethoxypentanoyl chloride 19 (430 mg, 
2.36 mmol, 1.2 eq) and TiCl4 (0.21 mL, 1.97 mmol), 21d was 
isolated as yellow solid (190 mg, 40 %). 1H NMR (300 MHz, 
CDCl3): δ = 1.32 (t, 3 H, J = 7.56 Hz, CH3), 2.74 (q, 2 H, J = 7.5 Hz, CH2), 3.56 (s, 3 H, 
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OCH3), 4.29 (t, 2 H, J = 4.56 Hz, CH2), 4.57 (t, 2 H, J = 4.59 Hz, CH2), 6.09 (s, 1 H, CHAr),  
6.78 (s, 1 H, CHAr), 11.97 (s, 1 H, OH); 13C NMR (75 MHz, CDCl3): δ = 11.3 (CH3), 28.8 
(CH2), 55.7 (OCH3), 64.5, 70.1 (CH2), 97.1, 102.0 (C), 110.5, 111.0 (CH), 155.0, 165.9, 169.9 
(C); IR (KBr): ν~ = 3427 (s), 2960 (s), 1670 (s), 1571 (s), 1377 (m), 1257 (s), 1103 (s), 1040 
(m), 949 (m), 846 (s) 799 (s), 738 (s), 613 (s), 531 (m) cm−1; GC-MS (EI, 70 eV): m/z (%) = 
240 (M+, 8%), 225 (100), 207 (8), 183 (21), 141 (56), 97 (12), 75 (24), 43 (21); elemental 
anylysis: calcd (%) for C12H16O5 (240.25): C 59.99, H 6.71; found: C 60.47, H 6.73. 
 
Methyl 6-ethyl-2,4-dihydro-3-methylbenzoate (21e) 
Starting with 1,3-bis(silyl enol ether), 4f (500 mg, 1.82 mmol), 
3,3-dimethoxypentanoyl chloride 19 (390 mg, 2.18 mmol, 1.2 eq) and 
TiCl4 (0.20 mL, 1.82 mmol), 21e was isolated as yellow solid (250 mg, 
65 %). mp. 98-100 °C; 1H NMR (400 MHz, CDCl3): δ = 1.13 (t, 3 H, J = 7.44 Hz, CH3), 2.08 
(s, 3 H, CH3), 2.82 (q, 2 H, J = 7.4 Hz, CH2), 3.90 (s, 3 H, OCH3), 5.45 (s, 1 H, OH), 6.22 (s, 
1 H, CHAr) 11.97 (s, 1 H, OH); 13C NMR (75 MHz, CDCl3): δ = 7.5, 15.6 (CH3), 29.6 (CH2), 
51.6 (OCH3), 104.3, 108.5 (C), 109.0 (CHAr) 146.2, 158.1, 162.2, 172.2 (C); IR (KBr): ν~ = 
3334 (w), 2960 (w), 1623 (s), 1438 (s), 1263 (s), 1194 (s), 1159 (s), 1109 (s), 1053 (m), 944 
(w), 873 (s), 803 (s), 787 (m) cm−1; GC-MS (EI, 70 eV): m/z (%) = 210 (M+, 42%), 178 (100), 
160 (10), 150 (40), 135 (11), 107 (10), 77 (13); elemental analysis: calcd. (%) for C11H14O4 
(210.09): C 62.85, H 6.71; found: C 62.47, H 6.73. 
 
Methyl 6-ethyl-2,4-dihydro-3-isobutylbenzoate (21f) 
Starting with 1,3-bis(silyl enol ether), 4i (600 mg, 
1.89 mmol), 3,3-dimethoxypentanoyl chloride 19 (400 mg, 
2.26 mmol, 1.2 eq) and TiCl4 (0.21 mL, 1.89 mmol), 21f 
was isolated as yellow solid (315 mg, 66 %). mp. 66-68 
°C; 1H NMR (400 MHz, CDCl3): δ = 0.93 (d, 6 H, J = 6.63 Hz, (CH3)2), 1.16 (t, 3 H, J = 7.44 
Hz, CH3), 2.48 (d, 2 H, J = 7.35 Hz, CH2), 2.85 (q, 2 H, J = 7.41 Hz, CH2), 3.92 (s, 3 H, 
OCH3), 5.08 (s, 1 H, OH), 6.23 (s, 1 H, CHAr) 11.93 (s, 1 H, OH); 13C NMR (75 MHz, 
CDCl3): δ = 15.7, 22.6, 28.1 (CH3), 29.6, 31.9 (CH2), 51.8 (OCH3), 104.6 (C), 109.2 (CHAr), 
112.5, 146.6, 158.3, 163.3, 172.4 (C); IR (KBr): ν~ = 3469 (m), 2949 (m), 1643 (s), 1595 (s), 
1435 (m), 1411 (m), 1294 (s), 1270 (S), 1194 (m), 1155 (s), 1112 (s), 1022 (m), 982 (s), 824 
(s), 740 (w) cm−1; GC-MS (EI, 70 eV): m/z (%) = 252 (M+, 17%), 220 (12), 209 (11), 177 
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(100), 91 (6), 77 (6); elemental analysis: calcd (%) for C14H20O4 (252.31): C 66.65, H 7.99; 
found: C 66.20, H 7.79. 
 
Ethyl 6-ethyl-2,4-dihydro-3-octylbenzoate (21g) 
Starting with 1,3-bis(silyl enol ether), 4m (600 mg, 1.55 
mmol), 3,3-dimethoxypentanoyl chloride 19 (330 mg, 1.86 
mmol, 1.2 eq) and TiCl4 (0.17 mL, 1.55 mmol), 21g was 
isolated as yellow oil (265 mg, 53%). 1H NMR (300 MHz, CDCl3): δ = 0.87 (t, 3 H, J = 6.93 
Hz, CH3), 1.17 (t, 3 H, J = 7.4 Hz, CH2), 1.25-1.30 (m, 14 H, (CH2)7), 1.41 (t, 3 H, J = 7.1 Hz, 
CH3), 2.86 (q, 2 H, J = 7.11 Hz, CH2), 4.40 (q, 2 H, J = 7.14 Hz, CH2), 5.75 (s, 1 H, OH), 
6.21 (s, 1 H, CHAr), 12.03 (s, 1 H, OH); 13C NMR (75 MHz, CDCl3): δ = 14.0, 14.1, 16.0 
(CH3), 22.6, 22.9, 28.8, 29.3, 29.5, 29.7, 29.8, 31.9, 61.2 (CH2), 104.7 (C), 109.3 (CHAr), 
113.7, 146.5, 158.1, 163.0, 172.0 (C); IR (neat): ν~ = 3407 (w), 2972 (m), 1615 (m), 1414 (s), 
1266 (s), 1156 (s), 1117 (s), 1029 (w), 810 (m)m) cm−1; GC-MS (EI, 70 eV): m/z (%) = 322 
(M+, 19), 276 (18), 259 (19), 178 (100), 151 (51); elemental analysis: calcd (%) for C19H30O4 
(322.44): C 70.77, H 9.38; found: C 71.02, H 9.44. 
 
Methyl 6-ethyl-3-hexyl-2,4-dihydrobenzoate (21i) 
Starting with 1,3-bis(silyl enol ether), 4k (500 mg, 1.45 
mmol), 3,3-dimethoxypentanoyl chloride 19 (320 mg, 1.74 
mmol, 1.2 eq) and TiCl4 (0.16 mL, 1.45 mmol), 21i was 
isolated as yellow oil (220 mg, 52%). 1H NMR (300 MHz, 
CDCl3): δ = 0.87 (t, 3 H, J = 7.11 Hz, CH3), 1.15 (t, 3 H, J = 7.44 Hz, CH3), 1.26-1.33 (m, 8 
H, (CH2)4), 2.61 (t, 2 H, J = 7.86 Hz, CH2), 2.83 (q, 2 H, J = 7.41 Hz, CH2), 5.75 (s, 1 H, 
OH), 6.22 (s, 1 H, CHAr), 11.95 (s, 1 H, OH); 13C NMR (75 MHz, CDCl3): δ = 14.1, 15.7 
(CH3), 22.6, 22.9, 28.8, 29.5, 29.6, 31.8, 61.2 (CH2), 104.7 (C), 109.3 (CHAr), 113.8, 146.5, 
158.3, 162.9, 172.5 (C); IR (neat): ν~ = 3407 (w), 2972 (m), 1615 (m), 1414 (s), 1266 (s), 
1156 (s), 1117 (s), 1029 (w), 810 (m) cm−1; GC-MS (EI, 70 eV): m/z (%) = 280 (M+, 25%), 
248 (21), 231 (21), 191 (14), 178 (100), 150 (11); elemental analysis: calcd (%) for C16H24O4 
(280.36): C 69.36, H 8.90; found: C 69.31, H 8.89. 
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Methyl 6-ethyl-2,4-dihydroxy-3-(phenylpropyl)benzoate (21j) 
Starting with 1,3-bis(silyl enol ether), 4t (600 mg, 1.58 
mmol), 3,3-dimethoxypentanoyl chloride 19 (340 mg, 1.90 
mmol, 1.2 eq) and TiCl4 (0.17 mL, 1.58 mmol), 21j was isolated 
as yellow solid (230 mg, 46 %). mp. 69-71 °C; 1H NMR (300 MHz, CDCl3): δ = 1.13 (t, 3 H, 
J = 7.4 Hz, CH3), 1.80-1.90 (m, 2 H, CH2), 2.61-2.69 (m, 4 H, (CH2)2), 2.81 (q, 2 H, J = 7.3 
Hz, CH2), 3.89 (s, 3 H, OCH3), 5.01 (s, 1 H, OH), 6.17 (s, 1 H, CHAr), 7.13-7.24 (m, 5 H, Ph), 
11.92 (s, 1 H, OH); 13C NMR (75 MHz, CDCl3): δ = 15.7 (CH3), 22.5, 29.5, 30.1, 35.7 (CH2), 
51.8 (OCH3), 104.7 (C), 109.3 (CHAr), 113.3 (C), 125.6, 128.2, 128.3, (CHPh), 142.4, 146.7, 
158.1, 163.0, 172.4 (C); IR (KBr): ν~ = 3427 (s), 2960 (s), 1670 (s), 1571 (s), 1377 (m), 1257 
(s), 1103 (s), 1040 (m), 949 (m), 846 (s) 799 (s), 738 (s), 613 (s), 531 (m) cm−1; EI-MS (EI, 
70 eV): m/z (%) = 314 (M+, 25), 282 (6), 216 (3), 178 (100), 150 (6), 91 (15); elemental 
analysis: calcd (%) for C19H22O4 (314.38): C 72.59, H 7.01; found: C 73.01, H 6.83. 
 
General procedure for the synthesis of salicylates 29a-g and Dihydroisocoumarins: 
 
To a CH2Cl2 solution (5 mL) of 1,3-bis(silyl enol ether) 4 (1.0 eq.) and 28 (1.0 eq.) was 
dropwise added TiCl4 (1.0 eq.) at −78 °C. The reaction mixture was allowed to warm to 20 °C 
during 6−12 h. After stirring for additional 2−6 h at 20 °C, a saturated aqueous solution of 
NaHCO3 (20 mL) was added. The organic and the aqueous layers were separated and the 
latter was extracted with diethyl ether (3 x 25 mL). The combined organic layers were dried 
(NaSO4), filtered and the filtrate was concentrated in vacuo. The residue was purified by 
chromatography (silica gel, heptane/ ethyl acetate) to give 29a-g, 30b-d, 30j and 30k. 
 
Methyl 2-(2-chloro-2-phenylethyl)-6-hydroxy-4-methylbenzoate (29a) 
Starting with 1,3-bis(silyl enol ether), 4b (500 mg, 2.07 mmol), 1-
Hydroxy-1-phenyl-5-(trimethylsilyloxy)hex-4-en-3-one 28a (490 mg, 
2.07 mmol) and TiCl4 (0.22 mL, 2.07 mmol), 29a was obtained as 
colourless solid (302 mg, 52%). 1H NMR (300 MHz, CDCl3): δ = 2.22 (s, 
3 H, CH3), 3.61 (dd, 2 H, J = 7.4, 2.9 Hz, CH2), 3.93 (s, 3 H, OCH3), 5.02 
(dd, 1 H, J = 7.4, 6.2 Hz), 6.41 (s, 1 H, ArH), 6.72 (s, 1 H, ArH), 7.29-7.35 (m, 5 H, Ph), 
11.23 (s, 1 H, OH); 13C NMR (75 MHz, CDCl3): δ = 21.5 (CH3), 46.7 (CH2), 52.3 (OCH3), 
64.1 (CH), 109.5 (C), 117.3, 125.9, 126.9, 128.3, 128.5 (CHAr), 139.4, 141.6, 145.3, 163.0, 
171.3 (C); IR (KBr): ν~ = 2955 (w), 1653 (s), 1568 (m), 1452 (s), 1317 (s), 1261 (s), 1207 (s), 
1092 (s), 955 (m), 855 (m) 728 (s), 691 (s) cm−1. GC-MS (EI, 70 eV): m/z (%) = 304 (M+, 
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35Cl, 35), 306 (M+, 37Cl, 13), 268 (32), 237 (86), 208 (24), 179 (100), 165 (31), 125 (45), 119 
(21), 89 (15), 77 (13); HRMS (EI): calcd. for C17H17O3Cl [M]+: 304.087148; found: 
304.08607. 
 
Methyl 3-allyl-6-(2chloro-2-phenylethyl)-2-hydroxy-4-methylbenzoate (29b) 
 Starting with 1,3-bis(silyl enol ether), 4w (500 mg, 2.07 mmol), 
1-Hydroxy-1-phenyl-5-(trimethylsilyloxy)hex-4-en-3-one 28a (490 
mg, 2.07 mmol) and TiCl4 (0.22 mL, 2.07 mmol), 29b was obtained 
as slight yellow oil (240 mg, 33%). 1H NMR (300 MHz, CDCl3): δ = 
2.04 (s, 3 H, CH3), 3.41 (d, 2 H, J = 2.5 Hz, CH2), 3.57 (dd, 2 H, J = 
7.6, 5.2 Hz, CH2), 3.94 (s, 3 H, OCH3), 4.98- 5.03 (m, 3 H), 5.91 (dd, 1 H, J = 12.4, 3.4 Hz, 
CH), 6.43 (s, 1 H, ArH), 7.24-7.34 (m, 5 H, Ph), 11.59 (s, 1 H, OH); 13C NMR (75 MHz, 
CDCl3): δ = 19.4 (CH3), 30.0, 46.5 (CH2), 52.1 (OCH3), 64.0, 80.8 (CH), 108.8 (C), 114.3 
(CH), 125.2 (C), 126.1, 126.7, 128.0, 128.5 (CHAr), 135.1, 136.7, 141.5, 143.6, 160.7, 171.6 
(C); IR (neat): ν~ = 2920 (m), 2856 (w), 1665 (s), 1625 (m), 1414 (w), 1290 (s), 1246 (s), 1159 
(s), 1115 (m), 1038 (w),  806 (s), 750 (s) 717 (s) cm−1; GC-MS (EI, 70 eV): m/z (%) = 344 
(M+, 35Cl, 43), 346 (15), 308 (26), 276 (67), 261 (39), 219 (100), 178 (15), 159 (22), 91 (23); 
elmental analysis: calcd. (%) for C20H21O3Cl (344.83): C 69.66, H 6.14; Found: C 69.61, H 
6.41.  
 
Methyl 2-(2-chloro-2-phenylethyl)-2-hydroxy-3-methoxy-4-methylbenzoate (29c) 
Starting with 1,3-bis(silyl enol ether), 4q (700 mg, 2.40 
mmol), 1-Hydroxy-1-phenyl-5-(trimethylsilyloxy)hex-4-en-3-one 
28a (670 mg, 2.40 mmol) and TiCl4 (0.26 mL, 2.40 mmol), 29c was 
obtained as slight yellow oil (350 mg, 44 %). 1H NMR (300 MHz, 
CDCl3): δ = 3.43 (dd, 2 H, J = 7.6, 5.8 Hz, CH2), 3.70 (s, 3 H, OCH3), 3.80 (s, 3 H, OCH3), 
4.87 (dd, J = 7.6, 5.9 Hz, CH), 6.28 (s, 1 H, ArH), 7.12-7.21 (m, 5 H, Ph), 11.24 (s, 1 H, OH). 
13C NMR (75 MHz, CDCl3): δ = 16.0 (CH3), 46.4 (CH2), 52.4, 59.8 (OCH3), 64.2 (CH), 110.5 
(C), 125.9, 126.9 (CHAr), 128.2 (C), 128.4 (CHAr), 133.8, 137.2, 141.6, 145.7, 156.3, 171.4 
(C). IR (neat): ν~ =  2953 (w), 1658 (s), 1440 (m), 1309 (w), 1252 (s), 1199 (m), 107 (m), 805 
(w), 696 (s) cm-1; GC-MS (EI, 70 eV): m/z (%) = 334 (M+, 35Cl, 6), 336 (M+, 37Cl, 2), 284 
(59), 266 (100), 208 (27), 251 (20), 236 (30), 165 (23), 77 (20); HRMS (EI) calcd. for 
C18H19O4Cl  [M]+: 334.096744; Found: 334.09664.  
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Ethyl 2-(2-chloro-2-phenylethyl)-6-hydroxy-4-methylbenzoate (29d) 
Starting with 1,3-bis(silyl enol ether), 4a (600 mg, 2.18 mmol), 1-
Hydroxy-1-phenyl-5-(trimethylsilyloxy)hex-4-en-3-one 28a (610 mg, 2.18 
mmol) and TiCl4 (0.24 mL, 2.18 mmol), 29d was obtained as slight yellow 
oil (255 mg, 37 %). 1H NMR (300 MHz, CDCl3): δ = 1.36 (t, 3 H, J = 7.1 
Hz, CH3), 3.55 (dd, 1 H, J = 13.2, 6.7 Hz, CH2), 3.75 (dd, 1 H, J = 13.2, 7.3 Hz, CH2), 4.41 
(q, 2 H, J = 7.1 Hz, OCH2CH3), 6.27 (s,1 H, ArH), 6.68 (s, 1 H, ArH), 7.27-7.30 (m, 5 H, Ph), 
11.45 (s, 1 H, OH); 13C NMR (75 MHz, CDCl3): δ = 14.0, 21.3 (CH3), 46.3, 61.8 (CH2), 63.7 
(CH), 109.5 (C), 117.2 (CHAr), 125.7, 127.0 (CHAr), 128.2 (C), 128.3 (CHAr), 139.2, 141.2, 
145.0, 163.0, 170.9 (C); IR (neat): ν~ = 2980 (w), 1654 (s), 1620 (m), 1570 (w), 1452 (m), 
1314 (s), 1258 (s), 1212 (s), 1095 (s), 1014 (w), 852 (w), 738 (m), 696 (s) cm-1; GC-MS (EI, 
70 eV): m/z (%) = 318 (M+, 35Cl, 27), 320 (M+, 37Cl, 9), 282 (28), 237 (79), 208 (27), 165 
(100), 125 (29), 91 (12), 77 (10). HRMS (EI) calcd. for C18H19O3Cl [M]+: 318.102296; Found 
318.10172. 
 
Isopropyl 2-(2-chloro-2-phenylethyl)-6-hydroxy-4-methylbenzoate (29e) 
Starting with 1,3-bis(silyl enol ether), 4e (600 mg, 2.07 
mmol), 1-Hydroxy-1-phenyl-5-(trimethylsilyloxy)hex-4-en-3-one 
28a (570 mg, 2.07 mmol) and TiCl4 (0.22 mL, 2.07 mmol), 29e 
was obtained as slight yellow oil (260 mg, 40 %). 1H NMR (300 
MHz, CDCl3): δ = 1.37 (d, 6 H, J = 6.3 Hz, (CH3)2), 2.11 (s, 3 H, 
CH3), 3.48 (dd, 1 H, J = 13.0, 7.5 Hz, CH2), 3.87 (dd, 1 H, J = 13.0, 6.8 Hz, CH2), 5.04 (t, 1 
H, J = 7.0 Hz, CH), 5.32-5.40 (m, 1 H, CH(CH3)2), 6.16 (s, 1 H, ArH), 6.66 (s, 1 H, ArH), 
7.24-7.30 (m, 5 H, Ph), 11.45 (s, 1 H, OH); 13C NMR (75 MHz, CDCl3): δ = 21.3, 21.9 (CH3), 
46.1 (CH2), 63.6, 70.1 (CH), 109.5 (C), 117.2, 125.8, 127.3, 128.2 (CHAr), 128.3, 139.1, 
141.0, 144.8, 163.1, 170.5 (C); IR (neat): ν~ = 2981 (w), 1650 (s), 1618 (m), 1571 (w), 1452 
(m), 1367 (m), 1310 (m), 1259 (s), 1214 (s), 1090 (s), 1041 (w), 1090 (s), 909 (w), 852 (m), 
738 (m), 695 (s) cm-1; GC-MS (EI, 70 eV): m/z (%) = 332 (M+, 35Cl, 27), 334 (M+, 37Cl, 9) 
296 (15), 254 (25), 237 (92), 208 (28), 179 (19), 165 (100), 125 (64), 91 (17); HRMS (EI): 
calcd. for C19H21O3 Cl [M]+: 332.117594; found: 332.117337. 
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General procdure for the synthesis of 3-aryl-3,4-dihydroisocoumarins 30a and 30e-f: 
To a THF solution of 29a (190 mg, 0.62 mmol) silica gel (Merck silica gel 60, 0.063-0.200 
mm, 70-230 mesh, 1.5 g) was added and the mixture was stirred at room temperature for 6-14 
h. After completion of the reaction (tlc control), THF was removed in vacuo. The residue was 
purified by chromatography (silica gel, heptane / ethyl acetate) to give 30a. 3-aryl-3,4-
dihydroisocoumarins, 30b-d, 30g-j and 30k were formed by [3+3] cyclization to give 6-(2-
phenyl-2-chloroethyl)salicylates which subsequently hydrolyzed and underwent a 
lactonization during the aqueous work-up or silica gel chromatography. This process can be 
regarded as a domino ′[3+3] cyclization / lactonization′ reaction. 
 
8-Hydroxy-6-methyl-3-phenylisochroman-1-one (30a) 
Starting with 29a (190 mg, 0.62 mmol) and silica gel (Merck silica 
gel 60, 0.063-0.200 mm, 70-230 mesh, 1.5 g), 30a was obtained as 
white solid (110 mg, 69%). 1H NMR (300 MHz, CDCl3): δ = 2.34 (s, 
3 H, CH3), 3.07 (dd, 1 H, J = 16.5, 3.3 Hz, CH2), 3.27 (dd, 1 H, J = 
16.3, 3.3 Hz, CH2), 5.56 (dd, 1 H, J = 12.0, 3.3 Hz), 6.56 (s, 1 H, ArH), 6.74 (s, 1 H, ArH), 
7.39-7.45 (m, 5 H, Ph), 10.92 (s, 1 H, OH); 13C NMR (75 MHz, CDCl3): δ = 22.0 (CH3), 35.2 
(CH2), 80.7 (CH), 105.9 (C), 116.5, 119.1, 126.1, 128.7, 128.8 (CHAr), 138.0, 139.0, 148.1, 
1662.2, 169.7 (C); IR (KBr): v = 3089 (w), 1652 (s), 1455 (m), 1277 (m), 1097 (s), 1060 (s), 
912 (w), 845 (s), 798 (s), 699 (s) cm−1 ; GC-MS (EI, 70 eV): m/z (%) = 254 (M+, 100), 236 
(69), 208 (61), 179 (40), 165 (51), 148 (31), 91 (28), 77 (22); elmental analysis: calcd. (%) for 
C16H14O3 (254.28): C 75.57, H 5.55; Found: C 75.11, H 5.56.  
 
7-Decyl-8-hydroxy-6-methyl-3-phenylisocoroman-1-one (30d) 
 Starting with 1,3-bis(silyl enol ether), 4o (700 mg, 1.81 
mmol), 1-Hydroxy-1-p-tolyl-5-(trimethylsilyloxy)hex-4-
en-3-one 28a (500 mg, 1.81 mmol) and TiCl4 (0.19 mL, 
1.81 mmol), 30d was obtained as colouless solid (320 mg, 
54 %). 1H NMR (300 MHz, CDCl3): δ = 0.88 (t, 3 H, J = 7.1 Hz, CH3), 1.24-1.36 (m, 16 H, 
(CH2)8), 2.32 (s, 3 H, CH3), 2.65 (t, 2 H, J = 8.2 Hz, CH2),  3.02 (dd, 1 H, J = 16.5, 3.2 Hz, 
CH2), 3.23 (dd, 1 H,  J = 12.5, 3.2 Hz, CH2 ),  5.54 (dd, 1 H, J = 12.1, 3.3 Hz, CH), 6.51 (s, 1 
H, ArH), 7.25-7.46 (m, 5 H, Ph), 11.21 (s, 1 H, OH). ); 13C NMR (75 MHz, CDCl3): δ = 14.1, 
20.1 (CH3), 22.6, 28.8, 29.3, 29.5, 29.6, 29.9, 31.8 (CH2), 80.8 (CH), 105.7, (C),  119.5, 
126.0, 128.5, 128.6 (CHAr), 135.5, 138.2, 145.5, 160.3, 170.2(C); IR (KBr): ν~ = 2920 (m), 
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2856 (w), 1665 (s), 1625 (m), 1414 (w), 1290 (s), 1246 (s), 1159 (s), 1115 (m), 1038 (w),  806 
(s), 750 (s) 717 (s) cm−1; GC-MS (EI, 70 eV): m/z (%) = 394 (M+, 67), 306 (46), 291 (18), 
264 (100), 249 (15), 192 (19), 91 (11); HRMS (EI): calcd. for C26H34O3 [M]+: 394.171172; 
found: 394.17200. 
8-Hydroxy-6-methyl-3-p-tolylisochroman-1-one (30g) 
Starting with 1,3-bis(silyl enol ether), 4b (600 mg, 2.30 
mmol), 1-Hydroxy-1-p-tolyl-5-(trimethylsilyloxy)hex-4-en-3-one 
28b (670 mg, 2.30 mmol) and TiCl4 (0.25 mL, 2.30 mmol), 30g 
was obtained as colouless solid (250 mg, 41 %). 1H NMR (300 
MHz, CDCl3): δ = 2.33 (s, 3 H, CH3), 2.37 (s, 3 H, CH3), 3.03 (dd, 1 H, J = 16.5, 3.2 Hz, 
CH2), 3.24 (dd, 1 H, J = 12.2, 3.4 Hz, CH2), 5.51 (dd, 1 H, J = 12.0, 3.3 Hz, CH), 6.55 (s, 1 H, 
ArH), 6.73 (s, 1 H, ArH), 7.24 (d, 2 H, J = 8.1 Hz, ArH), 7.33 (s, 1 H, J = 8.1 Hz, ArH), 10.93 
(s, 1 H, OH); 13C NMR (75 MHz, CDCl3): δ = 21.1, 22.0 (CH3), 35.1 (CH2), 80.7 (CH), 105.9 
(C), 116.5, 119.1, 127.9, 129.6 (CHAr), 135.1, 138.7, 139.1, 147.9, 147.9, 162.2, 169.8 (C); IR 
(KBr): ν~ = 2919 (w), 1660 (s), 1628 (s), 1578 (m), 1516 (w), 1349 (m), 1268 (m), 1230 (s), 
1202 (s), 1157 (m), 1095 (s), 1058 (s), 975 (m), 854 (s), 814 (s), 732 (m), 695 (s) cm-1; EI-MS 
(EI, 70 eV): m/z (%) = 268 (M+, 100), 250 (75), 222 (78), 179 (23), 148 (17) 91 (15); elmental 
analysis: calcd (%) for C17H16O3 (268.31): C 76.10, H 6.01; Found: C 75.98, H 6.32. 
 
7-Butyl-8-hydroxy-6-methyl-3-p-tolylisochroman-1-one (30i) 
Starting with 1,3-bis(silyl enol ether), 4h (700 
mg, 2.21 mmol), 1-hydroxy-1-p-tolyl-5-
(trimethylsilyloxy)hex-4-en-3-one 28b (650 mg, 2.21 
mmol) and TiCl4 (0.24 mL, 2.21 mmol), 30i was 
obtained as yellow solid (452 mg, 62 %).  1H NMR (300 MHz, CDCl3): δ = 0.92 (t, 3 H, J = 
7.1 Hz, CH3), 2.30 (s, 3 H, CH3), 2.34 (s, 3 H, CH3), 2.63 (t, 2 H, J = 8.1 Hz, CH2), 2.97 (dd, 
1H,  J = 16.5, 3.2 Hz,CH2 ), 3.20 (dd, 1 H, J  = 12.1, 3.4 Hz, CH), 5.48 (dd, 1 H, J = 12.1, 3.2 
Hz, CH), 6.51 (s, 1 H, ArH), 7.26 (d, 2 H, J = 8.0 Hz), 7.31 (d, 2 H, J = 8.1 Hz, ArH), 11.21 
(s, 1 H, OH). ); 13C NMR (75 MHz, CDCl3): δ = 14.0, 20.1, 21.2 (CH3), 23.0, 25.6, 31.0, 35.0 
(CH2), 80.8 (CH), 105.8, (C), 119.5, 126.1 (CHAr), 128.5, (C), 129.3 (CHAr), 135.3, 135.7, 
138.6, 145.5, 160.3, 170.3 (C); IR (KBr): ν~ = 2920 (m), 2856 (w), 1665 (s), 1625 (m), 1414 
(w), 1290 (s), 1246 (s), 1159 (s), 1115 (m), 1038 (w),  806 (s), 750 (s) 717 (s) cm−1; GC-MS 
(EI, 70 eV): m/z (%) = 324 (M+, 67), 306 (46), 291 (18), 264 (100), 249 (15), 192 (19), 91 
(11); HRMS (EI): calcd. for C21H24O3 [M]+: 324.171172; found: 324.17200. 
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7-Allyl-8-hydroxy-6-methyl-3-p-tolylisochroman-1-one (30j) 
Starting with 1,3-bis(silyl enol ether), 4w (600 mg, 
1.99 mmol), 1-hydroxy-1-p-tolyl-5-(trimethylsilyloxy)hex-4-
en-3-one 28b (581 mg, 1.99 mmol) and TiCl4 (0.22 mL, 1.99 
mmol), 30j was obtained as yellow solid (210 mg, 35 %). 1H 
NMR (300 MHz, CDCl3): δ = 2.29 (s, 3 H, CH3), 2.35 (s, 3 H, CH3), 2.99 (dd, 1 H, J = 16.6, 
3.3 Hz, CH), 3.21 (dd, 1 H, J = 12.2, 3.3 Hz, CH), ,3.42 (d, 2 H, J = 5.9 Hz, CH2), 4.81-5.11 
(m, 2 H, CH2), 5.49 (dd, 1 H, J = 12.0, 3.3 Hz, CH), 5.84-5.97 (m, 1 H, CH), 6.54 (s, 1 H, 
CHAr), 7.19 (d, 2 H, J = 7.9 Hz, CHAr), 7.31 (d, 2 H, J = 8.1 Hz, CHAr), 11.25 (s, 1 H, OH); 
13C NMR (75 MHz, CDCl3): δ = 20.1, 21.2 (CH3), 29.8, 34.9 (CH2), 80.8 (CH), 105.9 (C), 
114.8 (CH2), 119.6 (CHAr), 123.3 (C), 125.0, 129.6 (CHAr), 135.1 (CH), 135.2, 136.5, 138.6, 
146.3, 160.1, 170.2 (C); IR (KBr): ν~ = 3061 (w), 2904 (w), 1659 (s), 1432 (m), 1352 (m), 
1271 (s), 1239 (s), 1153 (s), 1070 (m), 1008 (m),  912 (m), 824 (s) 756 (s), 720 (m) cm−1; GC-
MS (EI, 70 eV): m/z (%) = 308 (M+, 100), 290 (82), 275 (86), 247 (28), 203 (19), 173 (14), 
115 (21), 91 (22); HRMS (EI) calcd. for C20H20O3 [M]+: 308.141298; Found: 308.14070. 
 
General procedure for the synthesis of functionalized 4-hydroxycyclopent-2-en-1-one-2-
carboxylates 3a-i and 6: 
A THF solution (2.5 mL/ mmol of LDA) of diisopropylamine (2.5 equiv.) and n-butyllithium 
(2.5 equiv., solution in n-hexane) was stirred at 0 °C for 30 min. The 1,3-dicarbonyl 
compound was added (1.1 equiv.) and the mixture was stirred for 1 h. To the solution was 
added the 1,2-diketone (1.0 equiv.) at −78 °C. The solution was stirred for 1 h and was then 
slowly warmed to 20 °C with stirring. To the solution was added silica gel (0.5 g / mmol of 
1,2-diketone) and the mixture was heated to reflux (tlc control). After cooling of the mixture 
to 20 °C, hydrochloric acid (5 mL, 10%), a saturated aqueous solution of sodium chloride (10 
mL), and diethyl ether (50 mL) were added. The organic and the aqueous layer were separated 
and the latter was repeatedly extracted with diethyl ether. The combined organic layers were 
dried (Na2SO4), filtered and the filtrate was concentrated in vacuo. The residue was purified 
by chromatography (silica gel, EtOAc, heptane).  
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Methyl 3-hydroxy-5-oxo-2,3-diphenyl-1-ene-1-carboxylate (33a) 
Starting with methyl acetoacetate 31a (1.12 mL, 10.46 mmol, 
1.1 equiv.), diisopropylamine (3.21 mL, 22.82 mmol, 2.5 equiv.), n-
butyllithium (8.74 mL, 22.82 mmol, 2.5 equiv.) and benzyl 32a (2.00 
g, 9.51 mmol), 33a was isolated by chromatography (heptane/ethyl 
acetate) as a slightly yellow solid (1.50 g, 51%). Reaction time: 24 h; mp. 129-130 oC.  1H 
NMR (250 MHz, CDCl3): δ = 2.98 (d, 1 H, 2J = 18 Hz, HCH-CO), 3.11 (d, 1 H, J = 18 Hz, 
HCH-CO), 3.76 (s, 3 H, OCH3), 7.17-7.44 (m, 10 H, Ph); 13C NMR (62 MHz, CDCl3): δ =  
52.4 (CH3), 55.0 (CH2-CO), 80.7 (COH), 124.5 (2CHPh), 128.6 (CHPh), 128.2 (2CHPh),  128.6 
(2CHPh), 128.8 (2CHPh), 130.5 (CHPh), 131.2, 134.3, 142.3, 164.7, 174.1, 200.0 (C); IR 
(KBr): ν~ = 3357 (w), 3060 (w), 2951 (m), 1735 (s), 1686 (s), 1434 (m), 1343 (s), 1229 (s), 
1059 (m), 779 (s), 704 (s), 513 (m) cm-1; MS (EI, 70 eV): m/z (%): 308.1 (M+, 22), 276.1 
(100), 208 (18), 129 (27), 105 (56); elemental analysis: calcd. (%) for C19H16O4 (308.327): C 
74.01, H 5.23; found: C 73.90, H 5.23. 
 
Ethyl 3-hydroxy-5-oxo-2,3-diphenyl-1-ene-1-carboxylate (33b) 
Starting with ethyl acetoacetate 31b (1.32 mL, 10.46 mmol, 1.1 
equiv.), diisopropylamine (3.35 mL, 23.77 mmol, 2.5 equiv.), n-
butyllithium (9.51 mL, 23.77 mmol, 2.5 equiv.) and benzyl 32a (2.00 g, 
9.51 mmol), 33b was isolated by chromatography (heptane/ethyl 
acetate) as a slightly yellow solid (1.82 g, 60%). Reaction time: 26 h. 1H 
NMR (300 MHz, CDCl3): δ =  1.12 (t, 3 H, 3J = 7.1 Hz, CH3), 2.95 (d, 1 H, 2J = 18.4 Hz, 
HCH-CO), 3.07 (d, 1 H, 2J = 18.4 Hz, HCH-CO), 4.19 (q, 2 H, 3J = 7.0 Hz, CH2); 13C NMR 
(75 MHz, CDCl3): δ = 13.8 (CH3), 55.0 (CO-CH2), 61.6 (OCH2), 80.8 (COH), 124.5 (2CHPh), 
127.7 (CHPh), 128.3 (2CHPh), 128.6 (2CHPh), 128.8 (2CHPh), 130.4 (CHPh), 131.2, 134.2, 
142.5, 163.8, 173.9, 199.9 (C); IR (KBr): ν~ = 3463 (s), 3062 (w), 2979 (m), 1737 (s), 1712 
(s), 1618 (m), 1447 (m), 1461 (m), 1373 (m), 1336 (s), 1211 (s), 1102 (m), 772 (m) cm-1; MS 
(EI, 70 eV): m/z (%): 322 (M+, 59), 276 (100), 105 (59); elemental analysis: calcd. (%) for 
C20H18O4 (322.36): C 74.52, H 5.63; found: C 74.43, H 5.36. 
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Isopropyl 3-hydroxy-5-oxo-2,3-diphenyl-1-ene-1-carboxylate (33c) 
Starting with isopropyl acetoacetate 31c (1.14 mL, 7.84 
mmol, 1.1 equiv.), diisopropylamine (2.51 mL, 17.82 mmol, 2.5 
equiv.), n-butyllithium (7.13 mL, 17.82 mmol, 2.5 equiv.) and 
benzyl 32a (1.50 g, 7.13 mmol), 33c was isolated by 
chromatography (heptane/ethyl acetate) as a yellow solid (0.97 
g, 41%). Besides, a small amount of 5 (10 mg) was isolated. Reaction time: 20 h; mp. 110-
111 °C. 1H NMR (250 MHz, CDCl3): δ = 1.10 (d, 3 H, J = 6.7 Hz, CH3), 1.16 (d, 3 H, J = 6.7 
Hz, CH3), 2.98 (d, 1 H, J = 18 Hz, HCH-CO), 3.10 (d, 1 H, J = 18 Hz , HCH-CO), 5.11 (sept, 
1 H, J = 6.7 Hz, OCH), 5.30 (s, 1 H, OH), 7.10-7.24 (m, 10 H, Ph); 13C NMR (75 MHz, 
CDCl3): 21.2, 21.4 (CH3), 55.0 (CH2), 69.5 (CH), 80.7 (COH), 124.5 (2CHPh), 127.7 (CHPh), 
128.2 (2CHPh), 128.6 (2CHPh), 128.8 (2CHPh), 130.2 (CHPh), 131.2, 134.3, 142.5, 163.4, 
173.5, 199.8 (C); IR (KBr): ν~ = 3373 (w), 2983 (m), 1718 (s), 1679 (s), 1610 (s), 1450 (m), 
1371 (s), 1323 (s), 1228 (m), 1095 (s), 1005 (s), 773 (m), 510 (m) cm-1; GC-MS (EI, 70 eV): 
m/z (%): 336.2 (M+, 24), 276.1 (100), 129.1 (33), 105.1 (76), 77.1 (26); HRMS (EI): calcd. for 
C21H20O4 [M]+: 336.135023; found: 336.13561.  
 
35: Compound 5 was isolated as a side-product during the synthesis of (33c) 
Formed as side with 33c. 1H NMR (300 MHz, CDCl3): 1.12 (d, 3 
H, 3J = 6.2 Hz, CH3), 1.14 (d, 3 H, 3J = 6.2 Hz, CH3), 2.11 (s, 1 H, 
OH), 2.75 (s, 1 H, CH), 4.37 (s, 1 H, OH), 5.11 (sept, 1 H, 3J = 6.2 
Hz, CH), 7.29-7.52 (m, 20 H, Ph); MS (CI, isobutane): 547.3 
([M+1]+); elemental analysis: calcd (%) for C35H30O6 (546.619): C 76.90, H 5.54; found: C 
76.81, H 5.49.  
 
Ethyl 4-ethyl-5-oxo-2,3-diphenylcyclopent-1-enecarboxylate (33d) 
Starting with ethyl 3-oxohexanoate 31d (1.68 mL, 10.46 mmol, 
1.1 equiv.), diisopropylamine (3.35 mL, 23.77 mmol, 2.5 equiv.), n-
butyllithium (9.51 mL, 23.77 mmol, 2.5 equiv.) and benzil 32a (2.00 g, 
9.51 mmol), 33d was isolated by chromatography (heptane/ethyl 
acetate) as a colourless solid (1.82 g, 55%). Reaction time: 24 h; mp. 97-
98 °C. 1H NMR (250 MHz, CDCl3): δ = 1.01 (t, 3 H, 3J = 8.2 Hz, CH3), 1.18 (t, 3 H, 3J = 7.3 
Hz, CH3), 1.81 (m, 2 H, CH2), 2.68 (t, 1 H, 3J = 7.9 Hz, CH), 4.25 (q, 2 H, 3J = 6.1 Hz, 
OCH2), 7.22-7.27 (m, 10 H, Ph); 13C NMR (75 MHz, CDCl3): δ = 12.9, 14.5 (CH3), 19.8 
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(CH2), 61.9 (CH2), 64.2 (CH), 84.9 (COH), 126.0 (2CHPh), 128.5 (CHPh), 128.7 (2CHPh), 
129.1 (2CHAr), 129.2 (2CHPh), 130.8 (CHPh), 131.4, 134.0, 143.8, 164.6, 173.1, 201.1 (C); IR 
(KBr): ν~ = 3390 (w), 2978 (m), 1719 (s), 1687 (s), 1629 (m), 1447 (s), 1373 (s), 1341 (s), 
1247 (s),1183 (m), 1019 (s), 963 (m), 699 (s) cm-1; GC-MS (EI, 70 eV): m/z (%): 350.2, (M+, 
7), 321.1 (31), 304.1 (100), 275.1 (38), 129.1 (24), 105.1 (54), 77 (23); HRMS (EI): calcd. for 
C22H22O4 [M]+: 350.150583; found: 350.15126. 
 
Methyl 3-hydroxy-5-oxo-2,3-di(p-methylphenyl)-1-ene-1-carboxylate (33e) 
Starting with methyl acetoacetate 31a (0.74 mL, 6.92 mmol, 
1.1 equiv.), diisopropylamine (2.21 mL, 15.72 mmol, 2.5 equiv.), n-
butyllithium (6.29 mL, 15.72 mmol, 2.5 equiv.) and 4,4-
dimethylbenzil 32b (1.50 g, 6.29 mmol), 33e was isolated by 
chromatography (heptane/ethyl acetate) as a slightly yellow solid (0.75 
g, 36%). Reaction time: 20 h; mp. 41-49 oC. 1H NMR (400 MHz, CDCl3): δ = 2.30 (s, 3 H, 
CH3), 2.34 (s, 3 H, CH3), 2.94 (d, 1 H, 2J = 18 Hz, HCH-CO), 3.07 (d, 1 H, 2J = 18 Hz, HCH-
CO), 3.78 (s, 3 H, OCH3), 7.07 (d, 2 H, 3J = 8.5 Hz,  ArH), 7.10 (d, 2 H, 3J = 8.5 Hz, ArH), 
7.17 (d, 2 H, 3J = 8.0 Hz, ArH), 7.30 (d, 2 H, 3J = 8.2 Hz, ArH); 13C NMR (100 MHz, 
CDCl3): δ = 21.0, 21.4 (CH3), 52.5 (OCH3), 55.3 (OCH2), 80.8 (COH), 124.3 (2CHAr), 128.1 
(C), 128.8 (2CHAr), 129.3 (2CHAr), 129.6 (2CHAr), 133.4, 137.6, 139.9, 141.3, 164.5, 173.9, 
199.6 (C); IR (KBr): ν~ = 1739 (s), 1608 (s), 1511 (m), 1435 (m), 1341 (s), 1216 (s), 1015 
(m), 820 (s); MS (EI, 70 eV): m/z (%): 336 (M+, 44), 304 (98), 236 (37), 206 (48), 143 (40), 
119 (100), 91 (38); elemental analysis: calcd. (%) for C21H20O4 (360.387): C 74.94, H 5.99; 
found: C 74.56, H 6.08. 
 
Isopropyl 3-hydroxy-5-oxo-2,3-di(p-methylphenyl)-1-ene-1-carboxylate (33f) 
 Starting with isopropyl acetoacetate 31c (1.0 mL, 6.92 
mmol, 1.1 equiv.), diisopropyamine (2.44 mL, 17.31 mmol, 2.5 
equiv.), n-butyllithium (6.92 mL, 17.31 mmol, 2.5 equiv.) and 
4,4-dimethylbenzil 32b (1.50 g, 6.29 mmol), 33f was isolated 
by chromatography (heptane/ethyl acetate) as a slightly yellow 
solid (1.20 g, 53%). Reaction time: 22 h; mp. 118-119 °C. 1H NMR (400 MHz, CDCl3): δ = 
1.16 (d, 3 H, 3J = 7.6 Hz, CH3), 1.20 (d, 3 H, 3J = 6.2 Hz, CH3), 2.29 (s, 3 H, CH3), 2.33 (s, 3 
H, CH3), 2.92 (d, 1 H, 2J = 18.4 Hz, HCH-CO), 3.04 (d, 1 H, 2J = 18.4 Hz, HCH-CO), 5.11-
5.18 (m, 1 H, OCH), 7.05 (d, 2 H, 3J = 7.7 Hz, ArH), 7.12 (d, 2 H, 3J = 8.3 Hz, ArH), 7.15 (d, 
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2 H, 3J = 8.0 Hz, ArH), 7.29 (d, 2 H, 3J = 8.3 Hz, ArH); 13C NMR (100 MHz, CDCl3): δ = 
21.1, 21.44, 21.48, 21.6 (CH3), 55.3 (CH2), 69.4 (CH), 80.7 (COH), 124.4 (2CHAr), 128.3 
(C), 128.8 (2CHAr), 129.0 (2CHAr), 129.5 (2CHAr), 134.1, 137.3, 140.0, 140.9, 163.7, 172.9, 
199.9 (C); IR (KBr): ν~ = 3428 (w), 2978 (m), 1727 (s), 1693 (s), 1601 (s), 1512 (m), 1326 (s), 
1224 (s), 1100 (s); GC-MS (EI, 70 eV): m/z (%): 364.2 (M+, 36), 304.1 (98), 236.1 (35), 206.1 
(48), 119.1 (100), 91.1 (39); elemental analysis: calcd. (%) for C23H24O4 (364.44): C 75.80, H 
6.63; found: C 75.74, H 6.74. 
 
Methyl 3-hydroxy-5-oxo-2,3-di(p-methoxyphenyl)-1-ene-1-carboxylate (33g) 
Starting with methyl acetoacetate 31a (0.87 mL, 8.13 
mmol, 1.1 equiv.), diisopropylamine (2.60 mL, 18.47 mmol, 2.5 
equiv.), n-butyllithium (7.38 mL, 18.47 mmol, 2.5 equiv.) and 
4,4-dimethoxybenzil 32c (2.00 g, 7.39 mmol), 33g was isolated 
by chromatography (heptane/ethyl acetate) as a slightly yellow 
solid (0.85 g, 32%). Reaction time: 20 h; mp. 50-52 °C. 1H NMR (250 MHz, CDCl3): δ =  
2.91 (d, 1 H, J = 18 Hz, HCH-CO), 3.06 (d, 1 H, J = 18 Hz , HCH-CO), 3.77 (s, 3 H, OCH3), 
3.80 (s, 3 H, OCH3), 3.81 (s, 3 H, OCH3), 6.78 (d, 2 H, J = 8.8 Hz, ArH), 6.88 (d, 2 H, J = 9.1 
Hz, ArH), 7.24 (d, 2 H, J = 8.2 Hz, ArH), 7.34 (d, 2 H, J = 9.1 Hz, ArH); 13C NMR (62 MHz, 
CDCl3): δ =  52.4 (OCH3), 55.2 (2C, OCH3), 55.5 (CH2-CO), 80.6 (COH), 114.0 (2CHAr), 
114.2 (2CHAr), 123.2 (C), 125.6 (2CHAr), 131.1, 132.1 (CHAr) (2CHAr), 135.3, 158.6, 161.6, 
164.9, 173.1, 199.5 (C); IR (KBr): ν~ = 3451 (w), 2839 (m), 1735 (s), 1603 (s), 1437 (m), 
1137 (s), 1029 (s), 835 (s), 779 (m); MS (EI, 70 eV): m/z (%): 368.1 (M+, 22), 336.1 (27), 
219.0 (21), 152.0 (78), 135 (100), 77 (29); HRMS (EI): calcd. for C21H20O6 [M]+: 
368.125102; found: 368.12544. 
 
Isopropyl 3-hydroxy-5-oxo-2,3-di(p-methoxyphenyl)-1-ene-1-carboxylate (33h) 
Starting with isopropyl acetoacetate 31c (1.18 mL, 
8.13 mmol, 1.1 equiv.), diisopropylamine (2.60 mL, 18.47 
mmol, 2.5 equiv.), n-butyllithium (7.38 mL, 18.47 mmol, 
2.5 equiv.) and 4,4-dimethoxybenzil 32c (2.00 g, 7.39 
mmol), 33h was isolated by chromatography 
(heptane/ethyl acetate) as a slightly yellow solid (1.36 g, 47%). Reaction time: 20 h; mp. 117-
118 oC. 1H NMR (400 MHz, CDCl3): δ = 1.13 (d, 3 H, 3J = 6.2 Hz, CH3), 1.17 (d, 3J = 6.2 Hz, 
3 H, CH3), 2.82 (d, 1 H, 2J = 18.4 Hz, HCH-CO), 2.95 (d, 1 H, 2J = 18.4 Hz, HCH-CO), 3.68 
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(s, 3 H, OCH3), 3.71 (s, 3 H, OCH3), 5.07-5.14 (m, 1 H), 6.68 (d, 2 H, 3J = 9.0 Hz,  ArH), 
6.79 (d, 2 H, 3J =8.9 Hz, ArH), 7.19 (d, 2 H, 3J = 9.0 Hz, ArH), 7.26 (d, 2 H, 3J = 8.9 Hz, 
ArH); 13C NMR (100 MHz, CDCl3): δ = 21.4, 21.6 (CH3), 55.2, 55.3 (OCH3), 55.4 (CH2), 
69.4 (OCH), 80.5 COH), 113.8 (2CHAr), 114..1 (2CHAr),123.4 (C),125.7 (2CHAr), 131.19  
(2CHAr), 133.2, 135.3, 158.9, 161.4, 164.2, 171.8, 199.8 (C); IR (KBr): ν~ = 3431 (w),  2984 
(m), 1740 (s), 1724 (s), 1516 (m), 1264 (s), 1242 (s), 1108 (s), 1063 (m),  817 (s), 788 (m), 
cm−1; MS (CI, isobutene): 397 [(M+1)+]; elemental analysis: calcd (%) for C23H24O6 
(396.439): C 69.68, H 6.10; found: C 59.56, H 6.29. 
 
Ethyl 3-hydroxy-5-oxo-2,3-di(p-bromophenyl)-1-ene-1-carboxylate (33i) 
Starting with ethyl acetoacetate 31b (583 mg, 4.48 mmol, 1.1 
equiv.), diisopropyamine (1.43 mL, 10.2 mmol, 2.5 equiv.), n-
butyllithium (4.1 mL, 10.2 mmol, 2.5 equiv.) and 4,4-dibromobenzil 
32d (1.50 g, 4.1 mmol), 33i was isolated by chromatography 
(heptane/ethyl acetate) as a slightly yellow solid (810 mg, 42%). 
Reaction time: 24 h; mp. 139-149 °C. 1H NMR (250 MHz, CDCl3): δ = 1.20 (t, 3 H, 3J = 7.6 
Hz, CH3), 2.97 (d, 1 H,2 J = 18 Hz, HCH-CO), 3.07 (d, 1 H, 2J = 18 Hz, HCH-CO), 4.25 (q, 2 
H, 3J = 7.6 Hz, CH2), 7.13 (d, 2 H, 3J = 9.1 Hz ,  ArH), 7.26 (d, 2 H, 3J = 8.5 Hz, ArH), 7.41 
(d, 2 H, 3J = 8.5 Hz, ArH), 7.48 (d, 2 H, 3J = 8.8 Hz, ArH); 13C NMR (75 MHz, CDCl3): δ = 
14.3 (CH3), 55.3 (CH2), 62.4 (OCH2), 80.9 (COH), 122.4, 125.8 (C), 126.8 (2CHAr), 130.3 
(C), 130.6 (2CHAr), 132.1 (2CHAr), 132.4 (2CHAr), 134.9, 141.7, 164.1, 199.8 (C) ); IR (KBr): 
ν~ = 3481 (w), 1744 (s), 1486 (m), 1336 (s), 1217 (m), 1072 (s), 1010 (s), 825 (m) cm−1; GC-
MS (EI, 70 eV): m/z (%): 482 (M+, 81Br, 10), 479.9 (M+, 79Br, 17), 433.9 (57), 281.1 (42), 207 
(100), 185 (49); elemental analysis: calcd (%) for C20H16O4Br2 (479.95): C 50.01, H 3.36; 
found: C 49.67, H 3.40. 
 
N,N-Dimethyl-5-oxo-2,3-diphenylcyclopent-3-enecarboxamide (36) 
Starting with N,N-diethylacetamide (0.82 mL, 5.22 mmol, 
1.1 equiv.), diisopropylamine (1.61 mL, 11.41 mmol, 2.5 equiv.), 
n-butyllithium (4.36 mL, 11.4 mmol, 2.5 equiv.) and benzil (1.00 g, 
4.75 mmol), 6 was isolated by chromatography (heptane/ethyl 
acetate) as a slightly yellow solid (725 mg, 43%). Reaction time: 
17 h; mp. 117-118 oC. 1H NMR (250 MHz, CDCl3): δ = 1.00 (t, 3 H, 3J = 6.4 Hz, CH3), 1.16 
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(t, 3 H, 3J = 7.3 Hz, CH3), 3.11-3.50 (m, 2 H), 3.55-3.85 (m, 2 H). 3.85 (s, 1 H, CH-C=O), 
6.77 (s, 1 H, CH=C), 7.25-7.68 (m, 10 H, Ph); 13C NMR (62 MHz, CDCl3): δ = 12.9, 14.3 
(CH3), 41.3, 42.7 (CH2),  63.4 (CH), 82.3 (COH), 124.6 (2CHPh), 127.5 (CHPh), 127.8 (CHPh), 
128.4 (2CHPh), 128.8 (2CHPh), 129.7 (2CHPh), 130.9 (CHPh), 131.2 (CH), 144.2, 167.7, 176.6, 
199.7 (C); IR (KBr): ν~ = 3399 (w), 2978 (m), 1691 (s), 1624 (s), 1571 (m), 1449 (s), 1309 (s), 
1223 (s), 1339 (m), 772 (s), 6004 (s) cm-1; MS (EI, 70 eV): m/z (%): 349.2 (M+, 33), 331.1 
(23), 249.1 (100), 105.0 (43), 72.1 (26); HRMS (EI): calcd. for C22H23O3N1 [M]+: 
349.166663; found: 349.16725. 
 
General procedure for the cyclization of functionalized 4-hydroxycyclopent-2-en-1-ones 
with dimethyl acetylenedicarboxylate (DMAD): 
To a toluene solution (25 mL) of the 4-hydroxycyclopent-2-en-1-one (1.0 equiv.) was added 
dimethyl acetylenedicarboxylate (DMAD, 8.0 equiv.) and p-toluenesulfonic acid (PTSA, 5 
mol-%). The mixture was heated at reflux (tlc control). After cooling of the reaction mixture 
to 20 °C, a saturated aqueous solution of NaHCO3 (10 mL) was added. The organic and the 
aqueous layer were separated and the latter was extracted with diethyl ether (3 x 20 mL). The 
combined organic layers were dried (Na2SO4), filtered and the filtrate was concentrated in 
vacuo. The residue was purified by chromatography (silica gel, EtOAc, heptane) to give  
34a-i.  
 
1,2,3-trimethyl-4,5-diphenylbenzene-1,2,3-tricarboxylate (34a) 
Starting with 33a (500 mg, 1.62 mmol), DMAD (1.60 mL, 
12.96 mmol) and  PTSA (12 mg, 5 mol-%), 34a was isolated by 
chromatography (heptane/ ethyl acetate) as a  yellow solid (302 mg, 
46%); mp. 143-144 oC. Reflux time: 8h; 1H NMR (250 MHz, 
CDCl3): δ = 3.48 (s, 3 H, OCH3), 3.92 (s, 3 H, OCH3), 3.93 (s, 3 H, OCH3), 7.0-7.21 (m, 10 
H, Ph), 8.03 (s, 1 H, ArH); 13C NMR (75 MHz, CDCl3): δ = 50.8, 50.9, 51.0 (OCH3), 125.9, 
126.0 (CHPh), 126.1 (2CHPh), 126.6 (2CHPh), 126.7 (2CHPh), 127.6 (2CHPh), 130.1, 130.8 (C), 
132.3 (CHPh), 135.4, 137.0, 139.1, 140.6, 141.7, 163.9, 165.8, 166.9 (C);  IR (KBr): ν~ = 1743 
(s), 1728 (s), 1588 (m), 1429 (s), 1299 (s), 1244 (s), 1156 (m), 1008 (s), 765 (m), 703 (s); MS 
(EI, 70 eV): m/z (%): 404.1 (M+, 68), 373.1 (100), 226.0 (11), 105 (22); HRMS (EI): calcd. 
for C24H20O6 [M]+: 404.125328; found: 404.12544. 
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3-Ethyl-1,2-dimethyl-4,5-diphenylbenzene-1,2,3-tricarboxylate (34b) 
Starting with 33b (400 mg, 1.24 mmol), DMAD (1.21 mL, 
11.84 mmol, 8 equiv.) and  PTSA (5 mol-%), 34b was isolated by 
chromatography (heptane/ ethyl acetate) as a yellow solid (293 mg, 
46%). 1H NMR (300 MHz, CDCl3): δ = 0.88 (t, 3 H, 3J = 7.1 Hz), 
3.92 (s, 6 H, OCH3), 3.95 (q, 2 H, 3J = 7.1 Hz), 7.01-7.21 (m, 10 H, Ph), 8.03 (s, 1 H, ArH); 
13C NMR (75 MHz, CDCl3): δ = 13.3 (CH3), 52.7, 52.8 (OCH3), 61.6 (OCH2), 127.2, 127.5 
(CHPh), 127.7 (2CHPh), 127.8 (2CHPh), 128.3 (C), 129.4 (2CHPh), 125.5 (2CHPh), 132.1 
(CHPh), 132.6, 134.3, 137.4, 138.9, 142.5, 143.5, 165.7, 167.3, 167.8 (C); IR (KBr): ν~ = 1745 
(s), 1726 (s), 1429 (m), 1337 (m), 1243 (s), 1161 (m), 1022 (m), 765 (m), 703 (s); MS (EI, 70 
eV): m/z (%): 418 (M+, 100), 373 (73), 327 (63), 306 (26), 226 (38), 133 (59), 57 (33); 
elemental analysis: calcd (%) for C25H22O6 (418.445): C 71.75, H 5.29; found: C 71.64, H 
5.04. 
 
3-Isopropyl-1,2-dimethyl-4,5-diphenylbenzene-1,2,3-tricarboxylate (34c) 
Starting with 33c (500 mg, 1.48 mmol), DMAD (1.23 mL, 
11.84 mmol) and PTSA (5 mol-%), 34c was isolated by 
chromatography (heptane/ ethyl acetate) as a yellow solid (293 
mg, 46%). Reflux time: 12 h; mp. 160-161 °C. 1H NMR (250 
MHz, CDCl3): δ = 0.91 (d, 6 H, 3J =  5.8 Hz), 3.92 (s, 3 H, OCH3), 3.93 (s, 3 H, OCH3), 4.83 
(sept, 1 H, 3J = 7.6 Hz), 6.99-7.20 (m, 10 H, Ph), 8.02 (s, 1 H, ArH); 13C NMR (62 MHz, 
CDCl3): δ = 21.1 (2C, CH3), 52.7, 52.8, (OCH3), 69.5 (CH), 127.2 (2CHPh), 127.5(CHPh), 
127.7 (C), 127.8 (2CHPh), 128.3 (CHPh), 129.4 (2CHPh), 129.7 (2CHPh), 129.9 (C), 132.5 
(CHPh), 134.5, 137.6, 139.1, 142.1, 143.8, 165.7, 167.0, 168.0 (C); IR (KBr): ν~ = 1740 (s), 
1723 (s), 1550 (m), 1499 (m), 1429 (s),1326 (s), 1241 (s), 1109 (s), 1000 (s), 910 (m), 700 (s), 
552 (m); GC-MS (EI, 70 eV): m/z (%): 432.2 (M+, 100), 373.1 (54), 359.1 (28), 327.1 (55), 
256.1 (35), 226.1 (62); elemental analysis: calcd (%) for C26H24O6 (432.47): C 72.20, H 5.59; 
found: C 72.21, H 5.56. 
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3-Ethyl-6-ethyl-1,2-dimethyl-4,5-diphenylbenzene-1,2,3-tricarboxylate (34d)  
Starting with 33d (400 mg, 1.14 mmol), DMAD (0.95 mL, 
9.13 mmol) and PTSA (5%), 34d was isolated by chromatography 
(heptane/ ethyl acetate) as a yellow solid (165 mg, 33%). Reflux 
time: 11 h. A small amount of impurity could not be separated. 1H 
NMR (250 MHz, CDCl3): δ = 0.92 (t, 3 H, 3J = 7.6 Hz, CH3), 1.17 
(t, 3 H, 3J = 7.3 Hz, CH3), 2.53 (q, 2 H, 3J = 6.4 Hz, CH2), 3.86 (s, 3 H, OCH3), 3.92 (s, 3 H, 
OCH3), 4.24 (q, 2 H, 3J = 6.5 Hz, OCH2), 6.95-7.18 (m, 10 H, Ph); 13C NMR (62 MHz, 
CDCl3): δ = 12.2, 13.9 (CH3), 19.1 (CH2),  52.6, 52.9 (OCH3), 61.5 (OCH2), 125.5 
(2CHPh),126.9 (CHPh), 127.5 (C), 128.0 (2CHPh), 128.8 (2CHPh), 129.6 (2CHPh), 129.7 (C), 
130.4 (CHPh), 131.0, 133.3, 133.7, 137.6, 139.4, 141.8, 163.8, 166.5, 171.8 (C); IR (KBr): ν~ = 
2950 (m), 1797 (s), 1646 (m), 1541 (s), 1331 (s), 1282 (w), 1232 (s), 1171 (m), 1062 (s), 966 
(m), 778 (m), 698 (s); GC-MS (EI, 70 eV): m/z (%): 446.2 (M+, 7), 400.1 (46), 353.1 (100), 
239.1 (28). 
 
1,2,3-trimethyl-4,5-di(p-methylphenyl)-benzene-1,2,3-tricarboxylate (34e) 
Starting with 33e (400 mg, 1.18 mmol), DMAD (1.16 mL, 
9.51 mmol, 8 equiv.) and PTSA (12 mg, 5 mol-%), 34e was 
isolated by chromatography (heptane/ ethyl acetate) as a yellow 
solid (340 mg, 86%); mp. 167-169 oC. 1H NMR (400 MHz, 
CDCl3): δ = 2.27 (s, 3 H, CH3), 2.28 (s, 3 H, CH3), 3.49 (s, 3 H, 
OCH3), 3.90 (s, 3 H, OCH3), 3.91 (s, 3 H, OCH3), 6.90 (d, 2 H, 3J = 8.2 Hz, ArH), 6.91 (d, 2 
H, 3J = 8.2 Hz, ArH), 6.98 (d, 2 H, 3J = 7.8 Hz, ArH), 6.99 (d, 2 H, 3J = 7.8 Hz, ArH), 7.24 (s, 
1 H, Ar); 13C NMR (100 MHz, CDCl3): δ = 21.0, 21.2 (CH3), 52.3, 52.7, 52.9 (OCH3), 128.3 
(C), 128.5 (2CHAr), 128.6 (2CHAr), 129.4 (4CHAr), 131.6 (C), 132.7 (CHAr), 134.3, 134.4, 
136.1, 137.0, 137.2, 142.5, 143.6, 165.9, 167.9, 167.0; IR (KBr): ν~ = 1738 (s), 1515 (m), 
1433 (s), 1297 (s), 1265 (s), 1222 (s), 1159 (m), 1065 (m), 1000 (s), 779 (m) cm-1; MS (EI, 70 
eV): m/z (%): 432 (M+, 100), 401 (82), 385 (21); elemental analysis: calcd (%) for C26H24O6 
(432.46): C 72.21, H 5.59; found: C 72.25, H 6.00. 
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3-Isopropyl-1,2-dimethyl-4,5-di(p-methylphenyl)-benzene-1,2,3-tricarboxylate (34f)  
Starting with 33f (500 mg, 1.37 mmol), DMAD (1.34 
mL, 10.97 mmol, 8 equiv.) and  PTSA (5 mol-%), 34f was 
isolated by chromatography (heptane/ ethyl acetate) as a yellow 
solid (250 mg, 40%);  mp. 155-157 oC.  1H NMR (400 MHz, 
CDCl3): δ = 0.93 (d, 6 H, 3J = 6.2 Hz, CH3), 2.27 (s, 6 H, CH3), 
3.90 (s, 3 H, OCH3), 3.91 (s, 3H, OCH3), 4.80-4.87 (m, 1 H,  OCH), 6.46 (d, 2 H, 3J = 8.2 Hz, 
ArH), 6.94 (d, 2 H, 3J = 8.2 Hz, ArH), 6.98 (d, 2 H, 3J = 7.8 Hz, ArH), 7.99 (d, 2 H, 3J = 7.8 
Hz, ArH), 7.98 (s,1 H, Ar); 13C NMR (100 MHz, CDCl3): δ = 20.08 (2C, CH3), 20.09 (CH3), 
20.16 (CH3), 51.7 (OCH3), 51.8 (OCH3), 68.3 (CH), 127.1, 127.5, 127.6 (C), 128.4 (2CHAr), 
128.6 (2CHAr), 130.6 (2CHAr), 131.5 (2CHAr), 133.5 (CHAr), 133.7, 135.2, 135.9, 136.2, 
141.3, 142.5, 164.9, 166.0, 166.9 (C); IR (KBr): ν~ = 2980 (m), 1725 (s), 1687 (s), 1598 (s), 
1513 (S), 1457 (m), 1327 (m), 1251 (s), 835 (m) cm-1; MS (EI, 70 eV): m/z (%): 460.2 (M+, 
100), 401.1 (24), 355.1 (35), 239.1 (20), 131 (26), 69 (75); elemental analysis: calcd (%) for 
C28H28O6 (460.526): C 73.62, H 6.12; found: C 73.73, H 6.34. 
 
1,2,3-trimethyl-4,5-di(p-methoxyphenyl)-benzene-1,2,3-tricarboxylate (34g) 
Starting with 33g (500 mg, 1.35 mmol), DMAD (1.13 
mL, 10.85 mmol, 8 equiv.) and  PTSA (5 mol-%), 34g was 
isolated by chromatography (heptane/ ethyl acetate) as a 
yellow solid (250 mg, 40%); mp. = 143-144 oC; 1H NMR 
(250 MHz, CDCl3): δ =  3.52 (s, 3 H, OCH3), 3.76 (s, 3 H, 
OCH3), 3.77 (s, 3 H, OCH3), 3.92 (s, 6 H, OCH3), 6.72 (d, 2 H, 3J = 9.1 Hz, ArH), 6.74 (d, 2 
H, 3J = 8.8 Hz, ArH), 6.95 (d, 2 H, 3J = 8.5 Hz, ArH), 6.96 (d, 2H, 3J = 8.5 Hz, ArH), 7.98 (s, 
1 H, ArH); 13C NMR (75 MHz, CDCl3): δ = 52.4, 52.7, 52.9, 55.0, 55.1 (OCH3), 113.3 
(2CHAr), 113.4 (2CHAr), 128.3, 129.6 (C ), 130.7 (2CHAr), 131.4 (2C), 132.6 (CHAr), 134.4, 
142.0, 143.3, 158.8, 158.9, 165.9, 167.8, 168.0 (C); IR (KBr): ν~ = 1745 (s), 1608 (s), 1575 
(m), 1516 (s), 1458 (m), 1435 (s), 1339 (s), 1248 (s), 1067 (m), 843 (m) cm−1; GC-MS (EI, 70 
eV): m/z (%): 464.2, (M+, 100), 433.1 (16), 401.1 (11) ); elemental analysis: calcd (%) for 
C26H24O8 (464.47): C 67.23, H 5.21; found: C 66.89, H 5.20. 
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3-Isopropyl-1,2-dimethyl-4,5-di(p-methoxyphenyl)-benzene-1,2,3-tricarboxylate (34h)  
Starting with 33h (500 mg, 1.26 mmol), DMAD 
(1.23 mL, 10.08 mmol, 8 equiv.) and  PTSA (5%), 34h was 
isolated by chromatography (heptane/ ethyl acetate) as a 
yellow solid (290 mg, 46%); mp. 130-132 oC;  1H NMR 
(400 MHz, CDCl3): δ = 0.95 (d, 6 H, 3J = 6.2 Hz, CH3), 
3.74 (s, 6 H, OCH3), 3.88 (s, 3 H, OCH3), 3.89 (s, 3 H, OCH3), 4.89 (sept, 1 H, 3J = 6.2 Hz, 
OCH),  6.70 (d, 2 H, 3J = 6.4 Hz, ArH), 6.72 (d, 2 H, 3J = 6.3 Hz, ArH), 6.92 (d, 2 H, 3J = 8.8 
Hz, ArH), 6.95 (d, 2H, 3J = 8.8 Hz, ArH), 7.24 (s, 1 H, ArH); 13C NMR (100 MHz, CDCl3): δ 
= 20.2 (2CH3), 51.7, 51.8, 54.1,, 54.2 (OCH3), 68.3 (CH),112.3 (2CHAr), 112.4 (2CHAr), 
127.1, 128.9, 129.9, 130.4 (C), 130.5 (2CHAr), 131.3 (2CHAr), 133.9 (CHAr), 140.8, 142.3, 
157.7, 158.0, 164.9, 166.0, 166.9 (C); IR (KBr): ν~ = 1741 (s), 1727 (s), 1608 (s), 1516 (s), 
1461 (m), 1351 (m), 1251 (m), 1160 (s), 1065 (s), 833 (m) cm-1; MS (EI, 70 eV): m/z (%): 
492 (M+, 100), 450 (20), 418 (25), 387 (19); HRMS (EI): calcd. for C28H28O8 [M]+: 
492.177507; found: 492.17787. 
 
3-Ethyl-1,2-dimethyl-4,5-di(p-bromophenyl)-benzene-1,2,3-tricarboxylate (34i) 
Starting with 33i (400 mg, 0.83 mmol), DMAD (0.81 
mL, 6.66 mmol, 8 equiv.)  and  PTSA (5 mol-%), 34i was 
isolated by chromatography (heptane/ ethyl acetate) as a yellow 
solid (325 mg, 68%); mp. 171-173 oC. 1H NMR (400 MHz, 
CDCl3): δ = 0.96 (t, 3 H, 3J = 7.1 Hz, CH3), 3.92 (s, 6 H, 
OCH3), 3.99 (q, 2 H, 3J = 7.1 Hz, OCH2CH3), 6.88 (d, 2 H, 3J = 8.4 Hz, ArH), 6.92 (d, 2 H, 3J 
= 8.4 Hz ,  ArH), 7.35 (d, 2 H, 3J = 8.4 Hz, ArH), 7.36 (d, 2 H, 3J = 8.4 Hz, ArH), 7.98 (s, 1 
H, ArH); 13C NMR (100 MHz, CDCl3): δ = 13.4 (CH3), 52.8, 52.9 (OCH3), 61.4 (OCH2), 
122.0, 122.2, 128.9 (C)  131.0 (2CHAr), 131.1 (2CHAr), 131.2 (2CHAr), 131.3 (2CHAr ), 132.5 
(CHAr), 132.6, 136.0, 137.5, 141.0, 142.2, 165.4, 166.8, 167.5 (C); IR (KBr): ν~ = 2950 (m), 
1742 (s), 1493 (m), 1249 (s), 1202 (s), 1073 (m), 835 (m), 701 (m), cm−1; MS (EI, 70 eV): m/z 
(%): 578.9 (M+, 81Br, 12), 575.9 (M+, 79Br, 100), 530.9 (37), 484.9 (33), 229 (31), 121.1 (36) 
91 (29); elemental analysis: calcd (%) for C25H20O6Br2 (576.237): C 52.11, H 3.52; found: C 
52.16, H 3.54. 
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Compound (37)  
Starting with 36 (200 mg, 0.57 mmol), DMAD (0.65 mL, 
4.58 mmol) and  PTSA (5 mol-%), 37 was isolated by 
chromatography (heptane/ ethyl acetate) as a yellow solid (165 mg, 
65%); mp. 143-144 °C. Reflux time: 10 h. 1H NMR (250 MHz, 
CDCl3): δ = 0.68 (t, 3 H, 3J = 7.3 Hz, CH3), 0.84 (t, 3 H, 3J = 7.3 Hz, CH3), 2.51-2.65 (1 H), 
2.90-3.06 (2 H), 3.40-3.49 (1 H). 3.88 (s, 3 H, OCH3), 3.91 (s, 3 H, OCH3), 7.01-7.60 (m, 10 
H, Ph), 8.02 (s, 1 H, ArH); 13C NMR (62 MHz, CDCl3): δ = 11.5, 12.5 (CH3), 37.6, 42.5 
(CH2), 52.73, 52.75 (OCH3), 127.2, 127.3 (C), 127.6 (2CHPh), 127.9 (CHPh), 128.5 (2CHPh), 
129.6 (2CHPh), 130.1 (2CHPh), 131.7 (CHPh), 131.8 (CHAr), 136.6, 137.2, 139.4, 140.7, 143.2, 
166.0, 167.0, 168.1 (C); IR (KBr): ν~ = 2951 (w), 1731 (s), 1628 (s), 1437 (m), 1267 (s), 1163 
(m), 1092 (m), 761 (s), 702 (s); cm-1; MS (EI, 70 eV): m/z (%): 445.1 (M+, 2), 386.1 (91), 
373.0 (100), 342.0 (17), 226.0 (33), 72.0 (54); HRMS (EI): calcd. for C27H27O5N1 [M]+: 
445.188455; found: 445.18837. 
 
General procedure for the synthesis of 1,2,3-triazoles: 
Mixture of acetyle (1.0 eq) and 2-azido-1,1-dimethoxyethane (1.2 eq) were suspended in a 1:1 
mixture of water and t-butanol (5 mL each). To this mixture was added copper turning (50 
mg) and an aqueous copper sulphate solution (1 M, 5 mol-%) and the mixture was heated at 
110 °C for two hours. After cooling, the reaction mixture was diluted with water (20 mL), and 
precipitated product was filtered off and washed with cold water (20 mL) and subsequently 
with petroleum ether to give the 40a and 40c as a colourless solid. In case of oil products, the 
mixture was extracted with EtoAc. The organic layers were combined and dried by NaSO4 
and solvent was removed on vacu.  
 
Dimethyl 1-(2,2-dimethoxyethyl)-1H-1,2,3-triazole-4,5-dicarboxylate (40a) 
Starting with DMAD 39a (600mg, 4.22 mmol ) and  2-
azido-1,1-dimethoxyethane 38 (664 mg, 5.06 mmol), 40a was 
obtained as colourless solid ( 875 mg, 85 %). 1H NMR (300 
MHz, CDCl3): δ = 3.35 (s, 6 H , OCH3), 3.96 (s, 3 H, OCH3), 
3.99 (s, 3 H, OCH3), 4.61 (t, 1 H, J = 5.63 Hz, CH), 4.73 (d, 2 H, J = 5.3 Hz, CH2); 13C NMR 
(100 MHz, CDCl3): δ = 51.2 (CH2), 52.6, 53.3, 55.1 (OCH3), 102.3 (CH), 131.7, 139.3, 159.1, 
160.3 (C); IR (KBr, cm-1): ~ν  = 2992 (w), 1728 (s), 1570 (w), 1471 (m), 1331 (m), 1277 (s), 
1156 (s), 1102 (m), 1063 (s), 1045 (s), 962 (m), 780 (w), 704 (w) . GC-MS (EI 70 eV): m/z 
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(%) = 242 (M+, 3 %), 213 (2), 150 (3), 75 (100); elemental alalysis: Calcd (%) for 
C10H15N3O6 (273.23): C 43.93, H 5.53, N 15.38; Found: C 44.31, H 5.50, N 15.25. 
 
Ethyl 1-(2,2-dimethoxyethyl)-1H-1,2,3-triazole-4-carboxylate (40b) 
  Starting with Ethyl propiolate  (500 mg, 5.09 mmol) and  
2-azido-1,1-dimethoxyethane 38 (739 mg, 5.60 mmol), 40b was 
obtained as slight yallow oil ( 985 mg, 84 %). 1H NMR (300 
MHz, CDCl3): δ = 140 (t, 3 H, J = 5.40, CH3), 3.41 (s, 6 H, 
OCH3), 4.41 (q, 2 H, J =  6.75 Hz, CH2), 4.52 ( d, 2 H, J = 4.83 Hz, CH2),  4.67 (t, 1H, J = 
5.53 Hz, CH), 8.19 (s, 1 H, CH); 13C NMR (100 MHz, CDCl3): δ = 14.3 (CH3), 51.8 (CH2), 
55.0 (OCH3), 61.0 (CH2), 102.0, 128.6 (CH), 140.0, 160.5 (C); IR (KBr, cm-1): ~ν  = 2963 (w), 
1721 (s), 1463 (w), 1375 (m), 1198 (s), 1124 (s), 1072 (s), 1037 (s), 839 (m), 776 (s), 697 (w); 
MS (CI, isobutane): 230 ([M+1]+); elemental analysis: Calcd. for C9H15N3O4 (229.23); C 
47.16, H 6.60, N 18.33; Found: C 47.6, H 6.62, N 18.17. 
 
1-(2,2-dimethoxyethyl)-4-phenyl-1H-1,2,3-triazole (40c) 
  Starting with Phenyl acetylene (500 mg, 4.89 mmol) and  2-
azido-1,1-dimethoxyethane 38 (705 mg, 5.38 mmol), 40c was 
obtained as colourless solid ( 851 mg, 75 %). 1H NMR (300 MHz, 
CDCl3): δ = 2.99 (s, 6 H, OCH3), 4.06 (d, J = 5.2 Hz, CH2), 4.24 (t, 
J = 5.2 Hz, CH), 6.81-7.01 (m, 3 H, Ph), 7.31-7.40 (m, 2 H, Ph), 7.41 (s, 1 H, CH); 13C NMR 
(100 MHz, CDCl3): δ = 51.9 (CH2), 55.1 (OCH3), 102.7 (CH), 120.8, 15.6, 128.0, 130.5 
(CHPh), 132.3, 147.8 (C). IR (KBr): ν~ = 3126 (s), 2996 (m), 2894 (s), 1466 (s), 1364 (m), 
1222 (s), 1124 (s), 1079 (s), 1018 (s), 924 (s), 772 (s), 836 (s), 768 (s), 693 (s), 542 (m) cm-1; 
MS (EI, 70 eV): m/z (%): 233 (M+, 16), 173 (13), 116 (19), 75 (100), 47 (18); elemental 
analysis: calcd. (%) for C12H15N3O2 (233.27): C 61.79, H 6.48, N 18.03; found: C 61.75, H 
6.44, N 17.78. 
 
2-(1-(2,2-dimethoxyethyl)-1H-1,2,3-triazole-4-yl)ethanol (40d) 
  Starting with But-3-yn-1-ol (500 mg, 7.13 mmol) and  2-
azido-1,1-dimethoxyethane 38 (995 mg, 7.84 mmol), 40d was 
obtained as slight yallow oil ( 1.17 g, 82 %).1H NMR (300 
MHz, CDCl3): δ = 2.94 (t, 2 H, J = 5.7 Hz, CH2), 3.40 (s, 6 H, 
OCH3), 3.60 (t, 2 H, J = 5.7Hz, CH2), 3.94 (s, 1 H, OH), 4.43 (d, 
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2 H, J = 5.22 Hz, CH2), 4.64 (t, 1 H, J = 5.16 Hz, CH), 7.52 (s, 1 H, CH); 13C NMR (100 
MHz, CDCl3): δ = 28.7, 51.7 (CH2), 54.9 (OCH3), 61.5 (CH2), 102.6, 122.8 (CH), 137.6 (C); 
IR (neat): ~ν  = 3373 (w), 2938 (w), 1458 (w), 1124 (s), 1049 (s), 979 (m), 819 (w) cm-1; MS 
(CI, isobutane): 202 ([M+1]+); elemental analysis calcd (%) for C8H15N3O3 (201.2): C 47.15, 
H 7.51, N 20.88; Found: C 46.96, H 7.32, N 19.25. 
 
2-(1-(2,2-dimethoxyethyl)-1H-1,2,3-triazole-4-yl)propan-2-ol (40e) 
Starting with 2-Methylbut-3-yn-2-ol (500 mg, 5.94 
mmol) and  2-azido-1,1-dimethoxyethane 38 (933 mg, 7.12 
mmol), 40e was obtained as slight yallow oil ( 1.08 g, 84 %). 1H 
NMR (300 MHz, CDCl3): δ = 1.59 (s, 6 H, CH3), 3.36 (s, 6 H, 
OCH3), 3.38(d, 2 H, J = 5.28 Hz, CH2), 4.59 (t, 1 H, J = 5.22 Hz, CH), 7.50 (s, 1 H, CH); 13C 
NMR (100 MHz, CDCl3): δ = 30.3 (CH3), 51.6 (CH2), 54.8 (OCH3), 102.5, 120.3 (CH), 155.5 
(C); IR (neat): ~ν  = 3392 (w), 2935 (w), 1375 (w), 1168 (m), 1125 (s), 105 (s), 958 (m), 856 
(m), 820 (w), 672 (w) cm-1; MS (CI, isobutane): 216 ([M+1]+); 2216; elemental analysis 
Calcd. (%) for C9H17N3O3 (215.25): C 50.22, H 7.96, N 19.52; Found: C 50.55, H 7.99, N 
17.90. 
 
1-(1-(2,2-dimethoxyethyl)-1H-1,2,3-triazole-4-yl)ethanol (40f) 
  Starting with But-3-yn-2-ol  (600 mg, 8.56 mmol) and  
2-azido-1,1-dimethoxyethane 38 (1.34 g, 10.27 mmol), 40f was 
obtained as slight yallow oil (1.46 g, 85 %). 1H NMR (300 
MHz, CDCl3): δ = 1.62 (d, 3 H, J = 6.51 Hz, CH3), 3.44 (s, 6 H, 
OCH3), 4.47 (d, 2 H, J = 5.22 Hz, CH2), 4.69 (t, 1 H, J = 5.4 
Hz, CH), 5.12 (s, 1 H, OH), 7.60 (s,  H, CH); 13C NMR (100 MHz, CDCl3): δ = 23.1 (CH3), 
51.7 (CH2), 54.9 (OCH3), 62.9, 102.5, 121.2 (CH), 142.2 (C); IR (neat): ~ν  = 3374 (w), 2973 
(w), 1224 (m), 1124 (s), 1053 (s), 979 (m), 892 (m), 820 (m), 778 (m) cm-1; GC-MS (EI 70 
eV): m/z (%) = 201 (M+, 2%) 170 (2), 158 (1), 141 (6), 98 (2), 75 (100), 47 (11); elemental 
analysis: calcd. (%) for C8H15N3O3 (201.22): C 47.75, H 7.51, N 20.88; found: C 47.51, H 
7.11, N 20.77. 
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2-(1-(2,2-dimethoxyethyl)-1H-1,2,3-triazole-4-yl)-N,N-dimethylmethanamine (40g) 
Starting with N,N-dimethylprop-2-yn-1-amine (500 mg, 
6.01 mmol) and  2-azido-1,1-dimethoxyethane 38 (870 mg, 
6.61 mmol), 40g was obtained as slight yallow oil ( 850 mg, 66 
%). 1H NMR (300 MHz, CDCl3): δ = 2.26 (s, 6 H, CH3), 3.39 (s, 6 H, OCH3), 3.60 (s, 2 H, 
CH2), 4.44 (d, 2 H, J = 5.19 Hz, CH2), 4.64 (t, 1 H, J = 5.4 Hz, CH), 7.58 (s, 1 H, CH); 13C 
NMR (100 MHz, CDCl3): δ = 44.9 (CH3), 51.6, 54.1 (CH2), 54.7 (OCH3), 102.6, 123.5 (CH), 
144.8 (C); IR (neat): ~ν  = 3392 (w), 2935 (w), 1375 (w), 1168 (m), 1125 (s), 105 (s), 958 (m), 
856 (m), 820 (w), 672 (w) cm-1; GC-MS (EI 70 eV): m/z (%) = 214 (M+, 6 %) 171 (100), 89 
(19), 75 (29), 58 (20); HRMS (EI): calcd. for C9H18N4O2 [M]+: 214.142232; found: 
214.14243. 
 
1-(2,2-dimethoxyethyl)-4-pentyl-1H-1,2,3-triazole (40h) 
  Starting with 1-heptyne (500 mg, 5.19 mmol) and  
2-azido-1,1-dimethoxyethane 38 (750 mg, 5.72 mmol), 
40h was obtained as slight yallow oil ( 740 mg, 63 %). 
1H NMR (300 MHz, CDCl3): δ = 0.91 (t, 3 H, J = 5.3 Hz, CH3), 1.21-1.36 (m, 4 H, (CH2)2), 
1.59 (m, 2 H, CH2), 2.71 (t, 2 H, J  = 7.8 Hz, CH2), 3.40 (s, 6 H, OCH3), 4.42 (d, 2 H, J = 5.2 
Hz, CH2), 4.63 (t, 1 H, J = 5.2 Hz, CH), 7.36 (s, 1 H, CH); 13C NMR (75 MHz, CDCl3): δ = 
14.0 (CH3), 22.4, 23.0, 25.6, 31.1, 51.6 (CH2), 55.1 (OCH3), 102.5, 121.9 (CH), 155.5 (C); IR 
(neat): ~ν  = 3392 (w), 2935 (w), 1375 (w), 1168 (m), 1125 (s), 105 (s), 958 (m), 856 (m), 820 
(w), 672 (w) cm-1; GC-MS (EI 70 eV): m/z (%) =  227 (M+, 2), 196 (3), 167 (100); elemental 
analysis calcd (%) for C11H21N3O2 (227.30): C 58.12, H 9.31, N 18.49; Found: C 57.55, H 
9.55, N 18.90. 
 
1-(2,2-dimethoxyethyl)-4-octyl-1H-1,2,3-triazole (40i) 
Starting with 1-Decyne (500 mg, 3.01 
mmol) and  2-azido-1,1-dimethoxyethane 38 
(472 mg, 3.61 mmol), 40i was obtained as 
slight yallow oil (650 mg, 80 %). 1H NMR 
(300 MHz, CDCl3): δ = 0.87 (t, 3 H, J = 6.9 
Hz, CH3), 1.26-1.32 (m, 10 H, (CH2)5), 1.59-1.62 (m, 2 H, CH2), 2.70 (t, 2 H, J = 7.3 Hz, 
CH2), 3.39 (s, 6 H, OCH3), 4.42 (d, 2 H, J = 5.2 Hz, CH2), 4.64 (t, 1 H, J = 5.1 Hz, CH), 7.41 
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(s, 1 H, CH); 13C NMR (100 MHz, CDCl3): δ = 14.0 (CH3), 22.6, 25.6, 29.0, 29.1, 29.3, 31.4, 
31.7, 51.7 (CH2), 55.4 (OCH3), 102.7, 122.7 (CH), 149.5 (C). 
 
5-(4-phenyl-1H-1,2,3-triazole-1-yel)-1,2,3-thiadiazole (42)  
Starting with 41 (500 mg, 1.40 mmol) and thionyl chloride (10 
mL), 42 was obtain as white solid (190 mg, 60%); 1H NMR (300 
MHz, DMSO): δ = 7.36-5.51 (m, 3 H, Ph), 7.85-7.88 (m, 2 H, Ph), 
9.44 (s, 1 H, CH), 9.44 (s, 1 H, CH); 13C NMR (100 MHz, DMSO): δ = 121.3 (CH), 125.5 
(CHPh), 128.9 (C), 129.0 (CHPh), 129.1 (C), 129.2,  (CHPh), 138.7 (CH), 147.9 (C); IR (KBr): 
ν~ =  2996 (m), 2894 (s), 1466 (s), 1364 (m), 1222 (s), 1124 (s), 1079 (s), 1018 (s), 924 (s), 
772 (s), 836 (s), 768 (s), 693 (s), 542 (m) cm-1; elemental analysis: calcd (%) for C10H7N5S 
(229.26): C 52.39, H 3.08, N 30.50; found: C 52.67, H 3.44, N 30.11. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
N N
N
N
NS
 98
References 
 
1.  Soejarto, D. D.; Farnswoth, N. R. Perspect. Biol. Med. 1989, 32, 244. 
2. Krohn, K.; Michel, A.; Bahramsari, R.; Floerke, U.; Aust, H. J.; Dreger, S.; Schulz, B.; 
Wray, V., Nat. Prod. Lett. 1996, 8, 43. 
3.  Berdy, J.  (Ed.), Handbook of Antibiotics, Little, Brown, Boston 1988. 
4.  Trigg, P. I. In Economic and Medicinal Plant Research, Vol.3, Wagner, H.;  Hikino, 
H.; Farnswoth, N. R. (Eds), Academic Press, London 1989, 19-55; Wu, Y. –L.; Li., Y.; 
Med. Chem. Res. 5, 1995, 569; Lee, I. -S.; Hufford, C. D. Pharmacol. Ther. 1990, 48, 
345. 
5.   Loo, T. L.; Freireich, E. J.; “Cancer chemo therapeutic drugs” in Principles of 
Pharmacology: Basic Concepts and Clinical Applications, Munson, P. L.; Mueller, R. 
A.; Breese G. R.; (Eds), 1995, 1475, Chapman and Hall, New York. 
6.  Topliss, J. G.; Clark, A. M.; Ernst, E.; Hufford, C. D.; Johnston, G. A. R.; Rimoldi, J. 
M; Weimann, B. J. Pure App. Chem. 2002, Vol. 74, 1957. 
7.   For a review of 1,3-bis-silyl enol ethers, see: Langer, P. Synthesis 2002, 441; Langer, 
P. Chem. Eur. J. 2001, 7, No.18, 3859. 
8.   a) Chan, T. H.; Brownbridge, P. J. Am. Chem. Soc. 1980, 102, 3534; b) Simoneau, B.; 
Brassard, P. Tetrahedron 1986, 14, 3767; c) Molander, G. A.; Cameron, K. O. J. Am. 
Chem. Soc. 1993, 115, 830; d) Brownbridge, P.; Chan, T.-H.; Brook, M. A.; Kang, G. 
J. Can. J. Chem. Vol. 61, 1983; e) Chan, T. H.; Chaly, T. Tetrahedron Lett. 1982, 23, 
2935; f) Chan T. H.; Prasad V. C. J. Org. Chem. 1986, 51, 3012. 
9.   Mukaiyama, T. Angew. Chem. 1977, 89, 858; Angew. Chem. Int. Ed. Engl. 1977, 16, 
817. 
10.  a) Reetz, M. T. Angew. Chem. Int. Ed. Engl. 1982, 21, 96; b) Murata S.; Suzuki M.; 
Noyori R., J. Am. Chem. Soc. 1980, 102, 3248. 
11.   Review: a) Jorgensen K. A. Angew. Chem. 2000, 112, 3702; Angew. Chem. Int. Ed. 
Engl., 2000, 39, 3558; b) Danishefsky S. J., Bilodeau M. T. Angew. Chem., 1996, 108, 
1482; Angew. Chem., Int. Ed. Engl, 1996, 35, 1380. 
12.   Review: a) Rasmussen, J. K. Synthesis 1977, 91; b) Mukaiyama, T.; Murakami, M. 
Synthesis 1987, 1043; c) Poirier, J. M. Org. Prep. & Proc. Int'l., 1988, 20, 317; d) 
Daves, G. D. Jr. Adv. in Metal-Organic Chemistr, Vol 2, 1991, Jai Press: Greenwich 
CT; e) Cahard, D.; Duhamel, P. Europ. J. Org. Chem. 2001, 1023-31. 
13.   Chan T.H., Paterson I., Pinsonault J. Tetrahedron Lett., 1993, 4183. 
 99
14.   Review: a) Pawlenko, S. in Houben-Weyl, Methodender Organischen Chemie, 4th 
Edn, In: Muller, E.; Bayer, O. Editors. Vol. XIII/5, Georg Thieme Verlag, Stuttgart, 
1980, 193; b) Kantlehner, W.; Kugel, W.; Bredereck, H. Chem. Ber. 1972, 105, 2264; 
c) Dedier, J.; Gerval, P.; Frainnet, E. J. J. Organomet. Chem. 1980, 185, 183; d) Emde, 
H.; Domsch, D.; Feger, H.; Frick, U.; Goetz, A.; Hergott, H. H.; Hofmann, K.; Kober, 
W.; Kraegeloh, K.; Oesterle, T.; Steppan, W.; West, W.; Schimchen, G. Synthesis 
1982, 1-26; e) Chu, D. T.; W. Huckin, S. N. Can. J. Chem. 1980, 58, 138-142. (f) 
Torkelson, S.; Ainsworth, C. Synthesis 1976, 722-724; g) Aizpurua, J. M.; Palomo, C. 
Synthesis 1982, 280; h) Yamamoto, Y.; Matui, C. Organometallics 1997, 16, 2204; i) 
Jin- Cong Zhou Molecules, 1999, 4, 310-315. 
15.  Römpp Lexikon Naturstoffe (W. Steglich, B. Fugmann, S. Lang-Fugmann, eds.), 
Thieme, Stuttgart: 1997. 
16.  a) Prelog, V.; Würsch, J.; Königsbacher, K. Helv. Chim. Acta 1951, 34, 258; b) 
Beringer, M.; Kuntz, I. J. Am. Chem. Soc. 1951, 73, 364; c) Bertz, S. H.; Dabbagh, G. 
Angew. Chem. 1982, 94, 317; Angew. Chem., Int. Ed. Engl. 1982, 21, 306; for 
intramolecular reactions of unsymmetrical derivatives, see: d) Yamaguchi, M.; 
Hasebe, K.; Minabi, T. Tetrahedron Lett. 1986, 27, 2401; e) Gilbreath, S. G.; Harris, 
C. M.; Harris, T. M. J. Am. Chem. Soc. 1988, 110, 6172 and following publications. 
17.  a) Ried, W.; König, E. Liebigs Ann. Chem. 1972, 757, 153; b) Covarrubias-Zuniga, A. 
Synth. Commun. 1998, 28, 1525; c) Covarrubias-Zuniga, A.; Rios-Barrios, E. J. Org. 
Chem. 1997, 62, 5688. 
18.  Barton, D. H. R.; Dressaire, G.; Willis, B. J.; Barrett, A. G. M.; Pfeffer, M. J. Chem. 
Soc., Perkin Trans. 1 1982, 665. 
19.  See for example: a) Danishefsky, S. J.; Singh, R. K.; Gammill, R. B., J. Org. Chem. 
1978, 43, 379; b) Fink, M.; Gaier, H.; Gerlach, H., Helv. Chim. Acta 1982, 65, 2563; 
b)  
20.  Reviews: a) Danishefsky, S. J.; Bilodeau, M. T., Angew. Chem. 1996, 108, 1482; 
Angew. Chem., Int. Ed. Engl. 1996, 35, 1380; b) Bednarski, M. D.; Lyssikatos, J. P. 
Comprehensive Organic Synthesis: Selectivity, Strategy and Efficiency in Modern 
Organic Chemistry, Trost, B. M. Ed., 1991, 2, 661. 
21.  a) Chan, T.-H.; Brownbridge, P. J. Am. Chem. Soc. 1980, 102, 3534; b) Brownbridge, P.; 
Chan, T.-H.; Brook, M. A.; Kang, G. J. Can. J. Chem. 1983, 61, 688; c) Molander, G. 
A.; Cameron, K. O. J. Am. Chem. Soc. 1993, 115, 830. 
 100
22.  See for example: a) Roberge, G.; Brassard, P., J. Org. Chem. 1981, 46, 4161; b) 
Townsend, C. A.; Davis, S. G., J. Chem. Soc., Chem. Commun. 1983, 1420; c) Sestelo, 
J. P.; d) del Mar Real, M.; Mourino, A.; Sarandeses, L. A., Tetrahedron Lett. 1999, 
985; e) Roush, W. R.; Murphy, M., J. Org. Chem. 1992, 57, 6622; f) Langer, P.; 
Kracke, B., Tetrahedron Lett. 2000, 4545. 
23.  For a review of 1,3-bis(silyl enol ethers), see: a) Langer, P. Synthesis 2002, 441. For a 
review of [3+3] cyclizations of 1,3-bis(silyl enol ethers), see: b) Feist, H.; Langer, P. 
Synthesis 2007, 327. 
24.  a) Chan, T.-H.; Brownbridge, P. J. Am. Chem. Soc. 1980, 102, 3534; b) Brownbridge, 
P.; Chan, T.-H.; Brook, M. A.; Kang, G. J. Can. J. Chem. 1983, 61, 688. 
25.  a) Rashid, M. A.; Reinke, H.; Langer, P. Tetrahedron Lett. 2007, 48, 2321; b) Nguyen, 
V. T. H.; Appel, B.; Langer, P. Tetrahedron 2006, 62, 7674; c) Nguyen, V. T. H.; 
Bellur, E.; Langer, P. Tetrahedron Lett. 2006, 47, 113. 
26.  Mamat, C.; Büttner, S.; Trabhardt, T.; Fischer, C.; Langer, P., submitted. 
27.  Murata, S.; Suzuki, M.; Noyori, R. J. Am. Chem. Soc. 1980, 102, 3248. 
28.  Bellur, E.; Görls, H.; Langer, P. Eur. J. Org. Chem. 2005, 2074. 
29  Freifeld, I.; Shojaei, H.; Langer, P. J. Org. Chem. 2006, 71, 4965. 
30.  a) Lee, H. J.; Lee, J. H.; Hwang, B. Y.; Kim, H. S.; Lee, J. J. J. Antibiot. 2002, 55, 
552; b) Hargreaves, J.; Park, J.-o.; Ghisalberti, E. L.; Sivasithamparam, K.; Skelton, B. 
W.; White, A. H. J. Nat. Prod. 2002, 65, 7. 
31.  Hussein, S. A. M.; Ayoub, N. A.; Nawwar, M. A. M. Phytochemistry 2003, 63, 905. 
32.  Nawwar, M. A. M.; Hussein, S. A. M.; Buddrus, J.; Linscheid, M. Phytochemistry 
1994, 35, 1349. 
33.  Fiedler, P.; Gambaro, V.; Garbarino, J. A.; Quilhot, W. Phytochemistry 1986, 25, 461. 
34.  Lee, S.-H.; Tanaka, T.; Nonaka, G.-i.; Nishioka, I. Chem. Pharm. Bull. 1991, 39, 630. 
35.  Yoshida, T.; Ahmed, A. F.; Okuda, T. Chem. Pharm. Bull. 1993, 41, 672. 
36.  Elix, J. A.; Jones, A. J.; Lajide, L.; Coppins, B. J.; James, P. W. Aust. J. Chem. 1984, 
37, 2349. 
37.  For a review, see: a) Moroz, A. A.; Shvartsberg, M. S. Russ. Chem. Rev. 1974, 43, 
679; for a recent example, see: b) Sinisi, R.; Sani, M.; Candiani, G.; Parente, R.; 
Pecker, F.; Bellosta, S.; Zanda, M. Tetrahedron Lett. 2005, 46, 6515, and references 
cited therein. 
38.  Review: Muci, A. R.; Buchwald, S. R. Topics Curr. Chem. 2002, 219, 131. 
 101
39.  a) Harkal, S.; Kumar, K.; Michalik, D.; Zapf, A.; Jackstell, R.; Rataboul, F.; 
Riermeier, T.; Monsees, A.; Beller, M. Tetrahedron Lett. 2005, 46, 3237, and 
references cited therein; b) Harkal, S.; Rataboul, F.; Zapf, A.; Fuhrmann, C.; 
Riermeier, T. H.; Monsees, A.; Beller, M. Adv. Synth. Catal. 2004, 346, 1742. 
40.  Ahmed, Z.; Langer, P. Synlett 2006, 3361. 
41.  Beer, R. J. S.; Davenport, H. F.; Robertson, A. J. Chem. Soc. 1953, 1262. 
42.  (a) Staunton, J.; Weissman, K. J. Nat. Prod. Rep. 2001, 18, 380. (b) Koskinen, A. M. 
P.; Karisalmi, K. Chem. Soc. Rev. 2005, 34, 677. (c) Fugmann, B. (Hrsg.) Römpp-
Lexikon Naturstoffe, Georg Thieme Verlag, Stuttgart, New York, 1997. 
43.  For a review, see: (a) Harris, T. M.; Harris, C. M. Tetrahedron 1977, 33, 2159. See 
also: (b) Murray, T. P.; Harris, T. M. J. Am. Chem. Soc. 1972, 94, 8253. (c) Harris, C. 
M.; Roberson, J. S.; Harris, T. M. J. Am. Chem. Soc. 1976, 98, 5380. (d) Harris, T. M.; 
Hay, J. V. J. Am. Chem. Soc. 1977, 99, 1631. (e) Hubbard, J. S.; Harris, T. M. 
Tetrahedron Lett. 1978, 47, 4601. (f) Sandifer, R. M.; Bhattacharya, A. K.; Harris, T. 
M. J. Org. Chem. 1981, 46, 2260.  
44.  Chan, T.-H.; Brownbridge, P. J. Chem. Soc., Chem. Commun. 1979, 578.  
45.  (a) Chan, T.-H.; Stössel, D. J. Org. Chem. 1988, 53, 4901. (b) Chan, T.-H.; Stössel, D. 
J. Org. Chem. 1986, 51, 2423. 
46.  Langer, P.; Krummel, T. Chem. Eur. J. 2001, 7, 1720. 
47.  Rahn, T.; Nguyen, V. T. H.; Dang, T. H. T.; Ahmed, Z.; Lalk, M.; Fischer, C.; 
Spannenberg, A.; Langer, P. J. Org. Chem. 2007, 72, 1957. 
48.  For a review of cyclizations of silyl enol ethers with oxalyl chloride, see: Langer, P. 
Synlett 2006, 3369. 
49.  Albrecht, U.; Nguyen, V. T. H.; Langer, P. Synthesis 2006, 1111. 
50.  Reim, S.; Nguyen, V. T. H.; Albrecht, U.; Langer, P. Tetrahedron Lett. 2005, 46, 
8423. 
51.  Some years ago, an isolated example of the cyclization of a protected β-ketoester was 
reported: Chan, T. H.; Chaly, T. Tetrahedron Lett. 1982, 23, 2935.  
52.  (a) Zhang, H.; Matsuda, H.; Kumahara, A.; Ito, Y.; Nakamura, S.; Yoshikawa, M. 
Bioorg. Med. Chem. Lett. 2007, 17, 4972. (b) Shimoda, H.; Matsuda, H.; Yamahara, 
J.; Yoshikawa, M. Biol. Pharm. Bull. 1998, 21, 809. 
53.  Patnam, R.; Chang, F.-R.; Chen, C.-Y.; Kuo, R.-Y.; Lee, Y.-H.; Wu, Y.-C. J. Nat. 
Prod. 2001, 64, 948. 
 102
54.  Yasuda, T.; Kayaba, S.; Takahashi, K.; Nakazawa, T.; Ohsawa, K. J. Nat. Prod. 2004, 
67, 1604. 
55.  Nozawa, K.; Yamada, M.; Tsuda, Y.; Kawai, K.-I.; Nakajima, S. Chem. Pharm. Bull. 
1981, 29, 2689. 
56.  Wang, Q.; Matsuda, H.; Matsuhira, K.; Nakamura, S.; Yuan, D.; Yoshikawa, M. Biol. 
Pharm. Bull. 2007, 30, 388. 
57.  Shimoda, H.; Matsuda, H.; Yamahara, J.; Yoshikawa, M. Biol. Pharm. Bull. 1998, 21, 
809. 
58.  Matsuda, H.; Shimoda, H.; Yamahara, J.; Yoshikawa, M. Biol. Pharm. Bull. 1999, 22, 
870. 
59.  Kawamura, M.; Kagata, M.; Masaki, E.; Nishi, H. Pharmacol. Toxicol. (Copenhagen) 
2002, 90, 106. 
60.  Umehara, K.; Matsumoto, M.; Nakamura, M.; Miyase, T.; Kuroyanagi, M.; Noguchi, 
H. Chem. Pharm. Bull. 2000, 48, 566. 
61.  Matsuda, H.; Shimoda, H.; Yamahara, J.; Yoshikawa, M. Bioorg. Med. Chem. Lett. 
1998, 8, 215. 
62.  (a) Yoshikawa, M.; Matsuda, H.; Shimoda, H.; Shimada, H.; Harada, E. Chem. Pharm. 
Bull. 1996, 44, 1440. (b) Yoshikawa, M.; Harada, E.; Naitoh, Y.; Inoue, K.; Matsuda, 
H. Chem. Pharm. Bull. 1994, 42, 2225. (c) Yoshikawa, M.; Uchida, E.; Chatani, N.; 
Kobayashi, H.; Naitoh, Y. Chem. Pharm. Bull. 1992, 40, 3352. 
63.  (a) Tori, M.; Asakawa, Y. Phytochemistry 1987, 26, 3323. (b) Matsuda, H.; Shimoda, 
H.; Yoshikawa, M. Bioorg. Med. Chem. 1999, 7, 1445. 
64.  (a) Nguyen, V. T. H.; Langer, P. Tetrahedron Lett. 2005, 46, 1013. (b) Hussain, I.; 
Nguyen, V. T. H.; Yawer, M. A.;  Dang, T. T.; Fischer, C.; Reinke, H.; Langer, P. J. 
Org. Chem. 2007, 72, 6255. 
65.  For reviews of domino reactions, see: (a) Tietze, L. F.; Beifuss, U. Angew. Chem., Int. 
Ed. Engl. 1993, 32, 131; Angew. Chem. 1993, 105, 137. (b) Tietze, L. F. Chem. Rev. 
1996, 96, 115. 
66.  Weiler, L., J. Am. Chem. Soc. 1970, 92, 6702.   
67.   Modern Arene Chemistry, Astruc, D. (ed.), Wiley-VCH: Weinheim, 2002.  
68.   Pericyclic Reactions - A Textbook, Sankararaman, S., Wiley-VCH: Weinheim, 2005. 
69.   For a recent application of this reaction, see: Rivera, J. M.; Martin, T.; Rebek, J. J. Am. 
Chem. Soc. 2001, 123, 5213. 
 103
70.    a) Dilthey, W.; Hurtig, G., Chem. Ber. 1934, 67, 2004; b) Dilthey, W.; Schommer, W.; 
Troesken, O., Chem. Ber. 1933, 66, 1627. 
71  a) Allen, C. F. H.; VanAllan, J., J. Org. Chem. 1945, 10, 333; b) Herz, W.; Lewis, E. 
J. Org. Chem. 1958, 23, 1646; c) Borchardt, A.; Hardcastle, K.; Gantzel, P.; Siegel, J. 
S. Tetrahedron Lett. 1993, 34, 273; d) Becker, H.; King, S. B.; Taniguchi, M.; 
Vanhessche, K. P. M.; Sharpless, K. B., J. Org. Chem. 1995, 60, 3940; e) Ohta, K.; 
Yamaguchi, N.; Yamamoto, I., J. Mater. Chem. 1998, 8, 2637. 
72.    Holtz, E.; Köhler, V.; Appel, B.; Langer, P., Eur. J. Org. Chem 2005, 532. 
73.    a) Okano, K.; Mizuhara, Y.; Suemune, H.; Akita, H.; Sakai, K. Chem. Pharm. Bull. 
1988, 36, 1358; b) Okano, K.; Suemune, H.; Sakai, K. Chem. Pharm. Bull. 1988, 36, 
1385; c) Suemune, H.; Miyao, Y.; Sakai, K. Chem. Pharm. Bull. 1989, 37, 2523; d) 
Okano, K.; Suemune, H.; Sakai, K. Chem. Pharm. Bull. 1989, 37, 1995; e) Okano, K.; 
Suemune, H.; Sakai, K. Chem. Pharm. Bull. 1990, 38, 532. 
74.  Katritzky, A. R.; Yang, Z.; Cundy, D. J., Heteroatom Chem. 1994, 5, 103. 
75.  Bellur, E.; Görls, H.; Langer, P., J. Org. Chem. 2005, 70, 4751. 
76.  Bischofberger, N.; Waldmann, H.; Saito, T.; Simon, E. S.; Lees, W.; Bednarski, M. D.; 
Whitesides, G. M., J. Org. Chem. 1988, 53, 3457. 
77.  Bertschy, H.; Meunier, A.; Neier, R. Angew. Chem., Int. Ed. Engl. 1990, 29, 777. 
78.  Bellur, E.; Langer, P., Tetrahedron Lett. 2006, 47, 2151. 
79.  Saalfrank, R. W.; Weiss, B.; Wirth, U.; Peters, K.; von Schnering, H. G. Z. 
Naturforsch. B 1989, 44, 587.  
80.  (a) Bourne, Y.; Kolb, H. C.; Radic, Z.; Sharpless, K. B.; Taylor, P.; Marchot, P. Proc. 
Natl. Acad. Sci. U.S.A. 2004, 101, 1449. (b) Lewis, W. G.; Green, L. G.; Grynszpan, 
F.; Radic, Z.; Carlier, P. R.; Taylor, P.; Finn, M. G.; Sharpless, K. B. Angew. Chem. 
Int. Ed. 2002, 41, 1054. 
81.  Huisgen, R. in 1,3-Dipolar Cycloaddition Chemistry; Padwa, A., ed.; Wiley: New 
York, 1984; pp 1-176. 
82.  (a) Rostovtsev, V. V.; Green, L. G.; Fokin, V. V.; Sharpless, K. B. Angew. Chem. Int. 
Ed. 2002, 41, 2596. (b) Krasinski, A.; Fokin, V. V.; Sharpless, K. B. Org. Lett. 2004, 
6, 1237. 
83. Katritzky, A. R.; Tymoshenko, D. O.; Nikonov, G. N. J. Org. Chem. 2001, 66, 4045. 
 
 
 
 
 104
84. CCDC-xxx contains all crystallographic details of this publication and is available free 
of charge at www.ccdc.cam.ac.uk/conts/retrieving.html or can be ordered from the 
following address: Cambridge Crystallographic Data Centre, 12 Union Road, GB-
Cambridge CB21EZ; Fax: (+44)1223-336-033; or deposit@ccdc.cam.ac.uk.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 105
X-Ray Crystals Data 
 
Data for compound 15o Chapter 2:  
Identification code  15o 
Empirical formula  C18H17NO4 
Formula weight  311.33 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group (H.-M.)  P21/c   
Space group (Hall)  -P 2ybc 
Unit cell dimensions a = 16.1123(4) Å α= 90°. 
 b = 10.4002(2) Å β= 92.6710(10)°. 
 c = 9.5600(2) Å γ = 90°. 
Volume 1600.24(6) Å3 
Z 4 
Density (calculated) 1.292 Mg/m3 
Absorption coefficient 0.092 mm-1 
F(000) 656 
Crystal size 0.40 x 0.39 x 0.32 mm3 
Θ range for data collection 2.33 to 29.00°. 
Index ranges -21≤h≤21, -14≤k≤12, -13≤l≤11 
Reflections collected 17495 
Independent reflections 4237 [R(int) = 0.0209] 
Completeness to Θ = 29.00° 99.9 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9712 and 0.9642 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4237 / 0 / 230 
Goodness-of-fit on F2 1.048 
Final R indices [I>2σ(I)] R1 = 0.0636, wR2 = 0.1602 
R indices (all data) R1 = 0.0968, wR2 = 0.1979 
Largest diff. peak and hole 0.459 and -0.383 e.Å-3 
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Data for compound 21a Chapter 3:  
 
Identification code  21a 
Empirical formula  C10H12O4 
Formula weight  196.20 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group (H.-M.)  Pbcm  
Space group (Hall)  -P 2c 2b 
Unit cell dimensions a = 8.5016(3) Å α= 90°. 
 b = 16.2098(5) Å β= 90°. 
 c = 6.6887(2) Å γ = 90°. 
Volume 921.76(5) Å3 
Z 4 
Density (calculated) 1.414 Mg/m3 
Absorption coefficient 0.110 mm-1 
F(000) 416 
Crystal size 0.72 x 0.27 x 0.11 mm3 
Θ range for data collection 2.51 to 29.99°. 
Index ranges -11≤h≤11, -13≤k≤22, -9≤l≤9 
Reflections collected 5372 
Independent reflections 1448 [R(int) = 0.0212] 
Completeness to Θ = 29.99° 99.7 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9880 and 0.9253 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 1448 / 0 / 91 
Goodness-of-fit on F2 1.058 
Final R indices [I>2σ(I)] R1 = 0.0376, wR2 = 0.1031 
R indices (all data) R1 = 0.0441, wR2 = 0.1096 
Largest diff. peak and hole 0.478 and -0.217 e.Å-3 
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Data for compound 29a Chapter 4:  
 
Identification code  29a 
Empirical formula  C17H17ClO3 
Formula weight  304.76 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group (H.-M.)  P1    
Space group (Hall)  -P 1 
Unit cell dimensions a = 7.5794(2) Å α= 101.665(2)°. 
 b = 8.5472(3) Å β= 93.335(2)°. 
 c = 11.9123(4) Å γ = 92.402(2)°. 
Volume 753.35(4) Å3 
Z 2 
Density (calculated) 1.343 Mg/m3 
Absorption coefficient 0.261 mm-1 
F(000) 320 
Crystal size 0.64 x 0.25 x 0.06 mm3 
Θ range for data collection 2.44 to 29.83°. 
Index ranges -10≤h≤10, -11≤k≤11, -16≤l≤16 
Reflections collected 18761 
Independent reflections 4268 [R(int) = 0.0773] 
Completeness to Θ = 29.83° 98.5 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9845 and 0.8510 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4268 / 0 / 196 
Goodness-of-fit on F2 0.958 
Final R indices [I>2σ(I)] R1 = 0.0412, wR2 = 0.0976 
R indices (all data) R1 = 0.0639, wR2 = 0.1064 
Largest diff. peak and hole 0.300 and -0.282 e.Å-3
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Data for compound 33b Chapter 5:  
 
Identification code  33b 
Empirical formula  C20H18O4 
Formula weight  322.34 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group (H.-M.)  P21/c   
Space group (Hall)  -P 2ybc 
Unit cell dimensions a = 10.9545(4) Å α= 90°. 
 b = 9.7930(3) Å β= 90.357(2)°. 
 c = 15.5740(5) Å γ = 90°. 
Volume 1670.71(10) Å3 
Z 4 
Density (calculated) 1.282 Mg/m3 
Absorption coefficient 0.089 mm-1 
F(000) 680 
Crystal size 0.85 x 0.75 x 0.45 mm3 
Θ range for data collection 2.46 to 28.00°. 
Index ranges -13≤h≤14, -12≤k≤12, -18≤l≤19 
Reflections collected 18208 
Independent reflections 3954 [R(int) = 0.0754] 
Completeness to Θ = 28.00° 97.9 %  
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3954 / 0 / 246 
Goodness-of-fit on F2 1.049 
Final R indices [I>2σ(I)] R1 = 0.0501, wR2 = 0.1305 
R indices (all data) R1 = 0.0594, wR2 = 0.1461 
Largest diff. peak and hole 0.348 and -0.242 e.Å-3 
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Data for compound 33j Chapter 5:  
 
Empirical formula  C22 H22 O4 
Formula weight  350.40 
Temperature  293(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 6.5959(5) Å α= 109.329(3)°. 
 b = 10.9449(8) Å β= 92.053(4)°. 
 c = 14.947(1) Å γ = 107.283(4)°. 
Volume 961.4(1) Å3 
Z 2 
Density (calculated) 1.210 Mg/m3 
Absorption coefficient 0.083 mm-1 
F(000) 372 
Crystal size 0.6 x 0.12 x 0.12 mm3 
Theta range for data collection 2.08 to 33.31°. 
Index ranges -10<=h<=9, -16<=k<=16, -22<=l<=22 
Reflections collected 26480 
Independent reflections 7147 [R(int) = 0.0253] 
Completeness to theta = 33.31° 96.4 %  
Absorption correction Multiscan 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 7147 / 0 / 235 
Goodness-of-fit on F2 1.034 
Final R indices [I>2sigma(I)] R1 = 0.0533, wR2 = 0.1445 
R indices (all data) R1 = 0.0916, wR2 = 0.1667 
Largest diff. peak and hole 0.359 and -0.177 e.Å-3 
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Data for compound 34a Chapter 5:  
 
Empirical formula  C24 H20 O6 
Formula weight  404.40 
Temperature  293(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1)/n 
Unit cell dimensions a = 10.2895(2) Å α= 90°. 
 b = 20.2579(3) Å β= 107.703(1)°. 
 c = 10.3277(2) Å γ = 90°. 
Volume 2050.80(6) Å3 
Z 4 
Density (calculated) 1.310 Mg/m3 
Absorption coefficient 0.094 mm-1 
F(000) 848 
Crystal size 0.41 x 0.32 x 0.2 mm3 
Theta range for data collection 3.17 to 32.28°. 
Index ranges -15<=h<=13, -29<=k<=30, -15<=l<=15 
Reflections collected 29524 
Independent reflections 7174 [R(int) = 0.0228] 
Completeness to theta = 32.28° 98.2 %  
Absorption correction multiscan 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 7174 / 0 / 271 
Goodness-of-fit on F2 1.045 
Final R indices [I>2sigma(I)] R1 = 0.0484, wR2 = 0.1415 
R indices (all data) R1 = 0.0658, wR2 = 0.1568 
Largest diff. peak and hole 0.279 and -0.227 e.Å-3 
 
 
 
 
 
 
 
 
 
 
 111
Data for compound 34c Chapter 5:  
 
Identification code  34c 
Empirical formula  C28 H28 O6 
Formula weight  460.50 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group (H.-M.) 1P    
Space group (Hall) -P 1 
Unit cell dimensions a = 10.6294(3) Å α= 82.7240(10)°. 
 b = 10.9743(3) Å β= 63.9770(10)°. 
 c = 12.0168(3) Å γ = 74.9550(10)°. 
Volume 1216.34(6) Å3 
Z 2 
Density (calculated) 1.257 Mg/m3 
Absorption coefficient 0.088 mm-1 
F(000) 488 
Crystal size 0.83 x 0.56 x 0.36 mm3 
Θ range for data collection 2.55 to 27.50°. 
Index ranges -13≤h≤13, -14≤k≤14, -15≤l≤15 
Reflections collected 35793 
Independent reflections 5498 [R(int) = 0.0209] 
Completeness to Θ = 27.50° 98.5 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9691 and 0.9306 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5498 / 0 / 314 
Goodness-of-fit on F2 1.047 
Final R indices [I>2σ(I)] R1 = 0.0382, wR2 = 0.1033 
R indices (all data) R1 = 0.0408, wR2 = 0.1072 
Extinction coefficient 0.037(3) 
Largest diff. peak and hole 0.365 and -0.195 e.Å-3 
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Data for compound 35 Chapter 5:  
 
Identification code  35 
Empirical formula  C35H30O6 
Formula weight  546.59 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group (H.-M.)  Pbca  
Space group (Hall)  -P 2ac 2ab 
Unit cell dimensions a = 17.2693(9) Å α= 90°. 
 b = 16.3400(8) Å β= 90°. 
 c = 20.1333(10) Å γ = 90°. 
Volume 5681.2(5) Å3 
Z 8 
Density (calculated) 1.278 Mg/m3 
Absorption coefficient 0.087 mm-1 
F(000) 2304 
Crystal size 0.50 x 0.26 x 0.03 mm3 
Θ range for data collection 2.65 to 21.47°. 
Index ranges -17≤h≤17, -16≤k≤16, -19≤l≤20 
Reflections collected 36426 
Independent reflections 3247 [R(int) = 0.0967] 
Completeness to Θ = 21.47° 99.7 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9974 and 0.9579 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3247 / 0 / 372 
Goodness-of-fit on F2 1.024 
Final R indices [I>2σ(I)] R1 = 0.0398, wR2 = 0.0826 
R indices (all data) R1 = 0.0793, wR2 = 0.0967 
Largest diff. peak and hole 0.279 and -0.218 e.Å-3 
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Data for compound 40a Chapter 6:  
 
Identification code  40a 
Empirical formula  C10H15N3O6 
Formula weight  273.25 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group (H.-M.)  Pna21 
Space group (Hall)   P 2c -2n  
Unit cell dimensions a = 14.9011(6) Å α= 90°. 
 b = 7.3659(3) Å β= 90°. 
 c = 23.7379(10) Å γ = 90°. 
Volume 2605.47(19) Å3 
Z 8 
Density (calculated) 1.393 Mg/m3 
Absorption coefficient 0.116 mm-1 
F(000) 1152 
Crystal size 0.77 x 0.76 x 0.20 mm3 
Θ range for data collection 2.73 to 27.99°. 
Index ranges -19≤h≤19, -9≤k≤8, -31≤l≤30 
Reflections collected 24464 
Independent reflections 5905 [R(int) = 0.0248] 
Completeness to Θ = 27.99° 99.8 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9771 and 0.9159 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5905 / 1 / 351 
Goodness-of-fit on F2 1.045 
Final R indices [I>2σ(I)] R1 = 0.0330, wR2 = 0.0891 
R indices (all data) R1 = 0.0374, wR2 = 0.0939 
Absolute structure parameter -0.2(7) 
Largest diff. peak and hole 0.233 and -0.203 e.Å-3 
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